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that treats damaged or diseased tissues. Progress in the field has been made incrementally since changes to
these inputs require meticulous iterative steps. However, recent advances in combinatorial chemistry and high
through-put screening (HTS) technology have made available a wider range of potential scaffold materials
with diverse properties, as well as new methods to accelerate the process of testing soluble factors or
combinations of factors.
To this end, a library of poly(β-amino ester)s has been developed as the first combinatorial library of
photopolymerizable and biodegradable materials. Polymers formed from this library were characterized with
respect to changes in chemistry, macromer molecular weight, and macromer branching, which all affected the
degradation, mechanics, and cellular interactions of the materials. Using set design criteria with respect to
degradation and cellular interactions, the library was screened to identify an osteoconductive material for use
in bone tissue engineering. The identified macromer, A6, was processed into porous scaffolds using a
particulate leaching technique.
When implanted, A6 scaffolds had minimal inflammation and tissue readily invaded the porous structure, but
no bone formation was observed with A6 scaffolds alone. However, in intramuscular and critical-sized cranial
defect studies, the addition of BMP-2 led to the induction of bone formation throughout the scaffold, which
surpassed control groups. Yet, in a femur window defect model, the empty defect healed equally to the A6
scaffold with BMP-2, illustrating the importance of a critical-sized defect in assessing tissue engineering
approaches.
Using HTS techniques, a library of 1040 soluble factors was screened for promoters and inhibitors of
osteogenesis in mesenchymal stem cells. 36 potential promoters and 20 potential inhibitors were identified,
using statistical outcomes to identify hits that met criteria related to alkaline phosphatase activity and viability.
Three of the promoters were investigated further using traditional culture to confirm their osteogenic
behavior.
This work illustrates the importance of combinatorial libraries and HTS techniques in identifying new
materials and soluble factors towards tissue regeneration applications and can be expanded to target a number
of different tissues and diseases.
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ABSTRACT 
 
COMBINATORIAL POLYMER SYNTHESIS AND HIGH-THROUGHPUT 
SCREENING TECHNOLOGY TO IDENTIFY OPTIMAL APPROACHES FOR 
MINERALIZED TISSUE ENGINEERING 
 
Darren M. Brey 
 
 Advisor: Jason A. Burdick, Ph.D. 
 
The general tissue engineering approach is to combine cells, scaffolding, and 
signaling molecules in a manner that treats damaged or diseased tissues.  Progress in the 
field has been made incrementally since changes to these inputs require meticulous 
iterative steps.  However, recent advances in combinatorial chemistry and high through-
put screening (HTS) technology have made available a wider range of potential scaffold 
materials with diverse properties, as well as new methods to accelerate the process of 
testing soluble factors or combinations of factors.   
To this end, a library of poly(β-amino ester)s has been developed as the first 
combinatorial library of photopolymerizable and biodegradable materials.  Polymers 
formed from this library were characterized with respect to changes in chemistry, 
macromer molecular weight, and macromer branching, which all affected the 
degradation, mechanics, and cellular interactions of the materials.  Using set design 
criteria with respect to degradation and cellular interactions, the library was screened to 
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identify an osteoconductive material for use in bone tissue engineering.  The identified 
macromer, A6, was processed into porous scaffolds using a particulate leaching 
technique. 
When implanted, A6 scaffolds had minimal inflammation and tissue readily 
invaded the porous structure, but no bone formation was observed with A6 scaffolds 
alone.  However, in intramuscular and critical-sized cranial defect studies, the addition of 
BMP-2 led to the induction of bone formation throughout the scaffold, which surpassed 
control groups.  Yet, in a femur window defect model, the empty defect healed equally to 
the A6 scaffold with BMP-2, illustrating the importance of a critical-sized defect in 
assessing tissue engineering approaches. 
Using HTS techniques, a library of 1040 soluble factors was screened for 
promoters and inhibitors of osteogenesis in mesenchymal stem cells.  36 potential 
promoters and 20 potential inhibitors were identified, using statistical outcomes to 
identify hits that met criteria related to alkaline phosphatase activity and viability.  Three 
of the promoters were investigated further using traditional culture to confirm their 
osteogenic behavior.   
This work illustrates the importance of combinatorial libraries and HTS 
techniques in identifying new materials and soluble factors towards tissue regeneration 
applications and can be expanded to target a number of different tissues and diseases. 
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CHAPTER 1: Introduction 
 
Tissue engineering involves the combination of cells, signaling factors, and 3-
dimensional scaffolding to repair or replace damaged or diseased tissues [1].  This field 
has relied on the iterative development of the various components and advances have 
been slow and have not met previous expectations.  Recently, the development and use of 
high-throughput and combinatorial techniques in tissue engineering has significantly 
enhanced this process through its efficient and productive platforms. Combinatorial 
techniques often eliminate or reduce tedious synthesis and purification steps, and 
techniques for more rapid assessment of these materials have improved, which can lead 
to more rapid polymer development [2].  High throughput assessment of combinatorial 
libraries of molecules, which has been used by pharmaceutical companies has translated 
more recently as a method of screening classes of soluble factors in order to identify 
stimulatory molecules for tissue repair [3].  As this field progresses, existing and new 
high-throughput techniques will be crucial in efficiently and rapidly developing ideal 
synergies between microenvironments and signaling factors for engineered tissues.  
These techniques will be reviewed in more detail in Chapter 3. 
One area where these high throughput and combinatorial techniques may make an 
impact is in mineralized tissue repair.  Bones are a dense connective tissue that provides 
structure, support, and protection to the body and organs.  Despite their strong and 
seemingly rigid form, bones are highly vascularized and are constantly under a state of 
remodeling, where old bone is broken down only to be replaced with new bone [4].  
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These characteristics help explain why bones are also highly capable of healing following 
a normal fracture, through well studied stages.  After an inflammatory period which 
forms a hemotoma in the first week after fracture, a soft callus is formed where 
osteoprogenitor cells begin to multiply and start creating extracellular matrix to support 
new mineralization.  This callus hardens until around 4 months post fracture, in which the 
callus is then resorbed through bone remodeling processes. 
Unfortunately, not all bone healing follows this paradigm.  If a large section of 
bone is removed, such as during trauma or some cancers, a “non-union” occurs and the 
bone will never fully heal and the defect will only be filled with fibrous tissue growth [5, 
6].  The standard treatment for these cases is bone graft surgeries.  Annually there are 
around 500,000 bone graft surgeries in the United States and over 2.2 million worldwide 
[7].  The current state of the art for these surgeries are autografts, which requires 
harvesting healthy bone tissue from another part of the body to be implanted at the 
diseased or traumatized site.  These approaches are not always ideal as they require a 
secondary surgery site (which can be painful and risks infection), as well as the limited 
bone tissue available if the defects are particularly large.   
As an alternative, allografts utilize decellularized bone harvested from cadavers.  
These implants run the risk of being immunologically rejected and can transmit disease.  
Other alternatives include man made materials such as metals and ceramics, but these are 
subject to wear and stress shielding, which cause surrounding bone to degrade with time.  
However, our approach involves the use of biodegradable polymers, optimized for 
cellular interactions, which will stimulate natural bone regeneration using therapeutic 
molecule delivery.  This route is advantageous over these other techniques in that the 
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scaffolding is not permanent, it requires only one surgery location, and is acellular so 
there is no rejection of non-native tissue.  The significance of this research is that this 
composite material, if successful, can be used universally in bone loss applications, since 
use does not require patient-specific tissues. 
Bone tissue engineering often involves one or more of the following components: 
(1) harvested osteoblast cells or osteoprogenitor cells, (2) osteoinductive signaling 
molecules, and (3) three-dimensional (3D) osteoconductive matrices to stimulate the 
body’s natural healing processes [8, 9].  In recent years, a dearth of research has been 
conducted on bone tissue engineering, ranging from new scaffolding materials to the 
delivery of a wide range of cells.  Our approach relies primarily on the development and 
optimization of biodegradable polymers for mineralized tissue formation. 
The basic design criteria for polymeric scaffolding for mineralized tissue repair 
have been laid out by many researchers [9, 10].  In particular, the scaffolds should be 
readily available to surgeons, promote bone infiltration, degrade predictably as bone 
infiltrates, be adaptable to irregular shapes and fractures, possess correct mechanical and 
physical properties, not induce soft tissue growth at the bone-implant interface, and have 
pore sizes from 200-400 μm [9].  It may also be beneficial for these materials to promote 
the formation of extracellular matrix and serve as carriers for cells or growth factors[10].   
Several polymers have been investigated for use as orthopaedic biomaterials due 
to their flexibility and range of physical properties.  Polylactic acid (PLA) and 
polyglycolic acid (PGA) have long been used in the medical fields for such items as 
biodegradable sutures.  However, the osteoconductive behavior of these materials has 
been demonstrated in 2D [11] and 3D [12] scaffolds.  In critical size defects, PLA and 
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PLGA scaffolding have been shown to support bone tissue formation [13].  
Poly(propylene fumarate)s (PPFs) have also been developed as in situ forming 
degradable polymers [14].  The double bonds in the backbone allow for thermal or photo 
polymerization with the addition of an initiator.  The addition of β-tricalcium phosphate 
has been shown to make PPF osteoconductive [15] and bone tissue ingrowth has been 
demonstrated in non-critical sized calvarial defects [16].  Tyrosine-derived 
polycarbonates have been shown to possess good compatibly and cellular response in 
orthopaedic applications, and good osteoconductivity when implanted into bone tissue 
[17]. 
The use of osteoinductive factors is also important in bone tissue engineering 
paradigms.  Many successful tissue regeneration approaches have involved the use of 
growth factors at an injury site.  Several factors have been used, including transforming 
growth factor-β1 (TGF-β1) [18], platelet derived growth factor (PDGF) [19], and bone 
morphogenetic proteins (BMPs) [20-22].  BMP-2 has been shown in many cases to speed 
the healing of bones in a variety of animal models [22-24]. 
This dissertation is meant to characterize a new library of materials with diverse 
properties and develop screening techniques and tools to evaluate the materials, using 
bone tissue engineering as a representative application.  Additionally, high-throughput 
screening techniques will be utilized to discover small molecules that influence 
osteogenesis in a range of cell types.  These techniques will help speed up the 
development of new materials and molecules that may be useful in bone tissue 
engineering. 
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CHAPTER 2: Research Overview 
 
2.1 Specific Aims and Hypotheses 
The field of tissue engineering has long searched for the proper combination of 
materials, soluble factors, and cellular therapies for a variety of clinical applications. 
These approaches have often involved narrowly focused studies on materials with only 
small variations, limited exposure to expensive growth factors or genetic therapies, or the 
use of different populations of multipotent stem cells.  Recently, combinatorial libraries 
of biomaterials have largely increased the pool of potential materials for use as tissue 
engineering scaffolding.  Although pharmaceutical companies have used combinatorial 
syntheses and screening techniques to identify potential drug therapies, these approaches 
are only now finding use within the field of tissue engineering.  This technology may be 
very useful in identifying formulations for optimal tissue regeneration approaches, as 
long as they are easily developed and screened. 
 In this dissertation, a new library of photocrosslinkable, biodegradable poly(β-
amino ester)s (PBAEs) has been developed as a class of materials for a range of 
biomedical applications. This library was screened to identify a polymer with 
osteoconductive properties.  Libraries of soluble factors were also screened using high 
throughput technology to identify potential osteoinductive properties.  The development 
of these material synthesis and screening techniques is crucial in rapidly detecting useful 
formulations for applications in tissue engineering. 
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Hypothesis: The governing hypothesis of this proposal is that high throughput screening 
(HTS) techniques can be used to more rapidly identify potential materials and soluble 
cues for tissue engineering applications, specifically mineralized tissue regeneration.  
Specific hypotheses are: (1) a combinatorial library of photopolymerizable poly(β-amino 
ester)s can be synthesized with tunable degradation, mechanical, and cellular interaction 
properties, (2) screening techniques can identify materials that have osteoconductive 
properties, and (3) HTS techniques can be utilized to discover new osteoinductive soluble 
cues. 
 
To test these hypotheses, the following specific aims were proposed and accomplished: 
Specific Aim 1. Synthesize and characterize a combinatorial library of poly(β-amino 
ester)s.  A library of easily synthesized, photopolymerizable, and biodegradable 
materials was synthesized through the addition reaction of commercially available 
diacrylates and amines.  The mechanical properties, degradation, and cellular interactions 
of these materials were investigated with changes in monomer chemistry, macromer 
molecular weight, and the addition of trifunctional monomers to induce branching. 
 
Specific Aim 2. Screen libraries of materials to optimize osteoconductive properties.  
Human mesenchymal stem cells (hMSCs) and osteoblast-like sarcoma cells (SaOS-2) 
were investigated in 2D in vitro cultures to screen for optimal osteoconductive 
macromers. Highly porous scaffolds were synthesized from the optimized material, 
loaded with recombinant human bone morphogenetic protein-2 (rhBMP-2), and 
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implanted in intramuscular, cranial, and femoral defects to confirm osteoconductive 
properties in vivo. 
 
Specific Aim 3. Use HTS techniques to identify new osteoinductive factors. HTS of 
the National Institute of Neurological Diseases and Stroke (NINDS) library of small 
molecules was used to identify potential osteogenic promoters of hMSC differentiation. 
The most potent promoters were characterized with materials identified in Aim 2 in vitro.   
 
2.2 Research Summary 
The motivation for the development of materials to support mineralized tissue 
formation has already been discussed in Chapter 1.  For critical-sized defects, current 
techniques are limited in their ability to form new native bone to replace the implant or 
grafted materials.  Chapter 3 reviews previous reports in the use of combinatorial libraries 
to expand the availability of materials that can be used for tissue engineering, techniques 
for screening and processing these materials, and the use of HTS techniques to identify 
molecules or cytokines that can be used to drive stem cell differentiation. 
The introduction of PBAEs as a photopolymerizable, biodegradable material will 
be discussed in Chapter 4.  The wide range of mechanical properties and degradation 
rates available with the library demonstrates the versatile potential that this library 
affords.  These characteristics can be further tuned by controlling the macromer 
molecular weight as explored in Chapter 5 or by the introduction of branching in Chapter 
6.  These changes add additional functionality and diversity to the polymers and provide 
basic material investigation of structure-function relationships.  These chapters will also 
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explore the ability of these materials to support cell attachment and growth, as well as 
techniques to produce porous scaffolds. 
The screening of the PBAE library for an osteoconductive material will be 
discussed in Chapter 7.  This includes using design criteria for initially reducing the 
library of 120 materials to 10 materials for further testing.  These candidates were put 
through in vitro testing to find the material that was the best in terms of cell viability and 
osteoconductive capabilities of attached MSCs.  The best material identified as A6, a 
combination of diethylene glycol diacrylate and isobutylamine, was then implanted as 3D 
scaffolds into different rat models to determine biocompatibility and the ability to support 
mineralized tissue formation into the scaffolds with and without the addition of an 
osteoinductive growth factor. 
The animal models in Chapter 7 investigated mineralization in scaffolds that were 
unloaded, which typically leads to intramembranous ossification.  In Chapter 8, a femur 
window defect was created and filled with the same scaffold.  The window defect should 
allow for straining of the scaffold, which is linked to endochondral ossification.  The 
mineralization was evaluated not only through microCT and histology, but the mechanics 
were measured to evaluate the functionality of the new bone produced. 
HTS techniques were used to evaluate a library of small molecules on 
mesenchymal stem cells (MSCs) and is covered in Chapter 9.  These molecules were 
tested for their promotion and inhibition of osteogenesis on MSCs, and the ‘hits’ for 
osteogenesis were then evaluated in typical 2D culture either alone or in combination 
with biodegradable polymers. 
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Finally, in Chapter 10, overall conclusions and future directions for this work are 
discussed.  This includes utilizations of the PBAE library for different tissues or 
applications and the limitations of the methods and models used.  The results and 
implications of the HTS of small molecules are further discussed, as well as possible 
studies for how these molecules could be used in treatment of FOP patients, a clinical 
scenario where mineralization is not desired. 
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CHAPTER 3: Review of High-Throughput and 
Combinatorial Technologies used in Tissue 
Engineering 
(Adapted from: A Peter, DM Brey, JA Burdick. High-throughput and 
combinatorial technologies for tissue engineering applications. Tissue Eng 
Part B Rev. 2009. 15(3):225-39.) 
 
3.1 Introduction 
Over the past few decades, scientists and engineers have sought to develop 
combinations of cells, scaffolds, and signaling molecules as the ideal microenvironments 
for application in tissue engineering [1-3].  The important environmental factors vary 
with the tissue of interest, as well as the type of cells recruited or delivered in the 
approach.  Through this research, numerous scaffolds have been developed from a wide 
range of materials and incorporating numerous molecules (e.g., growth factors) to 
enhance matrix production and accumulation [2].  This has advanced our understanding 
of the importance of many cues towards optimal tissue engineering approaches, yet the 
field of tissue engineering has proceeded in a relatively iterative fashion with the use of 
tedious low-throughput studies.  Due to the nature of the field, the input parameters to a 
tissue engineering approach are nearly endless and include the material selected, material 
properties, cell choice, culture environments, and soluble cues.   
With this in mind, the complexity of cell signaling with the environment due to the 
multitude of factors involved may have slowed down tissue engineering development, 
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due to the difficulty in isolating effects to one parameter.  For example, it is necessary to 
examine not only the bulk material properties such as mechanics and degradation, but 
also how scaffolds interact with cells through toxicity studies, as well as their ability to 
regulate cellular behavior such as adhesion, proliferation, or even stem cell differentiation 
[3, 4].  Adding to the complexity, proliferation and differentiation are largely controlled 
by cell-cell and cell-extracellular matrix (ECM) interactions, soluble factor stimuli, and 
the physical structure of the microenvironment itself [3, 4].  Additionally, intrinsic 
cellular factors such as small molecules and RNA also play an important role in cell 
signaling and differentiation [3]. 
Traditional methods of assessing these various factors have involved iterative 
approaches that require a tremendous amount of time and effort.  Recently, the 
development and use of high-throughput and combinatorial techniques in tissue 
engineering have significantly enhanced this process through its efficient and productive 
platforms.  For example, polymers may be synthesized through combinatorial processes, 
which accelerates the often tedious synthesis and purification schemes that may be 
necessary for development of non-toxic and biodegradable polymers [5].  Upon 
synthesis, the identification of optimal properties from large numbers of materials may 
also be performed through newly developed rapid assessment techniques [5].  This 
continues with the assessment of optimal cell/material interactions in a rapid fashion, 
often through the development of microdevices or use of printing technology [6].  For 
example, radically polymerized polymers with various functionalities can be synthesized 
in nanoliter volumes and plated in combinations onto a microarray to analyze the 
influence of the biomaterial on cell growth and differentiation [1].  These techniques also 
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include platforms such as microfluidics, which can analyze combinations of biomaterial 
gradient streams in a dynamic and temporally changing 3-dimensional 
microenvironment, and high-throughput screens to characterize the role of small 
molecules and RNAs in cellular behavior through the screening of large libraries of 
soluble factors [2, 3].  Notably, all of these areas may lead to the more rapid 
identification of optimal tissue engineering components and their unique combinations. 
While these techniques also have applications in gene therapy and drug candidacy 
analysis, this chapter will focus specifically on applications in tissue engineering for 
injury and degenerative disease treatments [4].  Regenerative medicine techniques are 
being developed for a wide range of treatments for conditions such as cardiac ischemia, 
liver disease, and spinal cord injury and combinatorial and high-throughput approaches 
are accelerating the process for many tissue types [6].  As this field progresses, existing 
and new high-throughput techniques will be crucial in efficiently and rapidly developing 
ideal synergies between microenvironments and signaling factors for engineered tissues 
to be successful in clinical applications.  This chapter will present the current landscape 
of high-throughput and combinatorial techniques as they apply to tissue engineering 
applications, the experimental and clinical benefits of these techniques, and the future 
directions of this rapidly growing field.  Specifically, the focus will be on (1) 
combinatorial polymer synthesis, (2) tools for the rapid assessment of material properties, 
(3) high-throughput assessment of cell/material interactions, (4) microfluidic devices for 
the rapid development of engineered environments, and (5) high-throughput screening for 
identification of small molecules that influence cellular behavior. 
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3.2 Combinatorial Polymer Synthesis 
In the pharmaceutical industry, researchers have used high-throughput, 
combinatorial techniques including automation, miniaturization, and parallel synthesis to 
transform their approach to developing new small molecules and discovering drug 
candidates [7]. These approaches are now being utilized in biomaterial development and 
in the field of tissue engineering due to the numerous advantages to accelerating material 
design and development.  This includes the synthesis of polymers with a wide range of 
chemical components and bulk properties.  Typically, polymer development has involved 
the use of tedious synthetic and purification steps, along with iterative design for material 
development since it is often difficult to predict the resulting polymer properties based on 
the polymer chemistry and structure.  With advanced approaches where syntheses are 
performed more rapidly, many polymers can be developed quickly and then screened for 
the desired properties.   
For over two decades, the pharmaceutical industry has developed and utilized 
methods in combinatorial synthesis and high-throughput analysis in its drug discovery 
efforts (originally reviewed by Gordon et al.[8] in 1994).  The goal was to create large, 
diverse combinatorial libraries and characterize their pharmaceutical effects through a 
range of techniques.  The synthesis and screening of combinatorial libraries primarily 
used either tagged methods (e.g., phage technology, peptides-on-plasmids, and encoded 
combinatorial libraries) or untagged synthesis/analysis techniques (e.g., “mixture 
synthesis” and “portioning-mixing”) [9].  These initial approaches have been expanded 
and there has been extensive research and development in combinatorial synthesis and 
characterization in identifying lead compounds and therapeutically-relevant combinations 
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for pharmaceutical applications [10, 11].  Beyond drug development, similar techniques 
have been applied to gene therapy efforts over the years to identify unique polymers that 
would be most effective in non-viral gene therapy approaches on a range of length scales 
[12-15].  One approach has been the combinatorial synthesis of degradable cationic 
polymers (e.g., poly(β-amino ester)s (PBAEs)) and the analysis of structure/function 
relationships, something that would not be possible on this scale without combinatorial 
synthesis procedures [12-14].  While there are numerous applications that would benefit 
from this technology, this section will focus on polymer development applicable to the 
field of tissue engineering. 
Some of the early combinatorial polymer libraries were created for subsequent 
high-throughput analysis of material properties specific to an application of interest (e.g., 
engineered bone and artificial medical implants).  One such library, developed by Kohn 
and coworkers [16], combined tyrosine-derived diphenols and diacids in permutationally-
designed monomer systems to produce alternating A-B type copolymers (A- contains 
reactive group for pendent chain attachments; B- allows for systematic variations in 
polymer backbone structure).  Combining these copolymers, the system allowed for the 
production and analysis of a library of 112 polyarylates with small structural differences 
and some similar properties, but also with slight differences in polymer free volume, 
bulkiness, flexibility, hydrophobicity, and cellular response that affected their potential 
utility in medical implant applications [16].  Another study investigated more traditional 
polymer combinations of poly(D,L-lactide) and poly(ε-caprolactone) and their resulting 
influence on osteoblast activity [17].  This study employed composition spread and 
temperature gradients (and specifically heat-induced phase separation) to synthesize and 
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screen hundreds of combinatorial polymers with varying characteristics and thereby 
demonstrated differences in osteoblast response. 
Since these early models, researchers have developed many additional methods of 
parallel, automated, and combinatorial polymer synthesis including polycondensation, 
radical polymerization (free-radical polymerization, controlled radical polymerization), 
ring-opening polymerization, polyolefins (mostly for applications in the chemical 
industry), and supramolecular polymerization [5].  For example, Gravert et al. [18] 
utilized free-radical polymerizations to construct block copolymers, which were 
subsequently twice split and used as macroinitiators to polymerize other sets of 
monomers.  The final polymers displayed variable solubility profiles and functionality 
and demonstrated that this process may be used for a variety of high-throughput 
applications.  Numerous other synthesis methods in controlled radical polymerization and 
ring-opening polymerization have been effective as well [5, 19-21].  Additionally, the 
development of synthesis methods for supramolecular polymers, which include both 
covalent and non-covalent bonds (as opposed to only covalent bonds), has introduced 
another variety of polymers with potential biomedical applications [5].  This research 
included the first method for fully automated production of supramolecular coordination 
polymers developed by Schmatloch et al. [22], which helped realize the potential for 
developing many new supramolecular polymers [5]. 
In 2006, we developed the first combinatorial library of degradable 
photocrosslinked biomaterials building on a previously developed library of potential 
gene carriers [13].  Specifically, a combinatorial approach was used to synthesize a 
library of 120 acrylate-terminated PBAE macromers that could be formed into networks 
  20 
using a photoinitiated polymerization.  The synthesis did not involve any purification 
steps and used commercially available reagents, which accelerated the synthesis process.  
This rapid process produced polymers that varied greatly in their property characteristics 
including degradation behavior (e.g. mass loss) and mechanical properties (e.g. elastic 
modulus) [23].  The general synthesis procedure and an example of the diverse mass loss 
between polymers are shown in Figure 3.1.  We also found that properties such as 
molecular weight and macromer branching significantly influence the resulting PBAE 
network and bulk properties [24, 25].  With the appropriate screening process, 
photocrosslinked polymer scaffolds could be selected to meet design criteria including 
optimal degradation profiles and mechanical properties for specific engineered tissue 
functions. 
 Figure 3.1 Combinatorial polymer synthesis. (a) Schematic of synthesis scheme for 
fabrication of poly(β-amino ester)s (PBAEs) from primary amines and diacrylates, where 
the versatility is found in the selection of reagents for synthesis (i.e., R1 and R2).  (b) 
Representative mass loss for polymers formed from a group of 120 PBAE macromers 
after 32 days.  The PBAE library exhibits a range of degradation and mechanical 
properties for diverse applicability in tissue engineering applications.    
 
Combinatorial syntheses can also be performed on the nanoliter-scale by mixing 
reactive macromers and spotting onto a surface [1, 26, 27].  This was performed with 24 
polymers in various combinations and ratios to produce 3456 individual spots on a single 
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array with the goal of analyzing cell-biomaterial interactions [27].  This platform relied 
on the use of a photoinitiated radical polymerization compatible with the technology.  A 
robotic handling system was modified to handle the unique challenges of polymerizing 
diverse monomers including the viscous nature of some acrylate monomers and the 
inhibition of radical polymerization by oxygen [1, 27].  Therefore, array synthesis was 
performed in an atmosphere of humid argon with oxygen present at <0.1% and used a 
long-wave UV lamp to quickly polymerize the monomers [1, 27].  One of the benefits of 
this technology is that it is relatively universal to radically polymerized materials, a group 
of materials that is gaining interest in tissue engineering [28].  For example, natural 
polymers such as hyaluronic acid (HA) can be modified to be photopolymerizable and 
utilized in tissue engineering applications [28-33].  Schmidt and coworkers [32] 
constructed a variety of photopolymerized, crosslinked glycidyl methacrylate-HA 
(GMHA) hydrogels with a corresponding range of degradation rates, swelling, mesh size, 
and other properties and demonstrated their potential use in wound healing applications 
by implanting them subcutaneously in rats.  Subsequently, in 2005, Burdick et al. [34] 
analyzed the use of photopolymerizable HA as a scaffold for both 3T3-fibroblasts and 
auricular swine chrondrocytes for macromers with a range of molecular weights and 
formed into gels at different concentrations.  With the range of polymers available, these 
nano-scale approaches may help in identification of unique materials as well as their 
combinations (i.e., copolymers) that would be tedious to characterize individually.  
Overall, the development of a large variety of advanced polymer libraries, both synthetic 
and natural, has laid the framework for the identification of highly effective 
microenvironments for tissue engineering applications. 
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These synthetic techniques can also be used with a variety of preparation 
techniques to further their combinatorial possibilities.  These preparation methods include 
flow-coating devices that produce thin films with gradients in thickness and temperature-
gradient thin film platforms that provide composition/thickness, 
composition/temperature, or thickness/temperature two-dimensional libraries, and 
methods using photopolymerization to create a gradient polymer film [5, 35-37].  A more 
recent setup employed the use of a microextruder with two feeder heads designed by 
Potyrailo et al. [38] that was capable of producing polymers with a variety of step or 
gradient polymer combinations for subsequent analysis.  Gradients provide the ultimate 
combinatorial synthesis method since polymer development extends beyond discrete 
formulations, providing even more compositions, as long as characterization techniques 
are available for assessment.  All of these synthesis and preparation methods have 
contributed to the development of combinatorial polymer libraries with unique properties 
and functionalities, which can then be analyzed in high-throughput to identify ideal 
polymeric combinations for applications such as tissue engineering.  Polymer synthesis in 
3-dimensional environments is also of interest for tissue engineering applications.  For 
example, scaffolds were constructed from varying compositions of two biodegradable 
tyrosine-derived polycarbonates, resulting in 3-dimensional combinatorial libraries on 
96-well plates [39].  This 3-dimensional design should provide a variety of 
microenvironments that are more similar to in vivo conditions and should thereby 
enhance the development of ideal polymer scaffolds for tissue engineering applications. 
As identified by Kohn [40] in 2004 and further described by Kohn et al. [41] in 
2007, one important issue to consider as combinatorial molecule synthesis moves from 
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drug discovery applications to material science and tissue engineering applications is the 
need for reproducibility in polymer synthesis (e.g., molecular weight and 
polydispersities).  With small molecule development, the chemical structure is the 
essential driving factor; however, there are a variety of factors that are significant when 
considering polymer design, including the polymer molecular weight, the molecular 
weight distribution of polymers within the sample, the presence of trace impurities, and 
the mechanism of fabrication, which all play a role in resulting material properties [40, 
41].  One solution to this issue is the use of parallel synthesis of polymers (i.e., using 
individual reaction vessels to synthesize many individual polymers simultaneously and 
separately) [40, 41].  The next step requires the characterization of the synthesized 
polymers with respect to their formed properties including surface protein adsorption, 
rate of degradation, cytotoxicity, level of biocompatibility in vivo and cellular response 
[40, 41].   
 
3.3 Tools for the Rapid Assessment of Material Properties 
The previous section indicates that the synthesis of a large number of polymers 
rapidly is possible; however, without ample techniques to characterize the properties of 
these materials, their rapid development may not be advantageous.  One of the earliest 
methods of rapidly assessing material properties was demonstrated by Kohn and 
colleagues [42] in 1998.  This was aimed at assessing the combinatorial polymer library 
consisting of 112 polyarylates that was described in the previous section.  In addition to 
creating many distinct polymers, this work enabled the researchers to determine 
relationships between polymer structure and glass transition temperature (Tg), 
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hydrophobicity, and mechanical properties.  These properties were determined by 
systematic analysis using gel-permeation chromatography (for molecular weight), 
differential scanning calorimetry (for Tg), thermogravimetric analysis (for decomposition 
temperature), and goniometry and sessile drop method (for air-water contact angle).  
Some of their conclusions included that oxygen substitution in the backbone is effective 
in increasing polymer Tg and in decreasing hydrophobicity (for substitution in the 
backbone and/or pendent chain) and that additional methylene groups in the backbone 
and/or pendent chain can significantly diminish polymer strength and stiffness.  Thus, 
these approaches can also be used to develop polymer structure/property correlations for 
future material development. 
In early 2004, Meier et al. [43] provided a comprehensive overview of the current 
development in high-throughput screening and assessment of material properties, which 
built on a previous review published in 2003 [5].  For the high-speed characterization of 
standard polymer molecular weights, recent high-throughput techniques have focused on 
using methods such as gel permeation chromatography in combination with high-speed 
columns, parallelization, and/or flow-injection analysis (FIA) [43, 44].  Parallelization 
utilizes more machines to run test samples, but is obviously limited by lab space and 
costs. New, higher speed columns allow for rapid size exclusion separations to occur in 
2-6 minutes rather than 30 minutes to 3 hours [44].  Additionally, researchers have 
utilized matrix assisted laser desorption ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) techniques for absolute determinations of molecular weight, 
molecular-weight distribution, and end group analysis of macromolecules (which can be 
optimized using multiple-layer spotting sample preparation techniques, online monitoring 
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of reactions, and/or ink-jet printing) [45-47].  Next, optical screening methods have been 
increasingly improved for high-throughput property and chemical composition 
assessment purposes [43].  These methods have been enhanced by combining them with 
imaging and commercial reader technologies for absorbance, fluorescence, and infrared 
(and near infrared) spectroscopy [43]. 
Infrared and near infrared spectroscopy-based techniques, including attenuated 
total reflection Fourier-transform infrared spectroscopy (ATR-FT-IR), are effective tools 
for measuring monomer/polymer compositions and polymerizations [48-50], while 
fluorescence spectroscopy approaches have been used to determine properties such as 
molecular weight, amount of branching, and catalyst selectivity [51].  Lastly, numerous 
methods have been developed to address the area of screening for morphology and 
physical properties, particularly for polymer film analysis [52-57].  These methods 
include using relationships between various physical properties and the preceding optical 
data, as well as the evaluation of thin films to determine adhesion, crystallization, or 
dewetting property characteristics [52, 53, 55-57].  Fast differential scanning calorimetry 
(DSC) analyses have been considerably accelerated with automated large sample array 
DSC. This field is still developing and should continue to improve the speed of property 
characterization while maintaining equal or even better accuracy of data compared to 
traditional methods [43]. 
In combination with the above mentioned synthetic nanoliter-spotting techniques, 
Tweedie et al. [26] synthesized a library of over 1700 photopolymerizable acrylate-based 
biomaterials using automated array synthesis and characterized the resulting mechanical 
properties with nanoindentation.  Nanoindentation is a method of measuring nanometer-
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scale displacement with respect to load while depressing the material’s surface with a 
rigid indenter.  These methods were found to be quick and accurate in determining 
numerous mechanical response characteristics and could potentially be applied to other 
sets of combinatorial/crosslinked polymers [26].  This example presents a situation where 
a technology was modified to accelerate material property characterization with a new 
rapid synthesis process.  An additional method for measuring mechanical properties of 
thin films was strain induced elastomer buckling instability for mechanical measurements 
[58].  This method utilizes the light scattering produced by the buckling of two 
mismatched polymers, the glassy thin film of interest and a softer silicone sheet. 
The rapid characterization of polymer properties and cellular responses will be 
vital for the continuing development of tissue engineering research.  As Kohn et al. [41] 
described, the chemical composition of polymeric scaffolds significantly affects its 
mechanical/cell interaction properties and therefore, will often determine the applicability 
of a potential engineered tissue scaffold.  Kohn et al. [41] cite recent studies that 
demonstrate how slight differences in polymer composition and structure (poly(L-lactic 
acid) vs. poly(DTE carbonate) and poly(DTE carbonate) vs. poly(DTB carbonate), 
respectively) can significantly affect cell response and long-term tissue growth including 
differences in bone resorption, inflammatory response, tissue degradation, tissue in-
growth, and foreign body response [59].  The considerable effects of minor polymeric 
differences support the need to develop and utilize high-throughput methods that rapidly 
and systemically characterize the many polymer compositions.  In the future, this may 
increasingly depend on computational programming as we will discuss in the subsequent 
section on assessing cell/material interactions [41].  Additionally, x,y spatially-resolved 
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libraries, in which polymer composition varies across the x and y coordinates, 
respectively, have also been utilized to assess a wide range of polymer mixtures using 
some of the analytical methods previously described (i.e., optical microscopy) [36, 41, 
60].  This type of method should also play an important role in the future development of 
rapid material characterization. 
The availability and quality of high-throughput assays for material 
characterization is commercially relatively limited, leading to inefficient iterative 
approaches for analysis.  Recently, there has been significant progress in characterizing 
various biomaterial assays and developing reliable and advanced high-throughput assay 
systems.  Additionally, the use of computational systems to artificially determine cell-
biomaterial interactions based on known properties has gained traction, but remains 
limited due to the complexity of these interactions [40].  These algorithmic systems have 
the potential to exponentially increase efficiency in developing and analyzing 
combinatorial virtual libraries by bypassing the actual, physical production of thousands 
of polymeric combinations.   It is clear that there is still room for the development of new 
techniques to rapidly characterize material properties from large libraries of polymers.  
Beyond bulk properties and towards tissue engineering applications, it is also necessary 
to rapidly characterize how cells interact with a range of materials.   
 
3.4 High-throughput Assessment of Cell/Material Interactions 
Using the vast array of combinatorial polymer libraries and many of the tools for 
material property analysis, the next step in developing the ideal microenvironment for 
engineered tissue is the high-throughput assessment of cell/material interactions.  This 
  29 
ideal microenvironment will often seek to mimic the natural environment of particular 
cell types or even improve on this environment by cultivating growth and proliferation 
[4].  Particularly in the field of tissue engineering, the extracellular environment, 
including surface properties such as roughness and hydrophobicity and specific cell-
surface interaction, maintains a large influence on cellular attachment, spreading, overall 
growth, and differentiation in the case of stem cells [1].  The use of high-throughput 
systems to improve the speed and breadth of characterizing and understanding these 
effects on cellular responses would significantly accelerate the process of developing 
effective engineered tissue constructs that could be utilized in medical applications. 
The development of systems for analyzing cell/material interactions in bulk began 
in the late 1990s, shortly after the production of the first large combinatorial polymer 
libraries.  In addition to developing a combinatorial polymer library and demonstrating 
rapid polymer property characterization, Kohn and coworkers [42] also performed one of 
the earliest high-throughput analyses of cell/material interactions in 1998.  This analysis 
studied the interaction between 42 polyarylate polymers (a subset of the 112 polymer 
library) and fibroblast cells, focusing on proliferation using an MTS (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) 
assay.  In general, these investigators found a linear correlation between decreased 
proliferation and increased surface hydrophobicity of materials derived from non-
oxygen-containing diacids.  The analysis also showed that all polymers derived from 
oxygen-containing diacids acted as good substrates for fibroblast proliferation.  Along 
with these findings and others, this study illustrated the ability to determine important 
material interactions with only small amounts of polymer material. 
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Since these early pioneering analyses, high-throughput assessment has seen 
significant growth in the volume of analyses, the breadth of cells and polymers studied, 
and the variety of cell responses that have been characterized.  In one study, over 1700 
combinatorial nanoliter-scale polymer spots of various (meth)acrylates were introduced 
to a single slide, thereby providing a high-throughput platform for analyzing cell 
attachment, cell spreading, and cell-type specific growth [1, 7].  This work examined the 
effects of these polymers on human embryonic stem (hES) cells and C2C12 cells (a 
mouse myoblast stem cell line), including cell growth, adhesion, and proliferation [1].  
Additionally, positive matches for cell attachment and spreading were also tested for 
differentiation into cytokeratin-positive cells.  A representative polymer array with cells 
attached is shown in Figure 3.2.  The process of successfully identifying cell/material 
interactions and the ease of producing and characterizing cytokeratin-positive cells in 
particular could be utilized in developing engineered epithelia tissue.  C2C12 cells 
showed similar attachment and growth to hES cells, but with success on almost all 
material combinations.  This differentiation between the two cell types could also be 
effectively used in advanced scaffolding for engineered tissue applications.  Lastly, it was 
found that cell growth and proliferation is dependent on the presence of retinoic acid for 
some specific polymer combinations, which could potentially be employed to control cell 
behavior in tissue engineering.  This study relied on fluorescent techniques that could be 
quantified with image analyses.  The importance of this work is that it assessed many 
formulations, including material/soluble factor combinations, rapidly and that it went 
beyond identifying correlations and focused on the identification of random combinations 
by utilizing the benefits of high-throughput studies. 
 Figure 3.2 Polymer arrays to assess cell/material interactions. (a−c) Examples of 
fluorescent images of human embryonic stem cells cultured on polymer arrays in the 
presence of retinoic acid for 6 days and then stained for cytokeratin 7 (green) and 
vimentin (red) (a-c, e) or nuclei (green) in (d). (f) Quantification of cell coverage as a 
function of polymer composition after 6 days.  These techniques are useful to identify 
unexpected relationships between material chemistry/properties and cellular interactions, 
including stem cell differentiation [1]. 
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This technology was further expanded to encompass arrays consisting of 3456 
individual combinations of biodegradable polymers and the interactions of human 
mesenchymal stem cells (hMSCs) was assessed with regards to properties such as 
attachment and spreading [27].  This platform maintained the added benefit on being able 
to synthesize and characterize polymeric materials using conventional methods instead of 
producing nanoliter-scale materials on the array.  Many of the combinations were found 
to foster attachment and growth including PLGA combined with L-lactide.  These 
characterizations display the potential of designing effective biomaterials to enhance stem 
cell development including neural stem cell growth and perhaps differentiation through 
engineered, combinatorial microenvironments.  Looking forward, Anderson et al. [27] 
identified the screening of biomaterial interactions with other microenvironment 
components such as proteins as a potential application for this specific high-throughput 
microarray platform. 
As researchers have continued to study cell/biomaterial interactions, these 
analyses have become increasingly complex and multifunctional.  For instance, Neuss et 
al. [61] developed a grid-based system for the screening of various combinations of 7 
different stem cell lines (including pluripotent embryonic and multipotent adult stem 
cells) and 19 polymeric materials.  Through this research, five factors (morphology, 
vitality, cytotoxicity, apoptosis, and proliferation) were characterized using multiplex 
assays for each of 140 combinations.  From this standardized, parallel analysis, they were 
able to identify combinations of stem cells and polymer scaffolds including human dental 
pulp stem cells on poly-DL-lactic acid and human preadipocytes on texin that support 
cell adhesion and proliferation and prevent apoptosis and necrosis.  This type of diverse 
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combinatorial assessment of numerous cell/material parameters should be extremely 
useful in quickly characterizing cell and scaffolding combinations for specific tissue 
engineering functions. 
As the field has progressed, high-throughput methods have increasingly taken 
advantage of fluorescence-based analysis of cellular responses.  For instance, 
investigators have recently developed a high-throughput method for testing the growth, 
adhesion, and morphology responses of mouse connective tissue fibroblast cells (L929) 
on a set of 214 polyurethane-based polymers [62].  In this study, a probe composed of 
nonfluorescent 5-chloromethylfluorescein diacetate was utilized to enter the cell and then 
display fluorescence when it was cleaved by intracellular esterases.  Combining image 
capture and screening analysis with the appearance of fluorescence enabled the team to 
rapidly quantify the growth, adhesion, and morphology of the fibroblasts.  In addition to 
identifying clear trends relating cellular adhesion and polymer structure, the researchers 
also emphasized that this methodology could be scaled up to 1024 individual experiments 
per slide, allowing very high-volume and quick analyses with only small quantities of 
materials [62].  Numerous other studies have also utilized fluorescence-based analyses of 
cell behavior [27, 63-65] or protein/material interactions [66] as these techniques are 
easily applied and effective. Modern transfection techniques have allowed researchers to 
transfect cell lines with genes for fluorescent proteins that are activated when the 
reporters of genes of interest are activated [3, 67].  This allows for passive observation of 
genetic activation of cell differentiation along desired lines. 
 Another trend is the progression towards complete microenvironment analyses, 
including both the extracellular matrix components and the soluble growth factors and 
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molecules.  This holistic approach should better represent the actual in vivo conditions 
and enhance the assessment of cellular response to these conditions.  Flaim et al. [67] 
developed one of the first models for this type of analysis, which consisted of a platform 
for 1200 simultaneous experiments studying the effects of 240 different 
microenvironments on stem cell behavior.  These microenvironments were composed of 
mixtures of both extracellular matrix (fibronectin, laminin, collagen I, collagen III, 
collagen IV) and soluble factors (wnt3a, activin A, bone morphogenetic protein-4, and 
fibroblast growth factor-4).  Flaim et al. [67] employed an overall microarray design but 
also utilized a multiwell platform, in which each well contained several spots where a 
single extracellular matrix arrangement was maintained and soluble factor composition 
was varied.  Growth levels were recorded by measuring the amount of nuclear DNA 
while differentiation was again measured using a fluorescence-based reporter gene.  This 
approach could potentially be utilized with any set of environmental factors and cell 
lines, thereby creating a more ‘natural’ environment for engineered tissue development. 
As mentioned previously, one of the recent advances in engineered tissue 
development was the design and production of the first large-pore polymer biomaterials 
that could be analyzed in 3-dimensional, high-throughput environments for their effects 
on cell behavior (developed by Yang et al. [39]).  Previous studies, including one 
performed by Levenberg et al. [68], had completed similar work including the analysis of 
hES cell growth and differentiation in a 3-dimensional 50% PLGA / 50% PLLA 
environment with growth factors.  While successful growth and differentiation was found 
with different growth factors in specific pore environments (250-500 μm), this study did 
not vary the polymer composition or analyze polymer variations in high-throughput [68].  
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In their advanced, high-throughput analysis, Yang et al. [39] found a relationship 
between increasing poly(desaminotyrosyl-tyrosine ethyl ester carbonate) content and 
increasing osteoblast adhesion.  It was also determined that protein adsorption affects cell 
responses including osteoblast adhesion for these polymeric scaffolds.  Overall, this 
analysis demonstrates a tremendous improvement over 2-dimensional films or surfaces 
that have traditionally been used in studying cell/material interactions.  This is due 
largely to the similarity of 3-dimensional environments to in vivo conditions, as well as 
the varying cell response to the environment structure and material topography.  Even so, 
in this case, Yang et al. [39] found that the cell adhesion trends in 3-dimensional 
scaffolds fit with the trends previously determined in 2-dimensional screening, which 
indicates that 2-dimensional screening may be used to effectively predict cell response in 
3-dimensional environments.  In the end, the capacity to use 3-dimensional screening for 
cell/material interactions should enhance the development of applicable polymeric 
scaffolding and engineered tissues. 
Beyond experimental assessment, computational system analysis of combinatorial 
polymer virtual libraries has been identified as an area of great potential in analyzing 
material properties for tissue engineering applications.  One recent development in 
computational methods was designed by Kohn and coworkers [69] to successfully predict 
the cell growth response to a biomaterial based on its chemical composition and physical 
properties such as glass transition temperature (Tg) and contact angle (θ).  The model, 
called the Logical Analysis of Data (LAD), was developed using 62 known polymers and 
was then able to distinguish between high and low growth polymers for 50 
uncharacterized materials and even correctly characterize several materials that cultivated 
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especially high cell growth.  This particular model was used to predict the response of rat 
lung fibroblasts and foreskin fibroblasts to the set of polymers, but could potentially be 
applied to other cell types and other biomaterials.  While this study demonstrates the 
potential of computational systems to enhance efficiency in combinatorial analysis by 
bypassing the physical construction of polymer libraries, this type of modeling software 
still requires further development, including the addition of more input parameters and 
output measurements, to become widely applicable across various analyses [69]. 
Quantitative structure activity relationship (QSAR) analyses have been previously 
used in the pharmaceutical industry, but are recently being applied to the study of 
cell/biomaterial interactions [70].  Recent models have utilized this quantitative analysis 
to predict cellular response and protein adsorption to biodegradable polymeric 
biomaterials [70, 71].  The model predicted the biological activity for 6 polyarylates with 
an average percent error of only 15.8% compared to the measured values using a 
quantitative system based on 5 parameters including the number of tertiary carbons, the 
number of branches in the pendent chain, the molar refractivity, the polar surface area, 
and the logarithm of the octanol-water partition coefficient [70].  A subsequent model 
again utilized 5 input parameters chosen through QSAR analyses and put into an 
Artificial Neural Network (ANN) platform to predict the protein adsorption and 
biological response for 77% and 71% of the polymeric test materials, respectively [71].  
Kohn and his colleagues [72] also utilized an ANN model to predict fibrinogen 
absorption and cell growth for the previously presented 112 polyarylate library.  
More recently, larger scale attempts at computationally predicting cell/material 
interactions have been pursued.  A study performed by Kholodovych et al. [73] analyzed 
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the cellular response to a combinatorial library of 2000 polymethacrylates using a 
Polynomial Neural Network (PNN) as opposed to the traditionally used ANN algorithms.  
The benefits of the PNN tool include its ability to assemble the architecture (i.e., the 
precise number of neurons in the input, output, and hidden layers, etc.) in response to the 
characteristics of the data and to handle very small or very large data sets [73].  These 
qualities will likely make PNN algorithms, in conjunction with QSPR analyses, 
extremely useful in the future for computationally screening many diverse 
cell/biomaterial interactions.  Even so, despite this progress, the computational prediction 
field still needs further development to become fully applicable across the wide range of 
polymeric materials and the complex variety of cell lines.  However, it could help to 
rapidly assess and identify optimal material formulations, beyond traditional 
experimental techniques. 
 Overall, the field of high-throughput assessment of cell/material interactions has 
experienced a tremendous amount of progress as a variety of platforms and analysis 
techniques have been designed to better identify successful microenvironments.  Even so, 
this field is still considered to be in its early stage [4].  In moving forward, researchers 
will need to continue to develop platforms and microenvironments that emulate actual in 
vivo conditions (i.e., scaffolding combined with soluble factors and fluidic 
environments), as well as move from the micro-scale to the macro-scale in order to fully 
approach tissue engineering applications [4]. 
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3.5 Microfluidic Devices for the Rapid Development of Engineered Environments 
 One effective method to assess cell/material interactions is the use of microfluidic 
systems.  Microfluidic systems can be used for a variety of applications and simulations, 
but for tissue engineering, these devices are primarily used for high-throughput 
screening, characterization of cell/material interactions, and the optimization of the 
conditions that precisely regulate cell behavior and fate [2], [74].  Like many other 
microscale techniques, microfluidics are inexpensive and able to operate with fewer cells 
and reagents [2].  In addition to these advantages, microfluidic devices provide a fluid, 
dynamic environment that is much more similar to in vivo conditions compared to 
traditional static platforms, such as those described in the previous section.   
One microfluidic platform that has gained use involves the generation of gradients 
of soluble or bound factors to assess the factor’s influence on interacting cells [75].  For 
instance, in 2005, Chung et al. [76] produced a microfluidic system that delivered a 
gradient of growth factors including epidermal growth factor (EGF), fibroblast growth 
factor 2 (FGF2), and platelet-derived growth factor (PDGF) to human neural stem cells 
(NSCs).  In response, these cells proliferated and differentiated into astrocytes 
proportionally to the concentration of growth factors.  Proliferation was directly 
proportional to growth factor concentration and conversely, differentiation occurred in an 
inversely proportional relationship with growth factor concentration.  For this 
experiment, the actual microfluidic device was produced using the techniques of rapid 
prototyping and soft lithography.  The gradient flow of multiple factors allows for the 
rapid optimization of culture conditions while using low concentrations of relatively 
expensive growth factors and cells [76].  These benefits of gradient-generating 
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microfluidic platforms should considerably enhance the process of optimizing culture and 
scaffolding conditions for a variety of tissue engineering applications.  Also, 
microfluidics allow precise control over the timing of multiple soluble factors. 
 Microfluidics have also helped identify ideal cell microenvironments through the 
development of control over soluble chemical distribution within a scaffold.  This 
strategy was explored in contrast to previous research, which has largely focused on 
adjusting the chemical and mechanical characteristics of the scaffold [77].  In 2007, Choi 
et al. [77] described a method for managing this distribution by using microfluidic 
channels constructed within the cell/biomaterial combination to complete convective 
mass transfer of the solutes.  The solute exchange is completed in two steps involving 
interfacial convective mass transfer between the flowing solutions and the walls of the 
microchannels and molecular diffusion between these walls and the bulk of the scaffold 
[77].  This model included a calcium alginate hydrogel and chondrocyte cell lines and 
utilized lithography to develop the microfluidic structure.  This precise control of soluble 
chemical distribution could help prevent necrosis from developing at the center of thick 
engineered tissues as well as guide cell growth towards regions within engineered tissue 
[77]. 
Khademhosseini and coworkers [78] have also developed microfluidic channels 
in cell-seeded agarose hydrogels using soft lithographic techniques.  This work showed 
that cell viability in large engineered tissue constructs can depend largely on the 
distribution of nutrients and oxygen through vasculature-like channels and proved that 
microfluidics can help overcome the difficulty in transport and exchange of materials, 
namely nutrients, that typically causes cell necrosis in large 3-dimensional engineered 
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tissues.  While further development is necessary, this method will certainly enhance the 
progress towards engineered 3-dimensional scaffolds with artificial vasculature that allow 
for the exchange of nutrients, waste, and signaling molecules.  The technology could also 
be used for assessment and screening of multiple environments in single constructs.  This 
work has been expanded to produce 3-dimensional cardiac organoids on a patterned 
hyaluronic acid (HA) platform [79].  In this model, seeded cardiomyocytes grew parallel 
to the pattern direction and subsequently detached from the scaffold to develop into 
contractile cardiac organoids.  For confirmation, contractile properties were assessed and 
quantified using imaging technology.  This method displays the double advantage of both 
growing and aligning the myocytes on a biocompatible scaffold and allowing for natural 
detachment of the contractile cells without requiring enzymes.  In addition to a variety of 
other studies, these methods, namely the microfluidic patterning, could potentially be 
used in biodegradable scaffolds to organize cell growth for the purposes of tissue 
engineering and full tissue replacement [79]. 
Other researchers have also used soft lithography techniques to develop hydrogel-
based microfluidic platforms.  For instance, in 2007, Figallo et al. [80] used soft 
lithography methods to design a micro-bioreactor array (MBA), which consists of layers 
of poly(dimethylsiloxane) (PDMS) and glass and maintains microfluidic channels 
throughout the system.  The microfluidic channels are able to supply the perfusion of a 
controlled medium and enhance the growth of cells in high density through advantages 
including the purging of residual non-polymerized reactants.  A schematic of the device, 
as well as representative cellular outcomes are shown in Figure 3.3.  The miniaturization 
of the bioreactor allows for better use of expensive media factors while still maintaining 
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this advantage of a fluid, dynamic system.  In different perfusion setups, the MBA system 
of twelve micro-bioreactors was utilized to compare the expression of smooth muscle 
actin and cell density (for various cells including human embryonic stem cells (hESCs)).  
Additionally, the group was able to analyze cell differentiation by quantifying the 
expression of cell differentiation markers using an in situ and automated image analysis 
system.  As noted by Figallo et al. [80], this complete system should prove to be quite 
useful for the study of cell behavior, especially the complex development of hESCs, in 
fluidic environments. 
 a cb 
Figure 3.3 Micro bioreactor arrays for identification of ideal cellular environments.  
Micro bioreactor arrays for identification of ideal cellular environments.  Microfluidic 
device (a) and well schematics (b) for configurations that include a bottom inlet/outlet 
(BIO) where the flow is directly over the cells and a middle inlet/outlet (MIO) 
configuration where the cells are in a well with fluid flow over top.   Human embryonic 
stem cells were cultured and stained for smooth muscle actin (red) and DAPI (Blue) in 
three different flow configurations (c): static (left column: a, d, g), perfused BIO (middle 
column: b, e, h) and perfused MIO (right column: c, f, i) at three different cell densities: 
60 ± 6 (top row: a, b, c), 160 ± 4 (middle row: d, e, f) and 314 ± 15 (bottom row: g, h, i). 
This technology is useful to assess microenvironments for tissue engineering, particularly 
under a range of flow conditions [80]. 
 
Other microfludic platforms have been developed for the purposes of complex 
cell culture and experimentation in conditions very similar to an in vivo environment.  In 
2007, Lee et al. [81] developed such a model consisting of a cell culture niche, an 
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artificial, microfluidic endothelial (perfusion) layer, and a nutrient transport vessel.  This 
system utilized microfluidics to direct mass transport on the microscale and to help 
localize cells for increased density and viability in certain areas of the microenvironment.  
More recently, chip-based microfluidic devices have been developed and utilized to 
produce microscale scaffolds.  For instance, Lee and colleagues [82] have constructed 
tissue engineering scaffolds by integrating poly(lactic-co-glycolic acid) (PLGA) 
microfibers into a microfluidic chip.  In this preparation, the microfibers were generated 
by precipitating streams of PLGA in dimethyl sulfoxide (DMSO) out of a water/glycerol 
mixture and varying the flow rate of PLGA to produce fibers of different widths [82].  
Neural progenitor cells were then grown on the 3D scaffolds to determine its potential for 
use in neural tissue engineering [82]. 
It is clear that complex environments are crucial to truly assess the potential of 
approaches in recapitulating the complex microenvironments found in vivo.  This 
includes systems that utilize fluid flow, 3-dimensional structures, and both bound and 
soluble cues.  Thus, microfluidics provide platform technology for rapidly assessing these 
environments, whether it is with gradients of cues or through the interface of fluid flow 
and arrays of polymers.  However, much of this previous work has focused on the 
assessment of known soluble cues (i.e., growth factors) for tissue engineering 
applications.     
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3.6 Screening Molecules for Stem Cell Differentiation 
The identification of molecules that control cellular behavior is essential to 
expand the breadth of cues that may be incorporated into tissue engineering approaches.  
One emerging field is the use of high-throughput screening (HTS) of molecule libraries 
for the control of stem cell differentiation.  Extensive studies have assessed potential 
drugs and growth factors looking for soluble cues to direct the fate of stem cells towards 
a desired phenotype.  These attempts have been limited to smaller studies of a limited 
number of factors due to the techniques in culture and cost of reagents and proteins.  
Additionally, efforts to recapitulate growth factor cocktails and precise timing of their 
delivery, as seen during development, have been similarly limited in scope and 
complexity.  With the advent of HTS techniques, smaller numbers of cells can be used to 
screen a wider range of potential drugs and cytokine delivery schemes in order to 
optimize stem cell differentiation.  Although many cell types could be investigated, this 
section will focus specifically on the use of HTS technology towards stem cell 
differentiation. 
To date, few studies have specifically investigated the use of HTS of small 
molecules for stem cell differentiation.  One of the earliest examples involved a study 
from the Schultz lab that screened a heterocycle combinatorial library [83].  This library 
was built using the template of known kinase inhibitor scaffolds, such as purine and 
pyrimidines, to include nearly 50,000 different small molecules of unknown potential.  
Originally, this library was thought to be a possible source for new ligands to further 
investigate the function of new proteins by inhibiting or stimulating their signaling; 
however, they soon began to investigate their differentiation potential on stem cells.  For 
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example, the library was screened with mouse embryonic mesoderm fibroblasts 
C3H10T1/2 cells for osteogenic differentiation [84].  The initial screen used increased 
alkaline phophastase (ALP) expression, which is important to bone mineralization, as a 
marker for differentiation.  15 compounds were identified that stimulated ALP activity, 
but the molecule they named purmorphamine was the most potent of these.  This 
compound was shown to be more potent than BMP-4 with optimized concentrations, and 
the combined effect of BMP-4 and purmorphamine were synergistic and not surrogate.  
The osteogenic nature of purmorphamine was confirmed with increases in the induction 
of the transcription factor Cbfa1 and histological staining for ALP on several other 
murine mesenchymal cell lines.  Further investigation [85] found that purmorphamine 
stimulated osteogenic differentiation along the hedgehog signaling pathway. 
Similarly, HTS was used to identify molecules from this library that drove 
neuronal [86] and cardiomyogenic [87] differentiation of murine embryonic stem cells.  
Hits were initially screened using transfection of reporter gene activated luciferase 
plasmids.  The use of the library to drive dedifferentiation [88] also led to the discovery 
of ‘reversine’ which allowed murine myoblasts to dedifferentiate into stem-like cells and 
then redifferentiate along osteogenic or adipogenic cell lines.  This could be important in 
discovering new autologous sources for cell therapies.  These discoveries were largely 
used to investigate the processes and signaling used during differentiation, not for actual 
therapy.   
More recent studies have screened libraries for suppressors of differentiation 
rather than looking for new promoters [85, 89].  These can be useful for treating certain 
disease progressions where it would be therapeutically advantageous to prevent 
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differentiation or in understanding the nature of diseases where normal function is 
inhibited but the causes are not understood.  The study by Yui et al. [85] screened over 
7500 commercially available compounds by investigating their effects on the normal 
embryonic development of the dorsal structures in zebrafish.  This required the 
observation and measurement of several individual embryos manually, so it lost some of 
the rapidity of the soluble factor assays previously discussed, but includes the complexity 
of the in vivo system that 2D culture lacks.  This method was able to identify 
dorsomorphin as a BMP Type I receptor inhibitor, which prevents osteogenic 
differentiation.   
A high throughput siRNA library was used to screen hMSCs for osteogenic 
suppressors by Zhao and Ding [89].  MSCs were transfected by a library of 10,000 
unique sequences, 2 per gene, and the ALP activity was then imaged.  An increase in 
ALP activity indicated that the inhibited gene was normally an osteogenic suppressor.  
This initial screen identified 55 ‘hits’ for osteogenic prevention, which included genes for 
a wide variety of kinases, extracellular matrix proteins, protein receptors, ion channels, 
amongst others.  From this initial screen, 12 were picked to investigate further for 
prevention of osteogenic differentiation.  Interestingly, the different suppressors fell in 
two types the authors designated ‘fate specific’ or ‘fate nonspecific.’  The fate specific 
genes were suppressors of osteogenic differentiation because they preferred an 
adipogenic lineage.  The fate nonspecific type prevented differentiation along any line.  
These would be important in maintaining the multipotency and proliferation of stem 
cells, and may be useful for understanding and prolonging a stem cell line in vitro or 
possibly in the dedifferentiation of committed cell lines. 
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One recent study by Mauck and coworkers [90] used HTS of hMSC pellets to find 
molecules that stimulate or suppress chondrogenesis.  Since MSCs typically undergo 
chondrogenesis in pellets, it was necessary to scale down pellet cultures for rapid 
assessment and culture in round bottom 384-well plates.  Chondrogenesis was assayed by 
measuring the glycosaminoglycan (GAG) content of the pellets after a week in culture.  
The setup was first run to evaluate the combinatorial effects of four different growth 
factors at different concentrations.  This allowed for the confirmation of BMP-2 and 
TGF-β as being very synergistic in chondrogenic differentiation, but also demonstrated 
how FGF-2 increased cell proliferation and chondrogenic potential of hMSCs.  The small 
volumes of the 384 well plates allow for extensive screening of different growth factor 
cocktails that are often limited in large scale experiments by the cost of cytokines.  
Secondly, the National Institute of Neurological Disorders and Stroke (NINDS) library 
was screened for both chondrogenic inducers and inhibitors.  The chondrogenic inhibitors 
eliminated compounds that led to a 40% reduction in DNA content to eliminate 
compounds that reduced GAG content due to their cytoxicity.  This method identified 24 
potential inhibitors, including many antimitotics, antibiotics, and antineoplastics among 
others.  Outcomes, which include hits for molecules that either induce or inhibit stem cell 
chondrogenesis are shown in Figure 3.4.  Dose response investigation may be useful in 
these cases to determine if changes in the dose would lead to further cell death or 
increased effectiveness.   
 
 Figure 3.4 High-throughput screening of small molecules that influence stem cell 
differentiation. Screening of a small molecule library (NINDS) to identify inducers (CM- 
hits, grey area) and inhibitors (CM+ hits, grey area) of mesenchymal stem cell 
chondrogenesis, measured by glycosaminoglycan (GAG) levels. This technology is 
applicable to a range of cell types useful in tissue engineering applications [90].  
 
HTS techniques are beneficial due to their ability to quickly screen large libraries 
of small molecules for desired outcomes.  Often, though, the hits are just the beginning, 
whereby the mechanisms of their action must be investigated and the optimization of the 
dosage must be further investigated.  Thankfully, the same HTS setups can aid in the 
optimization of dosage or the synergies of multiple factors.  As always, in vitro culture is 
often limited in capturing effects in an artificial environment that may not translate in 
vivo.  The zebrafish experiments [85] are interesting in their ability to add a level of 
complexity, but made it difficult to isolate the effects on specific cells.    
Rubin [91] lamented that often more information could be gleaned from these 
experiments if the researchers had more diverse sets of compounds and the expertise in 
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chemistry and drug design to further develop initial hits.  As such, often researchers are 
limited by smaller more established sets, such as the NINDS library, that is already 
characterized for other applications and may already be in use for other therapeutics.  
This has the benefit of a possibly faster implementation of these therapies if they are 
discovered, but that the larger research misses out on the true promise of these screens to 
investigate more diverse and uncharted libraries. 
From a tissue engineering standpoint, these small molecule discoveries can be 
useful in the design of materials, the differentiation of implanted cells, or to discover new 
cell sources.  Scaffolds can incorporate the release of newly discovered small molecules 
into the environment around these implants to either drive specific differentiation of 
incorporated cell therapies or to recruit native local stem cells and drive their 
differentiation for desired outcomes.  The molecules, as shown previously [88], can be 
used to dedifferentiate autologous cells towards a stem cell line that can then be expanded 
to increase cells numbers to therapeutic levels.  Then the cells can be differentiated along 
the desired lineage in vitro before implantation.   
 
3.7 Summary and Future Directions 
Through this chapter, we have discussed many of the stages involved in research 
and development for tissue engineering applications and have specifically focused on 
high-throughput and combinatorial techniques in polymer synthesis, material 
characterization, cell/material interactions including microfluidic platforms, and small 
molecule screening to direct cell behavior.  While combinatorial synthesis methods have 
been studied for years and for various applications, these techniques are still developing 
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as a crucial tool in rapidly producing a wide variety of polymeric materials as potential 
scaffolds.  In the future, miniaturization of polymer libraries to the nano-scale level, the 
design of 3-dimensional combinatorial libraries, and parallel synthesis methods should 
continue to influence the ease and utility of using libraries to develop polymer scaffolds.  
In assessing the characteristics of these large libraries, a variety of techniques, from 
parallelization to fluorescence spectroscopy, have been developed and employed, yet 
there is still room from improvement in the commercialization and standardization of 
these methods.  Moving forward, computational systems should play an increasingly 
important role in determining polymer properties and cell/material interactions as they 
become applicable to a wider variety of cell and/or material combinations.   
The high-throughput analysis of cell/material interactions is perhaps the most 
important step in developing a successful engineered tissue.  This field has also seen 
significant progress as researchers have produced more complex and high-throughput 
screening platforms as well as designing 3-dimensional screening environments and 
including additional factors such as soluble growth factors.  Microfluidic systems have 
also proved to be quite useful in replicating an in vivo environment and should be further 
utilized in studying a range of polymer arrays and soluble factors in high-throughput and 
under fluid conditions.  Ideally, microfluidic platforms will provide structural support; a 
3-dimensional, dynamic environment for analysis of cell behavior; and pathways to 
control solute and factor distribution/flow.  New imaging techniques will be developed 
that will help accelerate the identification of optimal environments during screening.  
Finally, although it is a young field, the application of high-throughput techniques to the 
screening of molecules for stem cell response has increased the speed of characterizing 
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large libraries of small molecules.  These techniques can help a number of engineered 
tissue factors, but should be most useful in controlling cell differentiation.  To this end, 
future research should maintain a partial focus on the standardization of techniques for 
measuring differentiation (e.g., the previously discussed fluorescence and transfection 
tools).  Additionally, the further development of analysis methods for the tremendous 
amount of data produced by these high-throughput systems will be necessary for the field 
to progress appropriately in the coming years.  Overall, all of these platforms and 
analyses will continue to contribute to the development of the ideal microenvironment for 
engineered tissue including the optimal synergy between cells, scaffolding, and 
extracellular factors.  In pursuing this goal, the use of high-throughput and combinatorial 
techniques should continue to enhance our progress towards in vivo testing and clinical 
tissue engineering applications 
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CHAPTER 4: A Combinatorial Library of 
Photocrosslinkable and Degradable Material 
(Adapted from: DG Anderson, CA Tweedie, N Hossain, SM Navarro, DM 
Brey, KJ Van Vliet, R Langer, JA Burdick. A combinatorial library of 
photocrosslinkable and degradable materials. Adv Mat 2006. 18(19): 
2614-8.) 
 
4.1 Introduction 
Photocrosslinkable and degradable polymers are finding a broad range of 
applications as drug delivery vehicles, tissue engineering scaffolds, and in the fabrication 
of microdevices [1-3].  However, the synthesis of multifunctional macromers that form 
these degradable networks commonly involves multiple functionalization and purification 
steps, which makes the development of large numbers of polymers with diverse 
properties difficult.  Here, we develop the first combinatorial library of degradable 
photocrosslinked materials.  A library of acrylate terminated poly(β-amino ester)s was 
synthesized in parallel, via a condensation reaction that combines primary or secondary 
amines with diacrylates.  This library of macromers was then photopolymerized to form 
degradable networks, with a wide range of degradation times (< 1 day to minimal mass 
loss after 3 months), mass loss profiles, and mechanical properties (~ 4 to 350 MPa).  We 
believe this library approach will allow for the rapid screening and design of degradable 
polymers for a variety of applications. 
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 The spatial and temporal control afforded during photoinitiated polymerizations 
has motivated their wide application in the general field of biomaterials [1, 3].  For 
example, photocrosslinkable hydrogels are used for the delivery of cells to injured tissues 
[4-8], for the encapsulation and controlled delivery of biological molecules [9-11], and 
for controlled fluid flow and cell confinement in microfluidics [12, 13].  Additionally, 
highly crosslinked photopolymers are currently used in dentistry [14] and are being 
developed as bone-replacement materials [15, 16] and for the fabrication of micro 
devices [17].  Many of these applications are only possible due to the controlled nature of 
this type of polymerization.  For example, photoinitiated control of polymerization allows 
for their application as injectable biomaterials [18, 19] with a non-cytotoxic 
polymerization process [20].  Additionally, through use of masks and lasers, the spatial 
control of the polymerization process allows for unique patterning and construction of 
complex materials [21].   
 Numerous photopolymerizable and degradable materials have been developed, 
including polyanhydrides, poly(propylene fumarates), poly(ethylene glycol), and 
polysaccharides [8, 15, 16, 18], all utilizing multiple reaction and purification steps for 
synthesis of the photopolymerizable precursors.  Despite this work, it has proven 
challenging to predict specific desirable properties (e.g., degradation and mechanics) 
from known chemical and structural details of the network precursors.  These properties 
are essential in the design of degradable polymers.  For instance, it may be desirable to 
synthesize a very hard material for some applications (e.g., orthopaedics), whereas a soft 
material is advantageous for other applications (e.g., tissue adhesive) [22, 23].  One 
potential solution to the inability to predict physical behavior is the generation of a higher 
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throughput approach to rapidly synthesize and screen photopolymerizable libraries of 
biomaterials.  Combinatorial polymer synthesis has been previously performed by 
numerous investigators [24-27] and has led to the identification of polymers with unique 
properties.  However, this has not been previously performed for the synthesis of 
photoreactive macromers that formed crosslinked and degradable polymers.     
To this end, we have synthesized degradable photocrosslinkable macromers 
through the conjugate addition of primary or bis(secondary) amines to diacrylates (Figure 
4.1) to form functionalized poly(β-amino ester)s.  Polymerization of the macromer occurs 
by a step-growth mechanism and the resulting linear macromers contain both esters and 
tertiary amines in their backbones [28]. Side chain functionalized polymers can be 
synthesized by incorporation of functionalized amines or diacrylates (e.g., R2 or R3 in 
Figure 4.1).  By altering the ratio of the diacrylate to amine, poly(β-amino ester)s with a 
wide range of molecular weights and end groups can be synthesized.  To form 
crosslinked networks, acrylate terminated poly(β-amino ester)s were readily obtained by 
performing synthesis with an excess of diacrylate (amine molar ratio of 1.2).  After 
photocrosslinking, the poly(β-amino ester) networks degrade under physiological 
conditions via hydrolysis of their backbone esters to yield small molecule bis(β-amino 
acid)s, diol products, and poly(acrylic acid) kinetic chains.  In addition to the simplicity 
of synthesis, the benefits of this system are that:  i) amine and diacrylate monomer 
reagents are inexpensive and commercially available, ii) polymerization can be 
accomplished without the need for additional protection/deprotection schemes because 
amines participate directly in the bond-forming processes in these reactions, iii) no 
byproducts are generated during synthesis which eliminates the need for purification 
  68 
steps, and iv) the conjugate addition reaction is generally tolerant of additional 
functionality such as alcohols, ethers, and tertiary amines, which further expands the 
available amines and diacrylates available for the library.   
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Figure 4.1 General polymerization scheme and chemical structures. Diacrylated 
macromers were synthesized by the condensation polymerization of an amine with a 
diacrylate (top).  The various monomers used included 12 amines and 10 diacrylates 
(bottom) to produce a library of 120 photopolymerizable macromers.  The macromers 
were crosslinked into polymers with exposure to ~10 mW/cm2 ultraviolet light (365 nm) 
for 5 minutes. 
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4.2 Materials and Methods 
4.2.1 Macromer synthesis and characterization 
 Macromers were synthesized in parallel by the mixture of the amine and 
diacrylate in a 10 ml scintillation vial.  The vial was reacted while stirring at 90ºC 
overnight.  Samples were stored at 4ºC prior to analysis.  The chemical structures and 
molecular weights of several polymer systems were verified with gel permeation 
chromatography and 1H-NMR. 
GPC was performed using a Hewlett-Packard 1100 Series isocratic pump, a 
Rheodyne Model 7125 injector with a 100-μL injection loop, and a Phenogel MXL 
column (5 μm mixed, 300 × 7.5 mm, Phenomenex, Torrance, CA). 70% THF/30% 
DMSO (v/v) + 0.1 M piperidine was used as the eluent at a flow rate of 1.0 mL/min. Data 
were collected using an Optilab DSP interferometric refractometer (Wyatt Technology, 
Santa Barbara, CA) and processed using the TriSEC GPC software package (Viscotek 
Corporation, Houston, TX). The molecular weights and polydispersities of the polymers 
were determined relative to monodisperse polystyrene standards.     
The macromer chemical structures were analyzed with proton nuclear magnetic 
resonance (1H-NMR, 360 MHz, DMX360, Bruker, Madison, WI).  The 1H-NMR spectra 
were taken for the initial diacrylates and amines and compared to the spectra for the 
synthesized macromers in each of the diacrylate to amine ratios.  The MMW was 
calculated using ratios of the areas of acrylate peaks (ppms) to the peaks in the macromer 
backbone. 
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4.2.2 Polymerization and degradation 
 The macromers were mixed with the photoinitiator 1,1-dimethoxy-1-phenyl 
acetophenone (DMPA, Sigma, dissolved 10 wt% in methylene chloride) and placed in a 
vacuum desiccator overnight for solvent removal.  The macromer/initiator mixture was 
placed between two glass slides separated with a 1mm spacer and polymerized with 
exposure to ~10 mW/cm2 ultraviolet light (Blak-Ray® UV lamp, 365 nm) for 5 minutes.  
Polymer slabs (~0.8 cm×1.2 cm, 3 per macromer) were cut from the samples, weighed, 
and placed in tissue culture cassettes.  The cassettes were submerged in 150 mM 
phosphate buffered saline (PBS) and placed on an orbital shaker in a 37ºC incubator for 
degradation.  At each time point, samples were removed, dried and weighed to determine 
the mass loss.  A3, A5, A10, A12, B3, B9, B12, C5, C7, C9, D3, D5, D9, D10, D12, E10, 
F3, F5, F8, F9, G3, G8, G10, G12, I3, I9, J5, J7, J9, J10, J12 crosslinked during the 
polymerization process and were not evaluated in the degradation study. 
 
4.2.3 Mechanical properties characterization 
 Macromers were dissolved at 1:2 v:v ratio in tetrahydrofuran containing 2 wt% 
DMPA and a spot volume of 10 µl was pipetted onto the surface of an epoxy monolayer-
coated glass slide (Xenopore XENOSLIDE E, Hawthorne, NJ) (~18 spots per slide).  The 
THF was allowed to evaporate for 30 - 60 minutes at room temperature.  The deposited 
macromer was then polymerized by exposure to long-wave UV (Blak-Ray®) for 10 
minutes in the presence of argon.  They were again vacuum desiccated for at least 7 days 
prior to analysis.  Polymer spot thickness was analyzed via contact profilometry (Tencor 
P10 Surface Profilometer, San Jose, CA) and was >200 µm for all spots. Nanoindentation 
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was conducted on a pendulum-based nanoindenter (force resolution: 1.5 µN, 
displacement resolution: 0.1 nm, force maxima: 30 mN, displacement maxima: 4 µm) 
equipped with a scanning stage (NanoTest600 NT1 and NT0, Micro Materials, Wrexham, 
UK) and fitted with a spherical indenter of radius R = 500 µm.  For this contact-based 
approach, it was necessary that polymers adhered well to the underlying slide substrate; 
polymers not meeting this criterion upon photocrosslinking were excluded from this 
analysis. Indentations were conducted in load control at a rate of 5 μN/s to a maximum 
depth of 600 nm, resulting in maximum loads ranging from 20 μN to 800 μN and contact 
strains < 1%. This method was previously described in detail [29].  Load-depth responses 
were analyzed for E via the method of Field and Swain [30].  Each of the 79 polymers 
was synthesized and analyzed in triplicate, with three indentations conducted per spot or 
a total of nine indentations per polymer.  
 
4.3 Results and Discussion 
The library of 120 diacrylate terminated poly(β-amino ester) macromers (12 
amines and 10 diacrylates reacted at a diacrylate to amine molar ratio of 1.2) was 
synthesized using the reagents shown in Figure 4.1.  These reagents were chosen to 
provide chemical diversity, including variations in hydrophobicity [31].  The synthesis of 
representative macromers was verified by nuclear magnetic resonance (NMR, Figure 4.2) 
and gel permeation chromatography (GPC, Figure 4.3).  The NMR results illustrate the 
disappearance of the amine protons during macromer synthesis and the prevalence of 
acrylate components in the final macromer.  The GPC results indicate that macromer 
molecular weights are ~2-3 kDa with polydispersities of ~1.5.  These results were 
completed with the Langer lab at the Massachusetts Institute of Technology and were not 
able to be repeated through on the equipment in our lab. 
 
Figure 4.2 NMR results for a diacrylate (J, top) and an amine (6, middle) used for the 
synthesis of a photopolymerizable macromer (J6, bottom). Note the acrylate peaks and 
disappearance of amine protons in the synthesized macromer. 
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Figure 4.3 Representative GPC results, including number average molecular weight (Mn, 
g/mol) and polydispersity (PDI), for synthesiszed macromers (a. A1, b. B1, c. D8). 
 
Eighty-nine liquid macromers from this library were polymerized into crosslinked 
and degradable networks of approximately 200 mg.  This polymerization was 
characterized using FTIR to monitor the acrylate double bond conversion (Figure 4.4).  
With UV exposure, the double bonds were consumed with time indicating macromer 
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conversion into a network.  The degradation behavior was monitored over several months 
in triplicate.  (Several macromers crosslinked during synthesis and were not investigated 
further; see methods section for more details.) We characterize degradation as the ability 
to cleave ester linkages in the polymer networks, which releases network components 
(i.e., crosslinks, kinetic chains) when immersed in 150 mM phosphate buffered saline 
while rotating at 37ºC. 
 
 
Figure 4.4 Representative FTIR plot of double bond conversion with UV exposure.  The 
FTIR intensity of the acrylate peak normalized to the carbonyl peak is consumed with 
increased UV exposure (0-407 seconds). 
 
The distributions of polymer mass loss at two time points (24 hours and 57 days) 
are shown in Figure 4.5.  The polymers exhibited a wide range of degradation behavior 
with mass loss of 100% within 24 hours for some networks, while others lost little mass 
even after 57 days of immersion.  As seen in Figure 4.5a (data included as Table 4.1), 
many of the polymers that had degraded within 24 hours (such as D, H, I, and J) were 
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synthesized from diacrylates containing hydrophilic ethylene glycol units.  Mass loss was 
much slower when a more hydrophobic amine (e.g., 7, which contains a long aliphatic 
chain) was incorporated into the macromer.  After 57 days (shown in Figure 4.5b), a 
number of other polymers completely degraded, while others lost only a small amount of 
their initial mass.   These results show a wide distribution of mass loss at these two time 
points and that chemical versatility, through unique combinations of amines and 
diacrylates, plays a role in polymer degradation behavior.  Since variations in polymer 
degradation behavior are desired depending on the application, these results indicate that 
the polymer library could be useful for applications where polymers completely degrade 
very quickly to applications where little mass loss is desirable for extended periods.      
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Figure 4.5 Degradation behavior of polymers fabricated from the macromer library. The 
mass loss after 1 (a) and 57 days (b) for the polymers formed from the macromer array 
synthesized with 12 amines (1-12) and 10 diacrylates (A-J).  Additionally, the mass loss 
profiles are reported for macromers synthesized with one diacrylate (A) and 4 amines (1, 
6, 7, and 9) (c) and one amine (7) and 4 diacrylates (A, D, I, E).  Degradation was 
performed by immersing the samples in PBS on an orbital shaker at 37ºC.  These results 
illustrate the breadth of degradation profiles that are obtained using the macromer library.    
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Table 4.1 Data (expressed as mean +/- standard deviation) for the degradation studies reported in 
Figure 4.5 
Macromer Polymer Mass 
Loss (1 day) 
Polymer Mass 
Loss (57 Days) 
 Macromer Polymer Mass 
Loss (1 day) 
Polymer Mass 
Loss (57 Days) 
A1 14.5 ± 0.2 100.0  F1 1.3 ± 2.2 16.7 ± 2.8 
A2 3.1 ± 2.2 100.0  F2 0.2 ± 0.3 10.3 ± 2.2 
A3 - -  F3 - - 
A4 97.6 ± 2.1 100.0  F4 10.5 ± 5.7 100.0 
A5 - -  F5 - - 
A6 0.1 ± 2.1 32.2 ± 2.7  F6 4.5 ± 0.1 24.7 ± 5.0 
A7 1.2 ± 1.0 66.5 ± 1.2  F7 1.1 ± 0.9 4.3 ± 1.9 
A8 98.3 ± 1.5 100.0  F8 - - 
A9 2.6 ± 1.6 100.0  F9 - - 
A10 - -  F10 0.5 ± 2.6 5.9 ± 3.8 
A11 99.5 ± 3.0 100.0  F11 3.9 ± 0.6 26.8 ± 4.8 
A12 - -  F12 6.1 ± 2.5 10.1 ± 4.8 
B1 0.2 ± 1.7 23.9 ±2.9  G1 30.8 ± 1.4 54.3 ± 3.8 
B2 0.2 ± 1.3 23.0 ±2.9  G2 42.7 ± 2.1 57.4 ± 5.7 
B3 - -  G3 - - 
B4 1.3 ±3.4 82.1 ±5.2  G4 31.3 ± 1.7 42.8 ± 5.5 
B5 - -  G5 41.3 ±1.3 51.5 ± 1.5 
B6 1.0 ±2.6 1.1 ± 3.4  G6 5.7 ± 1.2 43.4 ± 0.8 
B7 0.7 ± 0.7 1.5 ± 1.3  G7 7.3 ± 1.1 27.8 ± 5.5 
B8 99.5 ± 4.8 100.0  G8 - - 
B9 - -  G9 11.8 ± 1.7 53.6 ± 3.0 
B10 12.6 ± 3.3 53.4 ± 2.4  G10 - - 
B11 11.2 ± 1.3 76.0 ± 2.2  G11 5.6 ± 0.6 53.4 ± 8.6 
B12 - -  G12 - - 
C1 1.7 ± 2.4 4.4 ± 2.8  H1 99.3 ± 2.1 100.0 
C2 1.4 ± 1.7 8.8 ± 6.3  H2 100.0 100.0 
C3 10.5 ± 2.8 60.3 ± 2.2  H3 - - 
C4 1.9 ± 2.1 60.0 ± 1.8  H4 100.0 100.0 
C5 - -  H5 98.9 ± 2.5 100.0 
C6 3.0 ± 1.9 5.3 ± 1.0  H6 62.5 ± 1.1 38.3 ± 22.6 
C7 - -  H7 22.0 ± 1.9 100.0 
C8 3.9 ± 2.7 81.7 ± 4.7  H8 97.5 ± 2.2 100.0 
C9 - -  H9 - - 
C10 3.2 ± 1.8 48.5 ± 2.0  H10 38.0 ± 3.4 39.0 ± 11.7 
C11 5.8 ± 1.9 35.7 ± 2.7  H11 97.3 ± 1.4 100.0 
C12 4.2 ± 2.0 52.3 ± 3.1  H12 61.2 ± 1.5 52.6 ± 26.6 
D1 99.1 ± 3.0 100.0  I1 99.1 ± 0.5 100.0 
D2 97.1 ± 1.6 100.0  I2 92.4 ± 5.7 100.0 
D3 - -  I3 45.4 ± 3.5 49.7 ± 30.6 
D4 85.0 ± 0.5 87.2 ±2.6  I4 99.6 ± 4.2 100.0 
D5 - -  I5 - - 
D6 4.3 ± 2.2 100.0  I6 5.3 ± 0.5 66.5 ± 1.5 
D7 0.5 ± 0.5 100.0  I7 - - 
D8 98.9 ± 1.7 100.0  I8 99.7 ± 1.5 100.0 
D9 - -  I9 - - 
D10 - -  I10 - - 
D11 100.0 100.0  I11 100.0 100.0 
D12 - -  I12 - - 
E1 2.3 ± 0.3 50.6 ± 0.3  J1 99.0 ± 0.3 100.0 
E2 3.4 ± 1.6 36.8 ± 1.1  J2 97.7 ± 0.6 100.0 
E3 24.7 ± 2.5 62.0 ± 2.5  J3 55.3 ± 3.4 13.1± 31.7 
E4 2.7 ± 3.1 64.8 ± 2.5  J4 96.9 ± 0.8 100.0 
E5 18.9 ± 2.4 75.3 ± 1.4  J5 98.8 ± 1.9 100.0 
E6 4.7 ± 1.4 8.3 ± 1.4  J6 62.2 ± 1.2 55.4 ± 17.6 
E7 0.2 ± 0.8 4.1 ± 1.8  J7 18.2 ± 15.7 100.0 
E8 99.5 ± 2.4 100.0  J8 99.4 ± 2.8 100.0 
E9 5.2 ± 3.9 70.1 ± 6.4  J9 80.2 ± 15.4 100.0 
E10 - -  J10 47.8 ± 2.2 38.9 ± 22.4 
E11 23.7 ± 2.5 67.0 ± 1.9  J11 98.4 ± 1.1 100.0 
E12 20.0 ± 0.5 50.7 ± 15.4  J12 65.7 ± 3.3 69.6 ± 1.6 
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The degradation behavior for one specific diacrylate (A) polymerized with several 
amines and photocrosslinked is shown in Figure 4.5c.  Here, one chemical component 
was held constant and the other was altered to control the degradation profiles.  In this 
example, polymers degraded in ~1 week (A1), ~ 3 weeks (A9), ~3 months (A7), and > 3 
months (A6).  This trend cannot be inferred easily from the chemical structure of the 
amines indicated in Fig. 4.1, underscoring the advantage of a combinatorial approach for 
this application. Additionally, one amine (7) was polymerized with several diacrylates 
and photocrosslinked.  The degradation behavior is shown in Figure 4.5d and illustrates 
polymers that degrade in ~1 week (I7), ~ 2 weeks (D7), ~3 months (A7), and > 3 months 
(E7).  This result follows the general trend that polymers formed from the more 
hydrophilic macromers (e.g., I and D) degraded faster than polymers A (fewer ethylene 
glycol repeat units) and E (longer aliphatic chain).  The overall degradation profiles range 
from relatively linear mass loss to systems where mass loss is slow at early times and 
accelerates as network degradation proceeds.  These variations, achieved through simple 
chemical modifications, illustrate the versatility of this polymer library in tuning or 
choosing polymers with specific degradation properties.  This may prove useful in the 
identification of degradable polymers for tissue engineering and drug delivery.  For 
example, polymer matrices for tissue engineering ideally degrade slowly enough for 
sufficient tissue formation on the 3-dimensional scaffold, yet rapidly enough so that 
tissue development is not physically impeded.  The release rate of encapsulated drugs 
from delivery systems is commonly controlled by affecting the degradation rate of 
encapsulating polymers.  We expect this diversity in polymer degradation times could 
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prove useful in tuning encapsulated drug release kinetics to a target profile, an important 
factor in optimizing tissue regeneration [32]. 
As the mechanical properties of biomaterials are typically important for medical 
applications, the library was mechanically characterized. The elastic modulus (E) was 
determined for ~80 members of the polymer library using a rapid nanoindentation 
technique [29], as shown in Figure 4.6.   Within this library subset, E varied from ~4 to 
~350 MPa with an average modulus of 21.2 MPa (standard deviation of 5.3% among 
experiments on an individual polymer). Approximately 95% of the polymers exhibited E 
within the range of 4 to 25 MPa, which is on the order of moduli for elastomers and non-
biodegradable polyurethanes.  However, several polymers (e.g., F4, G9, H9) exhibited 
significantly greater E, on the order of moduli for nylon and high-density polyethylene 
[33, 34].  Although it would have been difficult to predict a priori that these specific 
polymers would exhibit superior elastic stiffness, especially since polymers with similar 
chemistry had moduli that were much lower, this property may be desirable for certain 
load-bearing or stress-matching applications. Importantly, mechanical stiffness does not 
correspond directly with degradation rate, demonstrating the potential to derive materials 
from this library with optimal stiffness and degradation behavior independently. 
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Figure 4.6 Mechanical behavior of polymers fabricated from the macromer library. The 
elastic modulus (E), determined with a nanoindentation method, is reported for 79 of the 
candidate polymers from the macromer library.  These polymers exhibit a range of E 
ranging from ~4 to ~350 MPa (note the log scale on the y-axis).   
 
At this point, diversity in polymer mechanics and degradation kinetics has been 
investigated based on the amines and diacrylates chosen for the macromer library.  The 
available degradation and mechanical properties of the library could be further expanded 
by adjusting the ratio of diacrylate to amine during macromer synthesis.  In this work, the 
ratio was held at 1.2 for the diacrylate to amine, leading to acrylate terminated 
macromers.  By decreasing the amount of diacrylate, the macromer molecular weight will 
increase, since the polymerizing chains will not terminate as quickly with more reactive 
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amines present.  Additional flexibility could also be attained by copolymerizing various 
macromers within the polymer library.   
 
4.4 Conclusions 
 In summary, we have synthesized and characterized the first library of degradable 
photocrosslinked materials.   The large diversity in degradation profiles and elastic 
moduli demonstrates the potential of this approach in the rapid optimization of material 
properties.  Since crosslinking is radically initiated, these materials may also find non-
medical uses as degradable plastics. The chemical diversity presented by these materials 
could offer other advantages, including potential for specific cellular interactions [35], 
modification of toxicity, and the facilitation of drug delivery [36, 37].  We believe this 
combinatorial approach will provide a new method for identification and optimization of 
degradable and photopolymerized materials. 
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CHAPTER 5: Controlling Poly(β-amino ester) Network 
Properties via Macromer Molecular Weight 
(Adapted from: DM. Brey, IE Erickson, and JA Burdick, “Influence of 
Macromer Molecular Weight and Chemistry on Poly(β-amino ester) 
Network Properties and Initial Cell Interactions,” J Biomed Mater Res A, 
2008, 85(3): 731-41) 
 
5.1 Introduction 
Injectable biomaterials have been used for many years for applications such as 
bone cements and for filling dental caries [1].  In recent years, injectable materials and 
specifically, photocrosslinkable polymers, have been developed for a variety of clinical 
applications; including adhesion prevention [2], tissue engineering [3-10], and drug and 
gene delivery [11].  Photopolymerization can be advantageous over other polymerization 
techniques for many of these applications because they occur rapidly at physiological 
temperature (37°C) and in biological environments without the use of solvents, which 
permits network formation in vivo [3].  Additionally, the polymerization is temporally 
and spatially controlled, which is not afforded by thermal initiation and allows for better 
control over the polymerization reaction (e.g., for minimizing exotherms) [1, 12] and for 
the fabrication of materials with complex structures (e.g., for tissue engineering scaffolds 
and microfluidic devices) [13-15]. 
For many of these intended applications, the overall mechanical properties of the 
biomaterial and the ability of the material to degrade (either enzymatically or 
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hydrolytically) in a controlled fashion are extremely important.  For instance, degradation 
is important in tissue engineering scaffolds to prevent the necessity of a secondary 
surgery for implant removal and may aid in healing if the degradation rate is matched to 
cell penetration and tissue formation.  In drug delivery, the controlled release of the 
payload is typically controlled by properties such as degradation and diffusion.  
Mechanics are an important design criteria for many applications if the material is to bear 
the load of the tissue [16], to control the interaction of cells with the material [17-19], and 
may be correlated to properties like swelling which subsequently controls encapsulated 
cell viability [20]. 
Numerous photopolymerizable and degradable biomaterials have been developed 
to date.  These include materials like poly(propylene fumarate)s (PPF) [21],  
photocrosslinkable polyanhydrides [22], poly(ethylene glycol)s [18, 23-25], and 
crosslinkable polysaccharides [4, 8, 10].  Typically, the syntheses of these polymers 
involve several reaction and purification steps.  These lengthy and often tedious synthesis 
procedures limit the potential variations in polymer chemistry and structure that can be 
developed and rapidly tested for various applications.  This is particularly important since 
the degradation, mechanical, and cellular interaction properties of these degradable 
polymer systems have proven difficult to predict based on chemistry alone; leading to 
long iterative processes for material development. 
To expedite the development of novel photocrosslinkable polymers, conjugate 
addition polymerizations have been used to create large libraries of poly(β-amino ester) 
(PBAE) macromers by combining commercially available primary and secondary amines 
with diacrylates [26, 27].  This procedure is relatively simple and does not require 
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protection/deprotection schemes, does not generate byproducts that must be removed 
through further purification steps, and is tolerant of most functional groups.  Similarly, 
through precise control over reagent concentration and selection of appropriate precursor 
molecules, a large library of PBAE macromers with acrylate end groups (ratio of acrylate 
to amine > 1) was synthesized that form degradable networks using photoinitiated 
polymerizations [28]. This macromer library was produced with only a diacrylate to 
amine ratio of 1.2, so variations in molecular weight were not investigated.  Networks 
formed from this macromer library were screened for degradation and initial mechanical 
properties and showed that a wide range of degradation behavior and mechanical 
properties are possible from the library.  Now, application-specific design criteria can be 
used to identify candidate polymers from this library that can be further developed for a 
variety of applications (e.g., tissue engineering, drug delivery, microfluidics).    
The overall aim of this study is to utilize the advantages of this synthesis process 
to further expand the library by investigating the control over macromer molecular 
weight (MMW) during synthesis and examine how this influences network reaction 
behavior, bulk properties, and degradation.  Specifically, three macromers from the 
original library were selected and utilized for this fundamental study of macromer 
structure/function relationships.  Additionally, for the first time, the interaction of cells 
with these novel materials was investigated.  This work represents another step towards 
the development of advanced polymers for a variety of biological applications, and 
specifically as scaffolding for tissue engineering. 
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5.2 Materials and Methods 
5.2.1 Macromer synthesis and characterization 
Acrylate terminated PBAEs were synthesized in parallel by the step-growth 
polymerization of commercially available primary amines and diacrylates [28].  The 
diacrylates and amines (Figure 5.1) included triethylene glycol diacrylate (J) and 1,6-
hexanediol diacrylate (C) (Scientific Polymer Products, Ontario, NY); 1,6-hexanediol 
ethoxylate diacrylate (E), 1-amino-2-methylpropane (6), and 1-(3-aminopropyl)imidazole 
(12) (Sigma, St Louis, MO); and 3-methoxypropylamine (1) (TCI America, Portland, 
OR).  These liquid reagents were mixed at molar ratios of 1:1, 1.05:1, 1.1:1, 1.2:1, and 
1.4:1 of diacrylate to amine (J6, C12 or E1) in glass scintillation vials at 90°C overnight 
while stirring (700 rpm, Telesystem HP15/RM, Variomag USA, Daytona Beach, FL).  
The sample notation is consistent with our previous report on the development of the 
initial photocrosslinkable macromer library [28].  The viscous liquid macromers were 
immediately used for testing, polymerized into networks, or stored at 4°C until use. 
 Figure 5.1 Chemical structures of diacrylates (J, E, C) and amines (6, 1, 12) used in the 
synthesis of acrylate terminated poly(β-amino ester)s. These macromers can be 
crosslinked into degradable networks using a free-radical photoinitiated polymerization. 
 
The macromer chemical structures were analyzed with proton nuclear magnetic 
resonance (1H-NMR, 360 MHz, DMX360, Bruker, Madison, WI) and Fourier transform 
infrared (FTIR, Nicolet 6700, Thermo Electron, Waltham, MA) spectroscopy.  The 1H-
NMR spectra were taken for the initial diacrylates and amines and compared to the 
spectra for the synthesized macromers in each of the diacrylate to amine ratios.  The 
MMW was calculated using ratios of the areas of acrylate peaks (ppms) to the peaks in 
the macromer backbone.  For FTIR analysis, a drop of the liquid macromer was placed 
on a zinc selenium crystal and spectra were obtained in attenuated total reflectance 
(ATR) FTIR mode.  The ATR-FTIR spectra were then analyzed to monitor variations in 
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the areas of the acrylate peaks (~1630 cm-1) normalized to the carbonyl peak (~1730cm-1) 
as the ratio of diacrylate:amine was altered.   
 
5.2.2 Photopolymerization and network characterization 
The photoinitiator 2,2-dimethoxy-2-phenyl acetophenone (DMPA, Sigma) was 
added to the liquid macromers at a final concentration of 0.5% (w/w) by addition of a 
10% (w/v) solution of DMPA in methylene chloride and solvent was removed in a 
vacuum desiccator overnight.  The polymerization behavior was monitored using an 
ATR-FTIR system with a zinc selenium crystal.  A drop of the macromer/initiator 
solution was placed directly on the horizontal crystal, covered with a glass cover slip, and 
exposed from above to ultraviolet light (~1.3 W/cm2 at tip of light guide, distance of 24 
cm, 365 nm, Omnicure Series 1000, Exfo, Quebec, Canada).  The change in area of the 
double bond peak (~1630 cm-1) was used to monitor double-bond conversion in real-
time.  Values were normalized to the area of the carbonyl peak (~1730 cm-1) and 
converted to double bond conversion using the initial peak areas.   
For mechanical testing, the macromer/initatior solution was placed between glass 
slides with either a 1 mm (tensile and degradation samples) or 2 mm (compression 
samples) spacer and polymerized with exposure to ~10 mW/cm2 ultraviolet light (365nm, 
Blak-Ray B-100 AP, Ultraviolet Products, Upland, CA) for 5 minutes.  The polymers 
were then cut into 25 mm x 5 mm slabs for tensile testing and 5 mm disks were punched 
for compression testing.  Tensile testing was performed on a materials testing machine 
(Microtester 5848, Instron, Norwood, MA) with a constant strain rate of 0.1% per second 
until macroscopic failure.  The elastic modulus was then calculated as the slope of the 
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linear portion of the stress versus strain plot.  Unconfined compression testing was 
completed on a custom made mechanical testing device designed as described in Soltz et 
al.[29]  Samples were creep tested under a 2 gram load until equilibrium and then 
stressed to 10% strain at 1μm/sec and allowed to relax.  The compressive moduli were 
calculated as the slope of the stress versus strain plots between 5 and 10% strain. 
The soluble (sol) fraction of the various networks was determined by placing 
polymer discs in methylene chloride overnight.  This allowed unreacted macromer to 
swell from the network.  After drying, the sol fraction was calculated as the percent of 
initial mass lost during overnight swelling (only one cycle).  Negligible mass loss was 
observed with subsequent swelling and drying cycles indicating that the sol fraction was 
removed during the first cycle.   
 
5.2.3 Polymer degradation 
Samples were polymerized as described above and 5 mm x 5 mm squares were 
cut from the 1 mm thick slabs and weighed (initial mass).  Samples were placed in 
histology cassettes and degraded in phosphate buffered saline (PBS) at 37°C (pH 7.4) on 
an orbital shaker.  Samples were removed after 1, 2, 4, 7, 10, 13, and 17 weeks of 
degradation, dried in an oven, and weighed (final mass).  The overall mass loss was 
calculated from the recorded initial and final mass values.  Mechanical properties with 
degradation were determined through tensile and compressive analysis of samples as 
described above after 2 and 4 weeks of degradation.   
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5.2.4 Cell interaction studies 
To prepare films for cell interaction studies, the macromer/initiator solutions were 
dissolved in ethanol at a 1:2 (w/v) ratio and pipetted (30 μl) into 24-well plates.  The 
ethanol was allowed to evaporate off overnight to leave a thin film of the macromer and 
initiator.  The plates were placed in a transparent chamber being purged with nitrogen 
and polymerized for 10 minutes with ultraviolet light (Blak Ray).  To sterilize the films, 
the plates were placed under a germicidal lamp in a laminar flow hood for 30 minutes.  
Wells were filled with PBS and left in an incubator overnight.  After washing with PBS, 
the wells were filled with growth media for 30 minutes prior to cell seeding. 
Human sarcoma osteoblast-like cells (SaOS-2, ATCC, Manassas, VA) were 
grown in media comprised of Modified McCoy’s Medium (ATCC) with 10% fetal 
bovine serum (FBS, Hyclone, Logan, UT) and 1% penicillin/streptomycin (Invitrogen, 
Carlsbad, CA).  SaOS-2 cells were seeded on the polymer films at 50,000 cells per well.  
The cells were cultured for 24 hours and fixed in 2.5% glutaraldehyde (Polysciences, 
Warrington, PA) for 15 minutes.  Phase contrast photomicrographs were taken using an 
inverted microscope (Axiovert, Zeiss, Oberkochen, Germany) and a digital camera 
(Axiovision, Zeiss).  The total cell number was determined by counting adhered cells in 
at least 5 random fields on 3 individual films for each composition at each time point.  
Cell area was measured using NIH ImageJ software (3 samples per polymer/ratio, 5 
pictures per well, 20 cells per picture, at least 300 cells per composition). 
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5.2.5 Statistical analysis 
Statistical analysis was performed using ANOVA with Tukey’s post-hoc among 
the groups with significance defined as a confidence level of 0.05.  All values are 
reported as the mean and the standard deviation of the mean. 
 
5.3 Results and Discussion 
5.3.1 Macromer synthesis and characterization 
Three macromers (E1, C12, and J6) were selected from our previously reported 
library of acrylate terminated PBAE macromers [28] and synthesized as shown in Figure 
5.1.  These specific macromers were chosen because they illustrated potential as 
scaffolding for tissue engineering due to their gradual mass loss and overall degradation 
times (~4 months).  For certain tissues, such as bone, this would allow for sufficient cell 
and tissue infiltration prior to complete degradation, yet would not inhibit tissue growth 
[30].  The initial macromer library incorporated a large range of chemical reagents 
(amines and diacrylates) and the influence of chemical alterations on polymer mechanics 
and degradation was investigated, however only one diacrylate to amine molar ratio was 
examined (i.e., 1.2).  This ratio controls the extent of polymerization that occurs before 
the amines are consumed and all macromer ends are terminated with acrylate groups 
(with a ratio > 1).  It is anticipated that simple alterations in the ratio can lead to changes 
in the MMW.   In this study, the diacrylate to amine ratio was varied at 1:1, 1.05:1, 1.1:1, 
1.2:1, and 1.4:1 in order to change the MMW of the macromer and investigate the 
influence of MMW on polymer properties and cell interactions.  It should be noted that 
the objective of this study is not to illustrate that one of these macromers is ideal for 
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tissue engineering, but to investigate the influence of chemical and structural alterations 
of the macromer on the final properties.  This information can then aid in development of 
biodegradable PBAEs for a specific application. 
The resulting macromers were characterized with 1H-NMR and representative 
spectra are shown in Figure 5.2.  These spectra demonstrate the chemical diversity of the 
different macromers, illustrate the complete consumption of amine protons during 
synthesis, and show the maintenance of peaks for acrylate reactive moieties.  Protons 
from the amine group are represented by a broad peak found around ~1.1 ppm and are 
found in the spectra of the initial amine reagents but are not present in any of the 
synthesized macromer spectra.  The area of acrylate peaks (labeled in Figure 5.2 as a and 
b at ~6.4, 6.0, and 5.7 ppm for one ratio) changed with variations in the diacrylate to 
amine ratios (i.e., smaller peaks for lower ratios) indicating variations in the MMWs (see 
Figure 4.4). 
 Figure 5.2 NMR spectra of macromers J6, E1, and C12 synthesized at a diacrylate to 
amine ratio of 1.2:1. Of interest is the maintenance of acrylate proton peaks (~6.4, 6.0, 
5.7 ppm) and the disappearance of the amine proton peaks (~1.1 ppm).  
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The MMW was calculated with 1H-NMR, via end group analysis (comparison of 
acrylate protons to backbone protons), and the results are shown in Table 5.1.  The area 
of the acrylate peaks (representing 6 hydrogen atoms, 3 per macromer end group) was 
divided by the area of a peak corresponding to distinct protons in the backbone (labeled c, 
d, e, and f).  This gives the average number of repeat units, and this value can be used to 
calculate the number average molecular weight (Table 5.1).  For all cases, the MMW 
increases as the diacrylate to amine ratio decreases, as expected since the reaction can 
proceed further prior to termination when a more equivalent molar ratio is used.  The 
calculated number average molecular weight is anticipated to be an overestimation of the 
MMW, since this analysis assumes that all end groups are diacrylates.  However, 
impurities in the original diacrylate reagents (which were 85-90% pure) can lead to end-
groups that are not acrylates, but hydroxyl groups.   
 
Table 5.1 Number of repeat units (n) and number average molecular weight (MMW) determined with end 
group analysis using 1H-NMR, as well as the sol fraction of the photopolymerized networks polymerized 
from the various macromers and MMWs. 
Macromer Ratio n MMW Sol Fraction (%) 
1:1 17.5 6070 47.5 ± 1.1 
1.05:1 12.2 4317 36.9 ± 1.0 
1.1:1 11.4 4049 24.5 ± 0.3 
1.2:1 5.8 2182 12.8 ± 1.9 
J6 
1.4:1 3.5 1406 2.2 ± 0.3 
1:1 13.8 5080 47.2 ± 0.4 
1.05:1 10.6 3945 44.9 ± 3.8 
1.1:1 8.3 3159 33.8 ± 0.9 
1.2:1 5.7 2230 17.4 ± 0.6 
C12 
1.4:1 3.6 1486 10.9 ± 0.4 
1:1 9.1 3982 48.9 ± 0.6 
1.05:1 8.0 3531 33.9 ± 0.4 
1.1:1 6.9 3111 23.2 ± 0.2 
1.2:1 5.7 2596 12.0 ± 0.7 
E1 
1.4:1 3.6 1768 4.3 ± 0.9 
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Additionally, the ATR-FTIR spectra of the various macromers at the different 
ratios were obtained to assess variations in the acrylate peak (~1630 cm-1) and are shown 
in Figure 5.3 for macromer E1.  The acrylate region (Figure 5.3A) is suppressed as the 
ratio decreases, indicating once again that the MMW is increasing.  Figure 5.3B shows 
the area of the acrylate peak normalized to the area of the carbonyl peak (~1730 cm-1).  
Again, these values illustrate an increase in acrylate concentration with an increase in the 
diacrylate:amine ratio during synthesis.  
 Figure 5.3 Macromer characterization with ATR-FTIR.  Initial ATR-FTIR spectra for 
the acrylate double bond (~1630 cm-1) with varying ratios of diacrylate to amine (A) and 
the normalized double bond concentration calculated as the ratio of the acrylate to 
carbonyl (~1730 cm-1) peak areas.   
 
5.3.2 Photopolymerization and network characterization 
Free radical polymerizations of the synthesized macromers were initiated by 
ultraviolet light exposure of the macromer with 0.5% DMPA as the initiator.  Although a 
solvent was used to add the initiator to the macromer, the solvent was evaporated prior to 
  101 
  102 
polymerization.  This reaction was monitored in real time using ATR-FTIR to determine 
the real-time conversion of the acrylate double bonds that form network kinetic chains 
and ultimately lead to a crosslinked polymer.  The conversion profiles (Figure 5.4A) of 
macromer E1 for all MMWs indicate that lower MMWs react much faster and to higher 
double bond conversions (Figure 5.4B) after 10 minutes than the higher MMWs.   This is 
likely due to the increase in the concentration of reactive groups for the lower MMWs 
and an increase in initial diffusion limitations for the higher MMWs.  The overall 
reaction behavior and ultimate double bond conversion is important because it is 
correlated to network mechanical properties and unreacted macromer that may leach 
from the network and be toxic.  The sol fraction, listed in Table 5.1, is also an indicator of 
the lack of the complete acrylate conversion with the high MMW.  The sol fraction for 
the 1:1 ratio is over 47% for all three macromer chemistries.  The high concentration of 
soluble factors is likely due to these unreacted double bonds found during monitoring of 
the reaction with ATR-FTIR.  These molecules are never reacted into the 3-dimensional 
network and are released when the network is swollen in methylene chloride.  Also, 
impurities in the original diacrylate reagents produce macromers with one or both ends 
without acrylate moieties, which increases the sol content. 
 
 Figure 5.4 ATR-FTIR of the double conversion with UV exposure. Real-time double 
bond conversion of macromer E1 synthesized at various MMWs and polymerized on a 
zinc selenium crystal with exposure to ultraviolet light measured with ATR-FTIR (A) and 
the double bond conversion after 10 minutes (B) of ultraviolet light exposure. 
 
The mechanical properties of polymers J6, C12, and E1 formed from all MMWs 
were measured in both tension and compression.  The tensile moduli for J6, C12, and E1 
for the different MMWs are shown in Figure 5.5A.  For all of the polymers, a general 
trend is seen between the tensile modulus and the MMW (i.e. the moduli increases with 
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increasing diacrylate:amine ratio).  For instance, J6 at the 1:1 ratio had a modulus of 0.22 
± 0.012 MPa and a modulus of 4.50 ± 1.08 MPa for the 1.4:1 ratio, which represents a 20 
fold increase in modulus.  The mean moduli were statistically different between ratios of 
the same polymer for all cases except 1:1 and 1.05:1 for C12 and J6, 1:1 and 1.1:1 for J6, 
and 1.05:1 and 1.1:1 for all polymers.  Lower MMWs (greater diacrylate:amine ratio) led 
to networks with a higher crosslinking density, which corresponds to a greater modulus.  
Variations in the chemistry also contributed to the tensile properties, as the moduli for the 
C12 polymers were significant greater than the corresponding ratios of all E1 polymers 
and the 1:1, 1.05:1, and 1.4:1 ratios of J6.  This is attributed to the polymer chemistry and 
not the actual MMW since the MW for the C12 polymer fell between the J6 and E1 
polymer at all ratios (see Table 5.1).  The J6 polymers are significantly larger that the E1 
for the 1.2:1, 1.1:1, and 1:1 ratios.   
 
 Figure 5.5 Mechanical property changes with respect to  chemistry, MMW, and 
degradation. Moduli calculated in tension (A) and compression (C) for polymers formed 
from the J6, C12, and E1 macromers at various MMWs.  The tensile (B) and compressive 
(D) moduli measured after 2 and 4 weeks of degradation in PBS at 37°C for the 1.4:1 
ratio of all three polymers. 
 
The compressive moduli (Figure 5.5C), shows a similar trend as the tensile 
moduli with respect to MMW.  For example, the compressive moduli for the J6 1.4:1 and 
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1:1 were found to be 7.93 ± 0.23 and 0.075 ± 0.003 MPa, respectively.  At the highest 
ratio, there was no significant difference between the three chemistries, but for the other 
ratios, the C12 polymers were significantly stiffer.  For the 1.05:1 ratio, the modulus for 
J6 was significantly larger than E1.   The lower MMWs correspond to higher reactive 
group concentrations and subsequently, higher crosslinking densities.  The reaction 
behavior indicates that this also leads to greater double bond conversions.  These 
properties correspond to alterations and control over the bulk mechanics of the polymer.  
The macromer chemistry can also play a role and the C12 macromers have a large 
imidazole ring in each repeat unit, which intuitively may alter polymer mechanics.   
The ability to change mechanical properties by altering the MMW could be useful 
for fine tuning these properties in order to properly adapt to a desired application.  This is 
useful in tissue engineering applications as different cell types prefer different 
extracellular environments.  Cells have been shown to exert forces on their environment 
in order to sense the stiffness of their environment [17] and subsequently respond to it.  
Thus, material properties can play a role in cellular interaction behavior.  Recently Engler 
and coworkers [31] reported that matrix elasticity directs mesenchymal stem cells (MSC) 
differentiation.  When MSCs were grown on polyacrylamide gels of different stiffnesses, 
but in the same media, the cells grown on the soft gels expressed neurogenic markers, 
stiffer gels were myogenic, and the stiffest gels displayed osteogenic markers.  Therefore, 
the ability to control matrix stiffness can be used to alter MSC differentiation without 
soluble factors.   
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5.3.3 Polymer degradation 
The degradation of the various polymers was monitored over 17 weeks and the 
mass loss profiles are shown in Figure 5.6.  Typically, degradation began with a period of 
rapid mass loss, likely due to unreacted macromer release as indicated by the sol fraction 
from Table 5.1.  The rate of degradation increased with a decrease in the diacrylate:amine 
ratios. For example, for the C12 polymer 88.2% of the mass is lost after 17 weeks for the 
1.05:1 ratio, whereas only 58.5% is lost for the 1.4:1 ratio.  As the MMW increases, there 
are more hydrolytically susceptible bonds between the crosslinks.  Therefore, there is a 
greater probability that multiple bonds are hydrolyzed in the crosslink and a polymer 
fragment (i.e., degradation product) can be released into solution.  With this control, the 
degradation rate can be tuned to a particular application. 
 Figure 5.6 Degradation with varying MMW. Network mass loss with degradation in PBS 
at 37°C for the various MMWs of J6 (A), C12 (B), and E1 (C).  
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The influence of polymer chemistry on degradation is apparent in the mass loss 
profiles.  In Figure 5.6, the degradation of the J6 polymers occurs much faster than the 
C12 or E1 polymers.  After 9 weeks, all of the ratios, except the 1:1.4 ratio, have 
degraded completely for the J6 polymer.  The C12 polymer (Figure 5.6B) has distinct 
separation between the ratios as degradation proceeds, but the mass loss appears to 
plateau, which may indicate that there are non-degradable crosslinks incorporated in the 
network.  E1 polymer degradation for all MMWs is fairly linear.  The influence of 
macromer chemistry on degradation was reported previously during the initial 
development of the PBAE macromer library, but now more control over the degradation 
behavior is afforded by alterations in MMW. 
In general, mass loss correlates with a decrease in both the compressive and 
tensile moduli as shown in Figure 5.5B and D.  J6 and E1 polymers were consistently 
weaker with degradation, for the ratios (1.4:1 shown in Figure 5.5) studied.  The C12 
polymer showed an initial decrease in mechanics after 2 weeks, but no change was 
observed between 2 and 4 weeks.  This may be due to a portion of non-degradable 
crosslinks in the network as mentioned previously.  The decrease in polymer moduli with 
time is typical of a bulk-degrading polymer, which may be useful for tissue engineering 
applications since the surface is not shed with degradation and could potentially support 
cellular adhesion and growth. 
The ability to control degradation can be utilized in a number of medical 
applications.  Since molecule release is typically controlled by both diffusion and 
degradation, degradation can be used to alter and optimize the release of therapeutic 
molecules from degradable polymers.  The local and controlled release of drugs and 
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growth factors can be used to treat diseased or damaged tissues without the side effects 
associated with larger, systemic treatments [32, 33].  For example, this has been 
demonstrated in slow release of chemotherapeutics in neuronal implants, drug eluding 
stents, and microsphere treatments for prostate cancer [33].  In tissue engineering, control 
over degradation can be used to optimize extracellular matrix production and distribution 
[34].  The desired degradation rate is likely specific to tissue type, as some tissues exhibit 
regenerative capabilities like skin and bone, while others have limited regenerative 
potential, such as cartilage [35].  Thus, the ideal degradation can be adjusted by varying 
the MMW of these polymers or others from our initial PBAE library. 
 
5.3.4 Cell interaction studies 
SaOS-2 cells, a human osteoblast-like cell, were seeded onto polymer films to see 
how well anchor dependent cells attached and spread on the polymers with changes in the 
polymer chemistry and structure (i.e., MMW).  This experiment gives some indication of 
the toxicity of the polymers and how substrate properties influence cellular interactions.  
As a control, cells were also cultured under typical conditions on tissue culture 
polystyrene (TCPS).   
Figure 5.7 shows photomicrographs of cells grown on the surface of the J6 
polymer at each ratio (Figure 5.7B-F) as well as a control on standard tissue culture 
polystyrene (TCPS) (Figure 5.7A) after 24 hours in culture.  While cells adhered to all 
surfaces, cells were in a more rounded morphology on the lower ratios (i.e., higher 
MMWs) and showed no spreading on the lowest ratio, unlike the controls.  As the ratio 
increased, the cells appeared to spread out more.  A similar trend was seen on the E1 
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polymers. However, cell viability was low on the C12 polymers, potentially due to 
changes in the pH as indicated by color changes in the phenol-red containing media.  This 
limits the use of this polymer for tissue engineering applications, but fortunately there are 
other potentially viable candidates from the polymer library. Quantification of cell 
adhesion is shown in Figure 5.8A.  There was no statistical difference in the numbers of 
cells adhered to the films with variation in the MMW.  The areas of cell spreading on 
films of polymer J6 are plotted as a histogram in Figure 5.8B.  For higher MMWs the 
cells, while similar in number in Figure 5.8A, are dominated by cells with spread areas 
less than 300 μm2.  As the ratio increases, the cells are more distributed with larger areas.  
The higher ratios have more of the most spread cells (>1000 μm2), but still not as many 
as the TCPS cells.  While these are just short term measurements (24 hr), they indicate 
that chemistry can play a role in cell adhesion, as the cells appear to adhere to the E1 
polymers more readily than the J6 polymers.  The MMW (i.e., diacrylate to amine ratio) 
influenced the spreading of cells on the polymer films to morphologies similar to that of 
the TCPS controls.  This could be due to a few differences caused by changing the 
MMW.  First, many anchorage dependent cells have more organized cytoskeletons and 
more stable adhesions to stiffer environments [17] (hence why attachment to the stiff 
TCPS is so high) and therefore spread better on the stiffer matrices of the more highly 
crosslinked networks.  Also, polymers from higher MMWs had a higher sol fraction, 
which may release more potentially toxic components into the media. 
 Figure 5.7 Cell Seeding on J6 thin films. Photomicrographs of SaOS-2 cells 24 hours 
after seeding on TCPS (A), and films of polymers from the J6 macromers synthesized at 
diacrylate:amine ratios of 1.4:1 (B), 1.2:1 (C), 1.1:1 (D) , 1.05:1 (E), and 1:1 (F).  The 
scale bar represents 200 μm. 
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 Figure 5.8 Cell adherence and spread on J6 and E1. Number of cells adhered to J6 
(white) and E1 (black) normalized to the number of cells adhered to the TCPS control 
(A).  The C12 films created an acidic environment and there were no cells adhered to the 
polymer after 24 hours.  Histogram of the percentage of cells in ranges of spreading area 
for polymer J6 (B). * denotes that the polymer was not transparent at that composition 
and could not be analyzed. 
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5.4 Conclusions 
We have shown that by varying the ratio of diacrylates to amines in forming three 
different PBAE macromers, we can adjust the MMW.  By increasing the diacrylate to 
amine ratio (i.e., decreasing the MMW), the photopolymerization is faster and more 
complete.  This leads to increased mechanical stiffness and decreased rates of mass loss.  
For given ratios, the chemical structure of the networks can also affect the mechanical 
properties and degradation.  The mechanical properties decreased with degradation, 
which is indicative of bulk degradation.  Two of the polymers were found to support 
attachment and spreading of human SaOS-2 cells, and spreading was heavily dependent 
on MMW, with greater cell spreading on polymers formed from lower MMWs.  
Although no claims can be made regarding the suitability of these specific compositions 
for tissue regeneration applications, particularly due to high sol fractions, this work is 
beneficial in better understanding fundamental structure-function relationships and can be 
used for better designing photocrosslinkable biomaterials.   
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CHAPTER 6: Controlling Poly(β-amino ester) Network 
Properties through Macromer Branching  
(Adapted from: DM Brey, JL Ifkovits, RI Mozia, JS Katz, JA Burdick, 
“Controlling Poly(β-amino ester) Network Properties through Macromer 
Branching,” Acta Biomaterialia, 2008, 4(2): 207-17) 
 
6.1 Introduction 
Radically polymerized materials are useful as biomaterials for numerous 
applications.  For instance, bone cements and methacrylate monomers for filling dental 
caries have a history of use in medicine [1].  Light-initiated photopolymerizations are a 
type of radical polymerization that occurs at physiologically relevant temperatures (37°C) 
and with numerous wavelengths of light [2].  Photoinitiated polymerizations also offer 
spatial and temporal control over the reaction, which is useful in minimizing 
polymerization exotherms [3] and for fabricating complex structures [4, 5]. 
Many biomaterials have been developed that are photopolymerizable and 
degradable, including polyanhydrides [6], poly(propylene fumarate)s [7], poly(ethylene 
glycol)s [8, 9], and polysaccharides [10, 11].  These materials have been investigated for 
a wide range of applications, including cartilage and bone regeneration [8, 11, 12], 
cardiovascular applications [13, 14], drug delivery [15, 16], and in microfluidic devices 
[17].  One limitation in engineering these materials toward a specific application is that 
tuning their properties iteratively or predicting their behavior can be tedious and difficult.   
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To accelerate the identification of potentially useful biodegradable and free-
radically polymerized polymers, Anderson et al. developed a combinatorial approach for 
the synthesis of a library of poly(β-amino ester) (PBAE) macromers that are rapidly 
synthesized and form networks with a wide range of properties [18].  Specifically, 
network degradation times ranged from less than one day to over 4 months and the 
mechanics spanned two orders of magnitude (~2 MPa to ~200 MPa).  The synthesis 
involves the reaction of commercially available diacrylates with amines and no 
purification of the synthesized macromers is necessary.  Brey, et al. [19] further expanded 
the library by investigating the influence of macromer molecular weight, through changes 
in the ratio of acrylate to amine, on network properties.  This led to changes in network 
mechanical properties, degradation rates, and cell adhesion. 
The primary objective of this work was to examine the importance of macromer 
branching on network properties, since branching can be easily altered during the 
synthesis of PBAEs by introduction of a reagent with higher functionality (e.g., 
triacrylate).  This structural feature has only been minimally investigated and little is 
known about the influence of macromer branching on biodegradable polymers.  To this 
end, one specific composition from the PBAE library was used and a triacrylate group 
was systematically introduced during synthesis, while maintaining the overall molar ratio 
of acrylates to amines.  The influence of PBAE macromer branching on the overall bulk 
properties and initial cellular interactions of formed networks was investigated.  
Information obtained was also used to control scaffold mechanical properties.  This will 
hopefully provide an additional tool to control scaffold properties for tissue regeneration. 
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6.2 Materials and Methods 
6.2.1 Macromer synthesis and characterization 
Acrylate terminated PBAEs were synthesized in parallel by the step-growth 
polymerization of a commercially available primary amine, 3-methoxypropylamine (1, 
TCI America), and different ratios of 1,6-hexanediol ethoxylate diacrylate (E, Sigma) and 
pentaerythritol triacrylate (PETA, Sigma).  These liquid reagents were mixed at 
diacrylate:triacrylate ratios of 100:0, 95:5, and 90:10 while holding the molar ratio of 
acrylate end groups to amines constant (2.4:1) in glass scintillation vials at 90°C 
overnight while stirring (700 rpm, Telesystem HP15/RM, Variomag USA).  The sample 
notation is consistent with our previous report on the development of the initial PBAE 
library [18].  Proton NMR spectra were recorded in deuterated chloroform on a Bruker 
Avance 300 MHz instrument and calibrated to the chloroform (7.27 ppm) impurity as an 
internal standard. 
 
6.2.2 Photopolymerization  
The photoinitiator 2,2-dimethoxy-2-phenyl acetophenone (DMPA, Sigma) was 
added to the liquid macromers at a final concentration of 0.5% (w/w) by addition of a 
10% (w/v) DMPA in methylene chloride.  The solvent was removed in a vacuum 
desiccator overnight and all polymerizations were performed in bulk.  The 
polymerization behavior was monitored using attenuated total internal reflectance – 
Fourier transform infrared (ATR-FTIR, Nicolet 6700, Thermo Electron) spectroscopy 
with a zinc selenide crystal collecting a spectrum every 17 seconds with a resolution of 
3.86 cm-1 for 10 minutes.  A drop of the macromer/initiator solution was placed directly 
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on the horizontal crystal, covered with a glass cover slip, and exposed from above to 
ultraviolet light (~1.3 W/cm2 at tip of light guide, distance of 24 cm, 365 nm, Omnicure 
Series 1000, Exfo).  The change in area of the double bond peak (~1630 cm-1) was used 
to monitor double-bond conversion with light exposure.  Values were normalized to the 
area of the carbonyl peak (~1730 cm-1) and converted to double bond conversion using 
the initial peak areas.  Three samples for each macromer group were tested. 
 
6.2.3 Network characterization 
In order to test the bulk polymer properties, the macromer/initiator solution was 
placed between glass slides with a 1 mm spacer and polymerized with exposure to ~10 
mW/cm2 ultraviolet light (365nm, Blak-Ray B-100 AP, Ultraviolet Products) for 10 
minutes.  Polymer discs (5 mm diameter x 1 mm thick) were then punched from the 
resulting networks for testing.  The soluble (sol) fraction of the various networks was 
determined by placing 3 disks of each polymer in methylene chloride.  This allowed 
unreacted macromer to swell from the network.  After drying, the sol fraction was 
calculated as the percent of initial mass lost during 48 hours of swelling.  Negligible mass 
loss was observed with subsequent swelling and drying cycles, indicating that the sol 
fraction was removed during the first cycle.   
For degradation analysis, 4 disks were punched from the slabs and weighed 
(initial mass).  Samples were placed in histology cassettes and degraded in phosphate 
buffered saline (PBS) at 37°C (pH 7.4) on an orbital shaker with frequent changes of the 
PBS.  Samples were removed after 2, 4, 7, and 10 weeks of degradation, dried in an oven, 
and weighed (final mass).  The overall mass loss was calculated from the recorded initial 
and final mass values.   
To investigate kinetic chain lengths, a previously reported isolation process was 
used [20].  Briefly, thin samples (0.56 mm thick x ~1.5 cm diameter) were rapidly 
degraded in 4 N NaOH over 3 days at 37°C.  Thin samples were used to limit depth 
variations with light attenuation.  The pH of the solution was then adjusted to 8-9 with 
the addition of 4 N HCL and filtered through a 0.45 μm syringe filter.  Samples were then 
dialyzed (Spectra/Por® Biotech Cellulose Ester Membrane, molecular weight cut off: 
500, Spectrum Laboratories) and lyophilized (Freezone 4.5, Labconco).  Finally, samples 
were dissolved in DI water at 2μg/ml and run in aqueous gel permeation chromatography 
(GPC, 1ml/min, 515 HPLC Pump, Ultrahydrogel Linear and 250 columns, 2414 
Refractive Index Detector, Waters) to determine the kinetic chain molecular weights 
compared to PEG standards ( nM = 5000, 35000, and 203000). 
 
6.2.4 Mechanical testing 
For mechanical testing, slabs were prepared as described above with either a 1 
mm (tensile, dynamic, degradation samples) or 2 mm (compression samples) spacer.  The 
polymers were then cut into 25 mm x 5 mm samples for tensile and dynamic testing and 
5 mm disks were punched for compression testing.  Mechanical properties with 
degradation were determined through tensile and compressive analysis of samples 
prepared as described above after 2, 4, and 8 weeks of degradation, using the previously 
described degradation procedure.   
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Tensile testing was performed on a materials testing machine (Microtester 5848, 
Instron) with a constant strain rate of 0.1% per second until macroscopic failure.  The 
elastic modulus was then calculated as the slope of the linear portion of the stress versus 
strain plot.  Unconfined compression testing was completed on a custom made 
mechanical testing device designed as described in Soltz et al.[21],  Samples were creep 
tested under a 2 gram load until equilibrium and then stressed to 10% strain at 1 μm/sec 
and allowed to relax.  The compressive moduli were calculated as the slope of the stress 
versus strain plots between 5 and 10% strain.   
The viscoelastic behavior of the samples was determined using a Dynamic 
Mechanical Analyzer (Q800 TA Instruments).  Rectangular strips (25 mm x 5 mm  x 1 
mm) of polymer were cut from polymer slabs and tested in a controlled strain mode at 1 
Hz, an amplitude of 10 μm, and a heating rate of 3°C/min from -100°C to 25°C.  The 
glass transition temperature, Tg, is reported as the inflection point of the tan δ (the storage 
modulus over the loss modulus) curve.  The crosslinking density, νc, was calculating 
using the theory of rubber elasticity [22]: 
 νc = E′ / 3RT (6.1)
where E′ is the storage modulus in the rubbery plateau region at a given temperature T, R 
is the gas constant (8.314 J K-1 mol-1), and assumes that Poisson’s ratio for a rubber is 
0.5. 
  
6.2.5 Cell interaction studies 
To prepare films for cell interaction studies, the macromer/initiator solutions were 
dissolved in ethanol at a 1:2 (w/v) ratio and pipetted (35 μl) into 24-well plates.  The 
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ethanol was allowed to evaporate off overnight to leave a thin film of the macromer and 
initiator.  The plates were placed in a transparent chamber being purged with nitrogen 
and polymerized for 10 minutes with ultraviolet light (Blak Ray).  To sterilize the films, 
the plates were placed under a germicidal lamp in a laminar flow hood for 30 minutes.  
Wells were incubated with PBS overnight to allow unreacted monomer to be removed.  
After washing with PBS, the wells were incubated with growth media for 30 minutes 
prior to cell seeding. 
Human sarcoma osteoblast-like cells (SaOS-2, ATCC) were grown in media 
comprised of Modified McCoy’s Medium (ATCC) with 10% fetal bovine serum (FBS, 
Hyclone) and 1% penicillin/streptomycin (Invitrogen).  SaOS-2 cells were seeded on the 
polymer films at 50,000 cells per well (24-well plate).  The cells were cultured for 2 and 
7 days, fixed in 2.5% glutaraldehyde (Polysciences) for 15 minutes, and cell nuclei were 
stained with DAPI (1:2500).  Phase contrast and fluorescent photomicrographs were 
taken using an inverted microscope (Axiovert, Zeiss) and a digital camera (Axiovision, 
Zeiss).  The total cell number was determined by counting adhered cell nuclei in at least 5 
random fields on 3 individual films for each composition at each time point.  Cell area 
was measured using NIH ImageJ software (3 samples per polymer/ratio, 5 pictures per 
well, 20 cells per picture, at least 300 cells per composition). 
 
6.2.6 Scaffold fabrication and characterization 
Porous scaffolds were fabricated using previously developed techniques of salt 
leaching [23] and sintered poly(methyl methacrylate) (PMMA) microbeads [24].  Briefly, 
a solution of 2:1 (w:v) macromer:ethanol containing DMPA and NaCl crystals (sieved to 
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100-300 μm) were mixed together (80:20 mass ratio NaCl:macromer) and packed into 
teflon molds.  The ethanol was evaporated overnight in a vacuum desiccator, and the 
resulting salt-macromer mixture was crosslinked with ultraviolet light exposure (as 
described above) between glass slides.  Samples were then cut, the salt was leached with 
several washes in DI water, frozen in liquid nitrogen, and lyophilized for scanning 
electron microscopy (SEM) and mechanical testing in compression as describe above. 
For spherical porosity, PMMA microbeads (250 μm, Polysciences) were packed 
into teflon molds, clamped between glass slides, and placed in an oven at 120°C for 22 
hours [24].  The glassy top layer was then scraped away, and the voids between the 
sintered spheres were filled with macromer/DMPA/ethanol solutions.  The ethanol was 
evaporated overnight in a vacuum desiccator, the constructs were crosslinked with 
ultraviolet light exposure (as described above) between glass slides, the PMMA was 
removed with several washes in methylene chloride, and the methylene chloride was 
removed with several washes in water.  Samples were then frozen and lyophilized before 
SEM analysis and compressive mechanical testing as described above. 
 
6.2.7 Statistical analysis 
Statistical analysis was performed using ANOVA with Tukey’s post-hoc among 
the groups with significance defined as a confidence level of 0.05.  All values are 
reported as the mean and the standard deviation of the mean. 
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6.3 Results and Discussion   
6.3.1 Synthesis of macromers 
Recently, a large library of PBAEs, synthesized via a step growth polymerization 
of liquid amines and diacrylates, was developed for biomaterial applications [18].  The 
biggest advantage to this system is that the reaction scheme is simple since there is no 
purification necessary and that a large number of networks formed from the PBAEs can 
be rapidly synthesized and screened for applications in tissue regeneration.  Although the 
diversity in properties through alterations in the macromer chemistry and molecular 
weight [19] was explored, no investigations have been completed on the influence of 
structural illustrate the diverse properties possible through this structural variation.  The 
macromer made from the diacrylates E and the amine 1 (E1) was selected because it did 
not have optimal cell interactions, and thus, could illustrate the potential improvement in 
properties with the addition of branching.  The system involved the synthesis of a 
diacrylate (E) and a primary amine (1) to form a linear diacrylated macromer, or 
alternatively, a system of branched multiacrylated macromers and linear diacrylated 
macromer with the features, namely branching, on network properties.   
Thus, we synthesized one macromer system (Figure 6.1), with a variety of 
branching structures, with the addition of small quantities of triacrylate (PETA).  This 
was performed in ratios of diacrylate to triacrylate (E:PETA) of 100:0, 95:5, or 90:0, 
while maintaining the overall molar ratio of acrylate end groups to amines constant.  
Higher E:PETA ratios (e.g., 85:15 or 80:20) led to crosslinking during synthesis and 
could not be examined, as opposed to the tested macromers which were viscous liquids.  
Incorporation of PETA into the macromer was confirmed by NMR spectroscopy through 
the disappearance of the acrylate peak specific to the PETA monomer at 5.9 ppm (Figure 
6.2). 
 
 
Figure 6.1 Schematic of monomers used in macromer synthesis.  Schematic of 
monomers used in macromer synthesis which is then photopolymerized and degraded in 
water or base.  The kinetic chains are the carbon chains with carboxyl side groups.   
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 Figure 6.2. 1H-NMR spectra of the E, PETA, and 1 reaction. (A) 1H-NMR spectra of E 
and PETA acrylate groups.  (B) 1H-NMR spectra of acrylate end groups mixture of E, 
PETA, and 1 before and after synthesis, demonstrating the incorporation of PETA into 
the macromer structure by the disappearance of the peak at 5.9 ppm (indicated by arrow). 
 
Polymer branch content can be determined using various techniques such as gel 
permeation chromatography (GPC), NMR, rheology, and small angle scattering [25].  
Based on the structures of the starting reagents, it is anticipated that the macromers will 
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contain short chain branches as opposed to long chain branches.  Long chain branches are 
defined as those, which have a molecular weight indistinguishable from the main chain.  
GPC and rheology are techniques that are useful for determining long chain branching as 
opposed to short chain branching [25].  Moreover, previous efforts to obtain GPC data for 
these macromers were unsuccessful due to their highly cationic nature [19].  Branching is 
quantified in rheology by using the Dow Rheology Index or the Long Chain Branching 
Index which are only applicable when a PDI of less than 2 exists.  Small angle scattering 
is also a technique that is more applicable for long chain branching.  High frequency 
(188.6 MHz) 13C NMR can be used to quantify short chain branching.  However, it is 
limited to high levels of short chain branching because it is very difficult to assign 
chemical shift values to side chains greater than six or more carbon atoms in length [25].  
Therefore, based on the chemical structures of the starting reagents, it is very difficult to 
quantify the branch content of this system via traditional techniques.   
 
6.3.2 Photopolymerization and degradation behavior 
The photopolymerization behavior of the macromers was monitored in real time 
using ATR-FTIR and the results are shown in Figure 6.3.  The rate of double bond 
conversion (Figure 6.3A) was slightly faster for the most branched system (90:10 
E:PETA) initially (α<0.05 at 2 minutes 50.7±2.0% vs 31.2±6.8% and 32.3±2.5%) and 
conversion plateaued for all samples at approximately 5 minutes.  However, there was no 
statistical difference between all macromer groups in ultimate double bond conversion 
after 10 minutes (Figure 6.3B).  Although the ultimate conversions are similar, the 
amount of unreacted macromer molecules may be higher for the less branched system, 
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since the probability is higher that a branched macromer with a greater number of 
functional groups is incorporated into the network.  This is apparent in our sol fraction 
calculations shown in Table 6.1.  The linear macromer (100:0 E:PETA) had almost twice 
the sol fraction that our most branched system (90:10 E:PETA) had.   The release of 
unreacted macromer is very important in the application of these polymers to biological 
systems, where released molecules may be toxic to the surrounding cells and tissue.  
Thus, macromer branching may be useful in limiting this effect. 
 Figure 6.3 Macromer reaction behavior. Real time double bond conversion with 
ultraviolet light exposure for E:PETA ratios of 100:0, 95:5, and 90:10 (A) and maximum 
double bond conversion after 10 minutes (B).  There was no statistical difference in the 
maximum conversion with changes in macromer branching. 
 
The mass loss with degradation in PBS at 37°C showed similar profiles between 
the macromers (Figure 6.4A).  In all groups, there was an initial period of more rapid 
mass loss and then a slowing of the rate of mass loss with time.  In the initial 2 weeks 
there was greater mass loss in the network formed from the linear macromer (E:PETA 
100:0), possibly due to the greater amount of sol fraction that is present in that system.  
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After 10 weeks, networks formed from the E:PETA 90:10 macromers had the greatest 
mass loss (a<0.05), but the difference was still only ~5% between the different networks.   
 
 
Figure 6.4 Degradation characterization of polymers with triacrylate. (a) Degradation of 
networks (in PBS at 37°C) formed with various macromers at ratios of E:PETA of 100:0, 
95:5, and 90:10, and (b) molecular weights  ( nM  and wM ) of kinetic chains isolated 
from degraded networks formed from the same macromers. 
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During polymerization, nondegradable linear kinetic chains (Figure 6.1) form 
from the free-radical polymerization of the acrylate groups.  These kinetic chains are a 
degradation product and the molecular weight of these chains can give some insight into 
the network formation and structure [20].  When isolated and analyzed (Figure 6.4b), a 
trend of an increase in molecular weight (both nM  and wM ) with an increase in 
branching was observed; however, there was no statistically significant differences 
between groups.   
 
6.3.3 Mechanical properties 
The mechanical properties of the networks were investigated in both tension and 
unconfined compression and the results initially as well as with degradation are found in 
Figure 6.5.   A statistically significant difference in moduli was found initially between 
all of the different macromers used and the 90:10 E:PETA macromer formed networks 
with a modulus almost double that formed from the 100:0 E:PETA macromer.  Similar 
trends were observed for the networks in both tension and compression.  The more 
complete crosslinking (lower sol fraction) and the greater chance of a macromer forming 
crosslinks between kinetic chains due to higher functionality likely contribute to this 
increase. 
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 Figure 6.5 Mechanical properties with changes in branching and degradation. Tensile 
(A) and compressive (B) moduli initially and with degradation for networks formed with 
various macromers at ratios of E:PETA of 100:0, 95:5, and 90:10. * denotes significance 
from other groups (0 weeks). 
 
With degradation, the mechanical properties decreased with time.  This is 
expected from bulk eroding networks and was observed regardless of the macromer 
branching.  However, the moduli of the higher branched networks actually decreased 
more quickly with degradation.  For instance, the moduli of networks formed from the 
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90:10 E:PETA macromer was actually the weakest at 8 weeks, potentially due to the 
greater mass loss at this point. 
The Tg was also measured using dynamic mechanical testing.  A representative 
plot of the temperature dependent mechanics is shown in Figure 6.6 and the data is listed 
in Table 6.1.  There was a trivial, but statistically significant change in Tg between 
networks formed from the 100:0 and 95:5 E:PETA macromers, and networks formed 
from the 90:10 E:PETA macromer had a more pronounced, higher Tg (α<0.05) than both 
of the other groups.  The crosslinking density (Table 6.1) is also significantly (α<0.05) 
larger as branching increases.  This reduces the amount of free volume as the chains are 
crosslinked together, preventing the microstructure from transitioning freely from the 
glassy to rubbery state and could explain variations in the Tg between groups.   
 
Table 6.1 Properties of networks formed of E, 1, and PETA with varying ratios of diacrylate and 
triacrylate.  
E:PETA Sol Fraction (%) Tg (°C) Storage Modulus 
(MPa) 
Crosslink Density 
(mol/m3) 
100:0 19.5 ± 1.1 -46.5 ± 1.0 2.30 ± 0.20 337.6 ± 28.7 
95:5 9.4 ± 0.4 -45.1 ± 0.3 2.99 ± 0.05 438.5 ± 7.1 
90:10 10.0 ± 1.2 -40.5 ± 0.4 3.92 ± 0.12 575.0 ± 18.0 
 
 Figure 6.6 Example plot of storage modulus (solid line) and tan δ (dashed line) for 
networks formed with E:PETA of 90:10. Tg is defined as the temperature at the peak of 
the tan δ curve. 
 
Others have reported the branching effects on the physical properties of polymers 
[26-28], yet not in the manner that is reported here.  For example, Tian et al. [28] melt 
grafted PETA and peroxide to linear polypropylene (PP) to form long chain branching 
PP.  They found that increased branching led to increased zero-shear viscosity and shear 
thinning at lower temperatures.  Additionally, the shear modulus (G′) and loss angle (tan 
δ) were increased and decreased, respectively, at lower temperatures with increased 
branching.  Previous work by Nivasu et al. [27], incorporated PETA as a monomer 
during network formation, but not into macromer synthesis as is shown here.  They found 
a reduction in polymerization efficiency, but did not investigate the influence of 
branching on mechanics and degradation.  A review by McKee et al. [29], discussed the 
effect of short chain branching on Tg, where short chain branching was found to lower Tg.  
These are somewhat different than our case because the end groups are not crosslinked, 
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so they are able to move.  From free volume theory, non-crosslinked branches have 
increased free volume due to these branches which decreases Tg.  In the case of 
crosslinked polymers, the free volume is reduced since the chains are actually bound 
together and not allowed to move independent of one another. 
 
6.3.4 Cellular interaction studies 
As an initial step towards investigation of branching influences on tissue 
engineering scaffolds, osteoblast-like cells (SaOS-2) were plated on thin films of 
networks formed from the various branched macromers and cultured for up to 1 week.  
Representative photomicrographs of the cells after 2 and 7 days are shown in Figure 6.7.  
While cells do adhere to the films in all cases, the attachment was much greater and the 
cells were more spread as the branching increased.  After one week, a clear difference 
can be seen in cellular morphology, where almost all of the cells on films formed from 
the 100:0 E:PETA are rounded, as opposed to many viable and spread cells are found on 
films formed from the 90:10 E:PETA macromers.  These observations are also inherent 
in the quantification of cell adhesion and spreading reported in Figure 6.8.  There is a 
statistical increase in adhesion (2 days) and proliferation (7 days) on networks formed 
from the branched macromers over the linear macromer at both time points, but none of 
the values reach that of control TCPS.  Again, the attachment and spreading are most 
similar to TCPS for that of the most branched macromer (90:10 E:PETA).  For spreading 
results, the percentage of cells that are less than 300 μm2 drops from 88% to virtually 
zero on films formed from the 100:0 to 90:10 E:PETA macromers.  There are still not as 
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many large cells (>1500 μm2) as there are on the controls, but the cell morphology is 
much more similar. 
 Figure 6.7 Osteoblast-like cells on control TCPS (A,B) and on films formed from 
macromers with E:PETA ratios of 100:0 (C,D), 95:5 (E,F), and 90:10 (G,H) after 2 days 
(A,C,E,G) and 1 week (B,D,F,H).  The scale bar represents 100μm. 
 141
 Figure 6.8 (a) Thousands of cells per cm2 after 1 week, † denotes significance from other 
groups, †† denotes significance from all other groups, * denotes significance to all other 
groups, and ** denotes significance from 100:0 at 7 days. (b) Histogram of cell areas 
(μm2) after 24 hours. 
 
These changes in cellular interactions with macromer branching may be attributed 
to a number of factors such as the presence of unreacted end groups (as demonstrated by 
FTIR conversion < 100%) and the mechanics of the polymer.  As shown here, the linear 
macromers led to networks with a greater amount of potentially unreacted molecules, 
which may be toxic to cells.  Additionally, others have reported the relationship between 
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substrate mechanical properties and cellular attachment and function [30-32], which may 
play a limited role.  Ultimately, these results illustrate the potential in using macromer 
branching to manipulate mechanical properties without altering other properties or 
unreacted end groups.  Mechanical properties can control cellular interactions, an 
important factor in the success of scaffolding in many tissue engineering approaches.  It 
should be noted that these networks were not chosen based on their superior interactions 
with cells, but because they are useful in illustrating these branching effects.  This 
approach will be useful for many polymers, and especially, for candidates from the 
PBAE library. 
 
6.3.5 Tissue engineering scaffolds 
As a final step towards illustration of the impact of macromer branching on the 
development of scaffolds for tissue regeneration, two different methods were investigated 
to develop interconnected, porous scaffolds.  These include both poragen leaching [23, 
33] and sintered-PMMA microbead [24] techniques that have been used successfully for 
scaffold fabrication from other polymers and are particularly appropriate for the 
formation of scaffolds from photoreactive macromers.  The polymerization around 
poragens allowed for simple control over the size of pores through the size of the salt 
crystals or microbeads and the interconnectivity was created by the packing of the salt-
macromer mixture or through the sintering of the beads. The porosity, pore size, and pore 
interconnectivity are important for the transport of nutrients and waste by diffusion, as 
well as the infiltration and growth of cells and vasculature [34-36].   
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The scaffolds created with the sintered microspheres are shown in Figure 6.9A.  
These scaffolds contain very regular, interconnected pores, created by the sintering of 
PMMA beads together, photocrosslinking of the macromer in the void space, and 
dissolution of the PMMA using a solvent.  The use of spheres may lead to a more regular 
structure than alternate poragens, and consequently, greater connectivity and mechanical 
properties [37].  When the scaffolds were tested in compression (Figure 6.9C), similar 
mechanical property trends were noted that were found with the slabs, with the 90:10 
samples significantly (α<0.05) greater than the 95:5 and 100:0.  Specifically, an increase 
in macromer branching led to scaffolds with greater moduli (though not significantly 
between 100:0 and 95:5), illustrating that the effects of macromer structure translate to 
scaffold properties.   
 
 Figure 6.9 Representative scaffolds fabricated with E:PETA of 95:5 for the sintering 
technique (a) and salt leaching techniques (c) and compressive moduli of scaffolds from 
the sintering (b) and salt leaching techniques (d) from various E:PETA ratios.  * denotes 
significance from the all other groups. 
 
As an alternate technique, a salt leaching process was also used to obtain porous 
scaffolds.  Figure 6.9B shows an example of the porous structure obtained with this 
technique, with most of the pores following the shape of the salt crystals and an 
interconnectivity in the structure.  Again, the compressive moduli (Figure 6.9D) follows 
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the same trend seen in the bulk polymer with an increase in moduli with increased 
branching.  The overall values are greatly reduced from the bulk polymer, but this is 
expected as there is only ~20% of the polymer remaining.  The samples made from the 
salts were considerably stronger than their PMMA microbead counterparts.  Observations 
of the SEM images indicate that the scaffolds formed from salt crystals are less 
interconnected and more polymer (and therefore lower porosity) than the sintered 
microsphere scaffolds.  There have been methods for more uniform interconnected pores 
[37] which may aid in strengthening the resulting material, but the microspheres here 
were randomly arranged. 
While the sintered microspheres lead to the desired scaffold microstructure and 
the material able to support cell growth in 2D culture, this is not possible as an injectable 
system.  The PMMA spheres must be formed into a rigid sintered structure prior to 
implantation and removed using toxic solvents.  The use of salt leaching may not be 
optimal, but alternate poragens, such as cytocompatible sugar crystals, may be explored.  
Thus, the composite could be used to fill a tissue defect, polymerized in situ, and then the 
porogen would dissolve to leave an interconnected porous structure behind. 
 
6.4 Conclusions 
The enhanced branching of network precursors, through the introduction of 
reagents with higher functionality during macromer synthesis, allows for further diversity 
of properties from a library of PBAEs.  Increased macromer branching led to an increase 
in the initial polymerization rate, but little change in the ultimate double bond conversion 
and degradation behavior were.  However, macromer branching significantly (α<0.05) 
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decreased the network sol fraction and increased the mechanical properties of networks 
and adherence and spreading of osteoblast-like cells on polymer films.  Finally, the 
macromers were used to form interconnected porous scaffolds using poragen leaching 
techniques, and scaffold properties followed the same trends in mechanical properties 
that were found in the bulk polymers.  Ultimately, this work indicates that the 
introduction of branching during macromer synthesis can lead to variations in scaffold 
properties towards tissue engineering applications. 
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CHAPTER 7: Screening PBAE Library for Osteoconductive 
Materials 
(Adapted from: DM Brey, C Chung, KD Hankenson, JP Garino, JA 
Burdick. Identification of Osteoconductive and Biodegradable Polymers 
from a Combinatorial Polymer Library. J Biomed Mater Res A. 
2010;93A(2):807-816.) 
 
7.1 Introduction 
Traditional polymer development for tissue engineering applications has been a 
time consuming and tedious process, as polymer synthesis often requires multiple 
reactions and purification steps.  Fortunately, technology is continuously being developed 
to accelerate various steps in the tissue engineering process, including the high-
throughput screening of materials and small molecule mediators of cellular behavior, the 
use of microdevices to screen cellular microenvironments, the technology to rapidly 
assess material properties, and the use of combinatorial polymer syntheses [1].  In 
general, combinatorial synthesis is a method to produce large libraries of compounds and 
materials through simplified single-step reactions [2].  This approach has been used 
widely in the pharmaceutical industry to greatly expand the pool of drugs for 
investigation, and to help identify structure-property relationships of bioactive molecules 
[3]. 
More recently, combinatorial libraries are being utilized to develop materials for 
biomedical applications; including gene delivery vehicles [4, 5], substrates for the culture 
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of stem cells [6, 7], and potential biodegradable materials for tissue engineered scaffolds 
[8-12].  For scaffold development, combinatorial syntheses are used to produce libraries 
of materials that can be screened and developed for a specific application based on 
desired properties.  For example, Brocchini et al. developed a library of 112 polyarylates 
that exhibited a range of physical and cellular characteristics [9].  This library has been 
used to develop predictive computational models of chemical structures and physical 
properties [13], cell growth [14], and the adsorption of fibronectin [15].  These models 
were then utilized to virtually design a polymethacrylate combinatorial library that 
predicted cell attachment, cell growth, and fibrinogen adsorption [13].  Experimentally 
measured values showed agreement in many of the predicted properties, which opens the 
door for future, faster and cheaper biomaterial development procedures. 
Beyond distinct chemical libraries, gradients of materials may also be used to 
identify optimal formulations to meet a given set of criteria.  Using these approaches, 
both Meredith et al. and and Yang et al. were able to optimize the combination of 
poly(D,L-lactide) and poly(ε-caprolactone) [10] and tyrosine-derived polycarbonates 
[11], respectively, for desirable osteoblast interactions.  Additionally, combinatorial 
synthesis on the nanoliter scale can greatly accelerate material discovery.  For example, 
3456 different individual combinations and ratios of 24 polymers were mixed in nanoliter 
spots on an array in order to determine cell-material interactions [7]. 
An important step in this approach is the identification of effective criteria that 
permit material selection for specific applications.  For tissue engineering, these criteria 
may include properties such as: degradation rate, mechanics, cell attachment, 
cytotoxicity, and biocompatibility [16].  Degradation allows a material to be replaced 
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with cells and tissue over time, but is also important for the temporal mechanical 
properties and the release of degradation products.  Mechanical properties are important 
for the stability of a scaffold, but have also been implicated in the differentiation of cells 
(e.g., mesenchymal stem cells, MSCs).[17]  Additionally, mechanical mismatching can 
lead to issues such as stress shielding, which weakens the surrounding bone in 
orthopaedic applications [18].  Cell attachment is needed for matrix deposition by 
anchorage dependent cells and can be facilitated through protein adsorption, such as 
fibronectin, or through the incorporation of known cell binding peptides (i.e., RGD) [19].  
Biocompatibility means that the material does not incur any significant inflammatory or 
immune response when implanted into the body [20].  Also, it is desirable for a material 
to not just be isolated from the body through a foreign body response, but to also 
integrate with tissues [20].  ‘Bioactive’ materials can be designed to support certain 
tissues or even be used to help drive differentiation with the addition of functional groups 
[21]. 
We have recently developed a combinatorial library of acrylate-terminated 
poly(β-amino ester)s (PBAEs) that form networks with a wide range of mechanical 
properties (3-300 MPa) and degradation rates (<24 hours to >100 days) based on 
chemical variations [8].  The macromers are formed through simple addition reaction 
without the need for purification, and thus meet the criteria for combinatorial synthesis.  
Additionally, the size and branching of the macromers can be modified to introduce 
further material control for a desired application [22, 23].  These macromers can be 
crosslinked into networks using a radical polymerization (e.g., photopolymerization) to 
form scaffolds for biomedical applications, which introduces further spatial and temporal 
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control over the materials [24].  Also, they can be processed into scaffolds using basic 
templating/poragen techniques [23] or through electrospinning into fibrous structures 
[25]. 
The diversity of this PBAE library allows for exploration for a range of tissue 
engineering applications, and in this work, the library was screened to identify an 
osteoconductive material for use in mineralized tissue regeneration. The candidates were 
first assessed for material properties and in vitro cellular interactions and an optimal 
candidate was processed into 3-dimensional scaffolds and implanted into rat cranial 
defects assess the bone regeneration potential.  An osteoinductive factor was also 
introduced to further illustrate the potential of the scaffold for mineralized tissue growth.  
This work has identified a novel biomaterial with beneficial characteristics for promoting 
bone regeneration; but perhaps more importantly, it illustrates a process that can be used 
for developing tissue engineering scaffolds from combinatorial libraries of biodegradable 
polymers. 
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7.2 Materials and Methods 
7.2.1 PBAE synthesis 
PBAEs were synthesized as described previously [8].  Briefly, 10 combinations of 
diacrylates and primary amines (all reagents were purchased from Sigma, Scientific 
Polymer Products, or TCI America) were chosen from previous data [8] according to 
their degradation rate to meet design criteria and mixed together in a molar ratio of 1.2:1, 
respectively, overnight at 90°C.  The reaction scheme and monomers used are shown in 
Figure 7.1 and the sample notation is from the original study on the library development 
[8].  The macromers were characterized with proton nuclear magnetic resonance (1H 
NMR, Bruker DMX360, 360 MHz) and were determined to be ~2000 Da.  The 
photoinitiator 2,2-dimethoxy-2-phenyl acetophenone (DMPA, Sigma) was added to the 
liquid macromers at a final concentration of 0.5% (w/w).  The viscous macromer 
solutions were then polymerized with exposure to ultraviolet light (~10 mW/cm2, 365 
nm, 10 min, Blak-Ray B-100 AP). 
 
 Figure 7.1 Reaction scheme for the synthesis of photopolymerizable and degradable 
poly(β-amino ester)s (top) and amines (numbered monomers, determines R2) and 
diacrylates (lettered monomers, determines R1) used in the synthesis (bottom).  The 
molecule notation is from the original report of the combinatorial library.[8] 
 
7.2.2 In vitro characterization 
Bulk slabs were obtained by polymerizing the macromers between two glass 
slides with a 1 mm thick spacer and cutting samples to a desired size.  Mass loss was 
monitored by placing 8 x 12 mm samples into phosphate buffered saline (PBS) at a pH of 
7.4 on an orbital shaker at 37°C.  At desired time points, the samples were removed, 
lyophilized, and the final mass compared to the initial mass.  The mechanical properties 
of the materials were assessed by compression of 5 mm diameter disks with a dynamic 
mechanical analyzer (Q800 TA Instruments) at a strain rate of 10%/min with the modulus 
determined as the slope of the stress/strain curve at low strains (<20%).   
 158
 159
To form thin films, macromers were dissolved in ethanol at 1:2 
(macromer:EtOH), added to 24-well plates (30 µl), the ethanol was allowed to evaporate 
overnight, and the macromer was crosslinked with UV exposure in a nitrogen 
environment.  Human MSCs (Lonza) were seeded on the films at a density of 5000 
cells/cm2 and cultured for up to 7 days. MSCs were grown in growth media (αMEM, 
17% fetal bovine serum, 1% penicillin/streptomycin, 1% l-glutamine) or osteogenic 
media (growth media, 10mM β-glycerol phosphate, 25 μg/mL ascorbic acid-2-phosphate, 
10 nM dexamethasone).  Viability was measured using a metabolic activity assay 
(Alamar Blue, Invitrogen), by adding 50 μl of the reagent to each well, incubating for 4 
hours, and reading the fluorescence in a plate reader (Bio-Tek Synergy HT, excitation-
545nm, emission-590 nm).  Osteogenic differentiation and activity of the MSCs in 
osteogenic media was measured with an alkaline phosphatase fluorescent assay (APF, 
Sigma), as alkaline phosphatase is an early indicator of bone formation.   
Cells were then cultured on the best candidate material over 3 weeks to further 
characterize the osteoconductivity of the materials.  RNA was extracted at 7, 14, and 19 
days using TRIzol® (Invitrogen), and isolated according to manufacturer’s instructions. 
RNA concentration and quality were determined using an ND-1000 spectrometer 
(Nanodrop Technologies), and 1 ug of RNA was reverse transcribed into cDNA using 
reverse transcriptase (Superscript II, Invitrogen) and OligoDT (Invitrogen).  Relative 
gene expression was determined using an Applied Biosystems 7300 Real-Time 
Polymerase Chain Reaction system for osteocalcin and normalized to the housekeeping 
gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Table 7.1) followed by 
normalization to the cell pellet gene expression levels at day 0 using the ΔΔCT method.   
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Table 7.1 Quantitative PCR primers and probes. 
Gene Forward Primer Reverse Primer Probe 
GAPDH AGGGCTGCTTTTAACTCTGGTAAA 
GAATTTGCCATGGGT
GGAAT 
CCTCAACTACATGGTTT
AC 
Osteocalcin CTGGCCGCACTTTGCAT CTGCACCTTTGCTGGACTCT CACCTGCCTGGCCAGC 
 
 
7.2.3 In vivo characterization 
Sprague Dawley (250-275 g, Charles River) rats were used for the animal models.  
NIH guidelines for the care and use of laboratory animals (NIHPublication #85-23 Rev. 
1985) were observed.  Polymer disks (n=3, 8 mm diameter, 1 mm thick) were implanted 
subcutaneously into dorsal pockets in rats for 2, 4, and 8 weeks in order to monitor in 
vivo degradation and investigate the inflammatory response of the local tissue as in [26].  
Scaffolds were prepared using a bead sintering and extraction procedure as described 
previously [23]. Briefly, 200 μm diameter PMMA beads (Polysciences) were sintered 
overnight in an 8 mm x 1.5 mm teflon mold, the macromer/initiator was added to fill the 
void spaces, and the sample was photopolymerized with UV exposure between two glass 
slides. The PMMA beads were removed with serial washings in methylene chloride and 
then the methylene chloride was evaporated from scaffolds in a fume hood.  Scaffolds 
(n=3) were characterized with scanning electron microscopy (SEM, JEOL 7500 HR-
SEM) and were implanted subcutaneously to confirm tissue infiltration and tissue 
response. 
Scaffold composites (1.5 mm thick) were then made by adding a small amount of 
collagen (Inamed Biomaterials) either alone or loaded with 2 μg of rhBMP-2 (R&D 
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systems). The collagen solution (61 μl) was allowed to gel at 37°C for 1.5 hours and the 
scaffolds were frozen and lyophilized.  Scaffolds were then implanted either 
intramuscularly (6 mm diameter) or into a critical-sized cranial defect (8 mm diameter) in 
rats.  For the intramuscular implants, scaffolds were implanted bilaterally into the 
adductor thigh muscle for 4 weeks [27].  For cranial implants, an 8 mm defect was made 
using a hand trephine across the sagittal suture, and compression fit with the A6 scaffold.  
Four groups were investigated (n=5/group) consisting of empty defects, defects filled 
with porous scaffold alone, defects filled with porous scaffold containing a small amount 
of collagen gel, and defects filled with polymer scaffold containing a small amount of 
collagen gel loaded with BMP-2.  Calvaria were removed at 6 weeks and fixed in 4% 
formalin.   
High-resolution x-rays were obtained using a MX-20 Faxitron (Faxitron) at 15 s 
and 25 kV.  The radiopacity was measured as the percent intensity of the defect area over 
the intensity of intact bone and analyzed with ImageJ software.  Calvaria were then 
scanned using a VivaCT40 uCT scanner (Scanco) with X-ray acquisition settings set at 
55 kVp and 145 mA and an integration time of 200 ms. Scans were performed with an 
isotropic voxel size of 10.5 μm and images were reconstructed in 1,024 x 1,024 pixel 
matrices. A lower threshold of 743.4 mg/cm3 and an upper threshold of 2000 mg/cm3 
were determined by visual inspection to best distinguish between bone and non-bone 
material. Scanco computer software was used to calculate the bone volume and the 
connectivity index.  Samples were then decalcified in 10% EDTA for 3 weeks, 
dehydrated, and then mounted in paraffin wax for histology.  Samples were processed 
using standard techniques for hematoxylin and eosin staining. 
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7.2.4 Statistics 
Statistical analysis was performed using ANOVA with Tukey’s post-hoc among 
the groups with significance defined as p-value less than 0.05. All values are reported as 
the mean and the standard deviation of the mean. 
 
7.3 Results and Discussion 
7.3.1 Polymer development 
As technology to rapidly produce large numbers of materials (e.g., combinatorial 
libraries) is developed, it is important to understand the process to identify optimal 
materials for desired applications.  For this paper, a previously developed library of 
PBAEs was assessed to identify osteoconductive materials for use as scaffolding in 
mineralized tissue regeneration.  The PBAE macromers are synthesized by the conjugate 
addition of commercially available amines and diacrylates (Figure 7.1), without the 
production of byproducts that would need purification; thus, large numbers of molecules 
are rapidly produced.  The availability of vasculature and progenitor cells in bone [16] 
affords potential acellular approaches that rely on the recruitment of these localized 
resources to scaffolding that is conducive to cellular interactions and may also include 
inductive cues to stimulate osteogenesis.  This may be advantageous for many instances 
over cellular approaches that would be patient specific and require additional steps prior 
to implantation to isolate and culture cells.  Thus, our approach is to identify an 
osteoconductive material from the library with the appropriate physical properties and 
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cellular interactions and then to include osteoinductive molecules to further improve 
tissue regeneration. 
For tissue engineering, the scaffold supports cell attachment and acts as a 
template to control the geometry and extent of produced tissue.  Ideally, this material 
would degrade with time and be replaced with new tissue.  This can be a delicate balance 
as losing mass too quickly could prevent adequate cell adhesion and support, whereas too 
slowly could inhibit the normal growth and replacement of natural tissue [28].  With this 
in mind, the desired degradation behavior for this application was determined to be 
gradual mass loss and complete degradation within approximately 3-5 months.  This will 
hopefully allow for minimal toxicity from the degradation products and support during 
the approximate time for a fracture to heal and the bony callus to resorb [29, 30].  
From the original PBAE library of 120 polymers, 10 macromers (Figure 7.1: A6, 
A7, B1, B2, C11, C12, E1, E2, E9, and J6) were identified as forming polymer networks 
that meet this mass loss criteria.  The shapes of the degradation profiles (Figure 7.2A) 
ranged from fairly linear to a more rapid initial release followed by a slower plateau 
region.  Differences may be attributed to variability in the hydrophobicity of the 
polymers, which could affect the rate ofwater uptake, or the presence of a soluble fraction 
that may be released rapidly.  A slower initial degradation may also be preferable as it 
allows cells to populate scaffolds before the substrate begins to degrade. 
 
 Figure 7.2 Bulk polymer degradation (A) and compressive moduli (B) of 10 candidate 
polymers formed from PBAE macromers that met design criteria from the initial 
combinatorial polymer library.  The A6 group possessed a statistically higher (p<0.05) 
modulus than all other groups. 
 
The compressive moduli for slabs of these 10 polymer networks are shown in 
Figure 7.2B.  The variation of this subset of materials was all in the same order of 
magnitude (~0.5 to 4.0 MPa), in contrast to the entire library which ranged over 2 orders 
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of magnitude [8].  The mechanical properties are important to the cellular 
microenvironment, as previous studies have shown that stem cells grown on stiffer 
substrates differentiate towards an osteogenic pathway, while cells that are grown on very 
soft surfaces differentiate towards other lineages [17].  The low modulus of these 
materials with respect to bone, as with all synthetic polymer systems, will restrict utility 
to non-load bearing defects or use in conjunction with other fixation techniques.  The A6 
network had the highest moduli of the 10 polymers, at 3.8 ± 0.3 MPa; however, since all 
of these samples possessed moduli in the same magnitude, mechanics were not used to 
exclude any candidates from the group. 
Next, the ability of cells to adhere and remain viable on the surfaces of these 
materials was investigated by growing MSCs on thin films of polymers and measuring 
the cellular metabolic activity (with the Alamar Blue assay), as reported in Figure 7.3A.  
The media in the wells with C11 and C12 quickly changed to yellow, indicating an acidic 
environment in which the cells did not survive. Similarly, cells grown on A7 did not 
remain viable and the polymer E9 prematurely crosslinked.  Therefore, these four 
materials were removed from further testing.  Cellular mitochondrial activity increased 
for other groups (B1, B2, E2, J6), but decreased between the 4 and 7 day time points.  
However, the mitochondrial activity steadily increased for polymers E1 and A6 over the 
entire week of culture.  Variations in the mitochondrial activity between polymers may be 
attributed to a number of factors including changes in protein adsorption, which can 
affect initial adhesion events, or the toxicity of degradation products that are eluted at 
different times in culture.  However, the presence of cells at the 7 day time point and 
proliferation with culture has generally been a good indicator of non-toxicity in these 
environments. 
 
 
Figure 7.3 Mesenchymal stem cell viability (measured with Alamar Blue) (A) and 
alkaline phosphatase activity after 3 days (B) after seeding onto films of candidate 
polymers formed from PBAE macromers.  * indicates significant difference (p < 0.05) 
from all other groups except B2. 
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Alkaline phosphatase (ALP) activity of MSCs grown on polymer thin films after 
3 days in osteogenic media (Figure 7.3B) was used as one measure of the 
osteoconductivity of these polymers.  Although ALP activity was observed by cells on all 
of these polymers, the ALP activity of the cells grown on A6 was significantly greater 
than the activity of the cells on all other polymers except B2.  Comparing the A6 and B2 
polymers, the A6 supported a steady increase in cell viability throughout the 1 week 
period and was higher after 7 days.  B2 and A6 had relatively similar linear degradation 
profiles, but A6 had a modulus that was roughly double that of polymer B2.  With these 
factors in mind, A6 was selected for further analysis as an osteoconductive polymer from 
the library. 
Osteoconductivity was also assessed by measuring osteocalcin gene expression of 
MSCs cultured on films of A6.  The osteocalcin expression (Figure 7.4A) greatly 
increased from the initial level throughout the duration of the experiment, and was 
significantly greater than MSCs grown on control tissue culture polystyrene (TCPS) at 2 
and 3 weeks.  Osteocalcin is an important non-collagenous matrix protein specific to 
bone, and an increased expression of 17.4 ± 11.0 and 3.95 ± 1.17 fold at 2 and 3 weeks, 
respectively, should indicate increased mineralized tissue production.  The up-regulation 
in osteocalcin is supported by the increase in ALP expression found in the shorter term 
studies.   
 
 
 Figure 7.4 Osteocalcin gene expression in mesenchymal stem cells cultured up to 3 
weeks in osteogenic media on TCPS (white) or A6 thin films (black), normalized to the 
expression of the same gene in cells at time of seeding.  * indicates a significant 
difference (p < 0.05) between the two groups at that time point. 
 
7.3.2 Subcutaneous implantation 
A longer term degradation study showed that the A6 polymer was completely 
degraded after 17 weeks in PBS (Figure 7.5A), which fits our 3-5 month degradation 
criteria.  For comparison, bulk slabs of A6 were implanted subcutaneously in rats to 
measure their inflammatory response, as well as the in vivo degradation profile.  The 
degradation of these samples was similar to what was seen in vitro, especially at 2 and 8 
weeks (Figure 7.5A), with ~50% mass lost after 8 weeks.  Histology of the A6 implants 
after 4 and 8 weeks are shown in Figure 7.5B and C, respectively. The polymer elicited a 
mild inflammatory response in the first 2 weeks with some new blood vessel formation 
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and macrophage recruitment to the polymer-tissue interface. With time, the polymer was 
encapsulated with a thin fibrous tissue, and there is no evidence of inflammation or 
necrosis within the adjacent subcutaneous fibroadipose tissue, skin adnexal structures or 
deep skeletal muscle.  In general, these results indicate a mild inflammatory response, 
typical of commonly used biodegradable polymers.   
 
 
Figure 7.5 Mass loss profiles of bulk A6 slabs in vitro (solid line) or after subcutaneous 
implantation (dashed line) (A) and representative tissue response to the A6 slabs 4 (B) 
and 8 weeks (C) after subcutaneous implantation.  SEM of A6 porous scaffolds showing 
large, interconnected porosity (D) and representative tissue response to A6 porous 
scaffolds 4 weeks after subcutaneous implantation (E), illustrating complete fibrous 
tissue infiltration. P = Polymer. 
 
Towards utility in 3-dimensional tissue engineering, porous A6 scaffolds (Figure 
7.5D) were fabricated using a previously described poragen leaching technique [23].  
Scaffolds exhibited large pores (~200 µm) and pore interconnectivity, both of which are 
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important design parameters for musculoskeletal tissue scaffolds [16, 31].  When 
implanted subcutaneously, minimal inflammation was observed and tissue fully 
infiltrated the acellular scaffolds (Figure 7.5E).  Histological assessment revealed that 
this tissue was fibrous and vascularized and there was no indication of mineralized tissue 
production within the scaffold, which is not expected without incorporation of inductive 
cues. 
 
7.3.3 In vivo assessment 
An important component for many tissue engineering approaches is the 
incorporation of inductive factors, such as direct recombinant growth factor delivery or 
through gene therapy [32].  In many cases, scaffolds incorporating these inductive factors 
improve their ability to produce functional tissue.  In this work, we introduced a known, 
FDA-approved osteoinductive factor (BMP-2) [33, 34] into the porous scaffolds by 
loading the molecule within a very small amount of collagen.  The collagen solution is 
simply pipetted into the porous scaffold and gelled with elevated temperature.  The 
collagen is easily remodeled by cells and the BMP-2 is released through both diffusion 
and cell-mediated degradation.  This made it difficult to quantify the specific release 
profiles obtained with this technique. 
Two models were used for the evaluation of these BMP-2 loaded osteoconductive 
scaffolds.  First, the scaffolds were implanted into an intramuscular implant site, as 
described by Hartman et al [27], to assess their ability to form ectopic mineralized tissue.  
For this preliminary experiment, only two groups were tested, A6 scaffold with BMP-2 
loaded collagen and the A6 scaffold with collagen alone, implanted for 4 weeks.  The 
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radiographs in Figure 7.6A (no BMP-2) and Figure 7.6B (with BMP-2, looking from a 
side view) indicate that ectopic mineralized tissue is formed, but only in the scaffolds 
incorporating the osteoinductive factor.  Likewise, histology of these implants show no 
evidence of bone formation in the unloaded samples (Figure 7.6C), yet mineralized tissue 
is observed in the BMP-2 loaded scaffolds (Figure 7.6D).  3D reconstruction of the newly 
produced bone using µCT demonstrates extensive mineralization with a pattern that 
resembles the interconnected pores of the scaffold.   
 Figure 7.6 Radiographs (A, B), histology (C, D, mineralized tissue identified with 
arrows), and micro-CT (E) of A6 scaffolds 3 weeks after intramuscular implantation 
alone (A, C) or when loaded with BMP-2 (B, D, E).  Ectopic mineralized tissue 
formation was only evident in samples that contained BMP-2 and the tissue formed a 
porous structure that templated the implanted scaffolds. 
 
The scaffolds were further assessed in a critical-sized cranial defect (8 mm) model 
in rats that does not support extensive healing without intervention [35].  The defect is 
not load bearing, and is common to the intramembranous bone healing of fractures that 
 172
 173
are rigidly fixed [36, 37].  Four groups were assessed; the negative control of an empty 
defect, the A6 scaffold alone, the A6 scaffold plus collagen gel filling the pores, and the 
A6 scaffold plus collagen gel loaded with 2 µg of BMP-2.  Treatments of collagen gel 
alone were not assessed since it would involve significantly more collagen to fill the 
defect site than what is used as a BMP-2 carrier.  After 6 weeks, radiographs (Figure 
7.7A) indicate that only the samples loaded with BMP-2 had consistent bone growth 
throughout the scaffold, while the other groups showed minimal growth, mostly at the 
outer edges.  The radiopacity (Figure 7.7B) of samples with BMP-2 was significantly 
greater than the other 3 groups, and there were no significant differences between these 
other groups. 
  
Figure 7.7 Radiographs of rat calvaria 6 weeks after 8 mm defect creation and either left 
empty or filled with A6 scaffolds alone or loaded with collagen or collagen and BMP-2 
(A). The percent radiopacity of the defect/scaffold radiographs compared to intact bone 
(B). † indicates significant difference (p < 0.05) from all other groups. 
 
Similarly, µCT images (Figure 7.8A) show consistent bone growth in the samples 
with BMP-2.  Again, while there is some growth in the empty defects, the cross sections 
show that this is very thin and only at the edges.  The bone volume (Figure 7.8B) showed 
similar results to the radiographic data, with significantly greater bone volume in the 
BMP-2 containing samples at 16.4 ± 4.1 mm3 compared to other groups.  The 
connectivity index (Figure 7.8C), a measure of the interconnectivity of the bone, is 
significantly higher in the BMP-2 samples as well.  Finally, histological samples of A6 
scaffolds (Figure 7.9) reinforced the µCT data.  In the untreated defects group, there is 
some growth of bone, but the majority of the defect is filled with thin fibrous tissue.  In 
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the groups of scaffolds without growth factor (regardless of the presence of collagen), 
there is tissue infiltration throughout the scaffolds, but the only bone growth is observed 
at the edges of the scaffold.  In the BMP-2 scaffolds, there is bone formation within the 
scaffold consistently from the outer edge all the way through to the middle. 
 
 
Figure 7.8 3-dimensional reconstructions (A) and quantification of the bone volume (B) 
and connectivity index (C) from µCT analysis of the groups 6 weeks after implantation in 
the calvarial defects. † indicates significant difference (p < 0.05) from all other groups. 
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 Figure 7.9 Histological sections of calvarial defects 6 weeks after treatment (top: 5x, 
bottom: 20x). Only samples with BMP-2 show bone formation throughout the scaffold 
(labeled with arrows) and polymer scaffold remains at this time point (labeled by P). 
 
The samples with BMP-2 showed bone formation throughout the scaffold and the 
bone was connected throughout due to the interconnectivity of the pores created by the 
sintered microbeads.  At 6 weeks, the new bone is still interdispersed within the 
remaining A6 scaffold.  There is no evidence of cartilage, potentially since the bone is 
forming through intramembranous ossification or perhaps because of the later time points 
of harvest.  BMP-2 greatly enhanced new bone formation within the scaffold, and could 
have recruited progenitor cells in the area to differentiate along an osteogenic lineage to 
produce mineralized tissues. There was no significant difference in the amount of bone 
formed in any of the other groups, and the bone that was formed was largely restricted to 
the perimeter of the defect.  Thus, it is believed that while the porous scaffolds identified 
as being inductive supported tissue growth and did not possess a highly inflammatory 
response, they do not have any inherent osteoinductive capabilities. 
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The use of combinatorial libraries can greatly increase the pool of materials for 
use in biomedical applications.  In this case, a relatively small but diverse set of PBAEs 
was screened for use in mineralized tissue engineering, but this library could also be used 
in the development of materials for drug delivery, gene delivery [4], or other tissue 
engineering applications [25].  The tunability of the properties through control of 
macromer synthesis [22, 23] and the flexibility afforded to the processing of 
photopolymerizable materials reflect the advantages of this particular library. 
This screen was accomplished with a relatively straight-forward approach using 
traditional bulk measurements of degradation, mechanics, and cell viability.  The 
complexity of this system can be quickly increased by investigating copolymers of the 
library constituents or investigating gradients of monomers.  The use of techniques that 
more rapidly screen these parameters, including with microdevices, will be important in 
identifying materials for given applications in the future.   
 
7.4 Conclusions 
By screening a library of 120 photocrosslinked PBAEs against design parameters 
(bulk properties, cellular adhesion and toxicity) for an application of mineralized tissue 
engineering, an osteoconductive material was identified.  Cells cultured on this optimal 
material exhibited enhanced viability profiles and alkaline phosphatase activity compared 
to other polymers.  When implanted subcutaneously, the material elicited minimal 
inflammation, and porous scaffolds were fully infiltrated with tissue.  While this material 
has no inherent osteoinductive properties, it was loaded with a known osteoinductive 
factor, BMP-2, which led to bone formation ectopically in an intramuscular location and 
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within a critical-sized bone defect.  This work presents a process for identifying potential 
scaffolding material for tissue engineering applications using a combinatorial library of 
biodegradable macromers that can be crosslinked into networks.  
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CHAPTER 8: Evaluation of Bone Formation in a Rat Femur 
Window Defect using Scaffolds from the 
Combinatorial Library 
 
8.1 Introduction 
Bone is one of the most regenerative tissues in the body and is capable, unlike 
most tissues, of healing without the formation of scar tissue and into tissue that has many 
properties of healthy bone [1]. Due to this fact, bone tissue has long been a target for 
tissue engineering technology in applications to accelerate bone healing, induce 
mineralization of critically sized defects and non-unions, and for reconstructive surgery 
[2, 3]. Schemes for regenerating mineralized tissue for bone tissue engineering are often 
based on principles identified during normal bone formation and healing (e.g., scaffold 
structure and soluble factor delivery). During development and fracture healing, bone 
forms through either endochondral ossification (EO) or intramembranous ossification 
(IO) [1].  
IO occurs in bones such as the calvaria and clavicle, and is characterized by 
osteoblasts that directly form bone matrix [1, 4]. The growth occurs from the center and 
grows outward between the bone and the periosteum. Conversely, EO occurs in long 
bones, and is distinguished by the formation first of cartilage. This cartilage then 
becomes hypertrophic and mineralizes, which then is used as a template for osteoblasts as 
they infiltrate and form bone tissue. This process is typical of long bone formation 
embryologically, as well as at the growth plate of children as they grow. In the end, the 
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final product of either process is histologically similar mineralized tissue, even though 
they arrive by very different steps [1].  
Naturally, most fractures in bones heal through a combination of IO or EO. After 
a break, there is an inflammatory phase in which macrophages release several cytokines 
to recruit osteoprogenitor cells to localize, proliferate, and begin to differentiate [1, 4] and 
new vasculature begins to form. This stage is followed by the formation of a fibrous 
callus for stabilization and the formation of vasculature at the fracture site during the 
reparative phase. This callus hardens with time into a bony callus as mineralization 
produces woven bone. Finally, the remodeling phase replaces the woven bone with 
lamellar bone and the callus is resorbed [4, 5].  
The type of ossification that dominates a fracture depends on the fixation and 
movement at the fracture site [4-9]. In cases where the fracture is rigidly fixed, such as 
the use of plates and nails, IO is likely the main process of mineralization. The stable 
surroundings of the callus allow for the direct production of bone matrix since there is no 
strain on the newly formed structures [7]. In contrast, if fracture sites are allotted some 
movement, such as in casting, then the dominant form of bone formation is through EO. 
The cartilage forms a more flexible environment that is slowly strengthened as the matrix 
is calcified and osteoblasts then further remodel the bone and mineralize [8].  
In tissue engineering paradigms, there are several other factors that can drive bone 
regeneration, and these strategies can influence the type of ossification that occurs. In a 
study by Tortelli, et al [10], when porous ceramic scaffolds were seeded with MSCs an 
EO process took place; however, IO occurred when these same scaffolds were seeded 
with mature osteoblasts. In scaffolds that deliver BMPs and other growth factors, results 
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have been mixed. In cellular laden implants that released both BMP and VEGF, bone was 
formed via EO [9, 11, 12], while the release of BMP-2 from acellular therapies found 
evidence of both IO and EO [13, 14]. Similarly, pore geometry influenced the path of 
bone formation [9, 14], with larger, more interconnected pores, which allows for a better 
flow of nutrients that prefers direct bone formation. When the pores were smaller or the 
diffusion of nutrients was impeded, there was usually the formation of cartilage first. 
Several small animal models exist for evaluating bone regeneration paradigms. 
One common method is the use of a critical-sized cranial defect which creates a large 
defect in the calvaria of rats (8 mm) or mice (4-6 mm) [15-21] (as presented in Chapter 
7). Calvarial defects are convenient since they are not a load-bearing bone and therefore 
require no external fixation and there is a large surface area to assess. Some of the 
difficulties include the proximity to the brain that increases risks during surgery and there 
are conflicting reports of whether the mineralization is through EO [20] or IO [18, 20]. 
For surgeries using long bones, segmental defects are the most common [11, 22-24]. 
These models usually involve a critical-sized (>5 mm) section of long bone that is 
removed, usually the femur [11, 22, 24], although the model has been performed with the 
radius. The long bone model is associated with EO [11, 22, 24], but requires fixation, 
which adds to the complexity of the model. 
Previous studies by our lab (see Chapter 7) have involved a critical-sized cranial 
defect model to study bone regeneration with a poly(β-amino ester) scaffold [16] and IO 
appeared to be the process of bone formation. An alternate animal model was used in this 
study, namely a rat femur window model [25], to investigate bone healing in a long bone, 
which develops through EO. These bones are load-bearing, so for this study, rather than 
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remove an entire cylinder of the bone, a window was cut into the bone shaft, still 
allowing the remaining bone to function. Upon euthanasia of the animal, the femur was 
excised and imaged using contact radiographs and µCT, processed histologically, and 
tested mechanically.  
 
8.2 Materials and Methods 
8.2.1 Polymer synthesis and scaffold fabrication 
PBAEs were synthesized as described previously [26] (Figure 8.1A, see previous 
Chapters). To form the A6 macromer, isobutylamine (Sigma) and diethylene glycol 
diacrylate (Scientific Polymer Products) were mixed together in a molar ratio of 1.2:1, 
respectively, overnight at 90°C. The reaction scheme and monomers used are shown in 
Figure 8.1 and the sample notation is from the original study on the library development 
[26]. The macromers were characterized with proton nuclear magnetic resonance (1H 
NMR, Bruker DMX360, 360 MHz) and were determined to be ~2000 Da. The 
photoinitiator 2,2-dimethoxy-2-phenyl acetophenone (DMPA, Sigma) was added to the 
liquid macromers at a final concentration of 0.5% (w/w). The viscous macromer solutions 
were then used to fabricate macroporous scaffolds. 
 Figure 8.1 (A) A previously identified osteoconductive PBAE, A6, is used to make (B) 
porous scaffolds using a poragen leaching technique.  The scaffolds (C,D) produced this 
way are shown to be highly porous with a high amount of interconnectivity. 
 
Porous scaffolds were fabricated using previously developed techniques of 
sintered poly(methyl methacrylate) (PMMA) microbeads [27, 28] as shown in Figure 
8.1B. For spherical porosity, PMMA microbeads (200 μm, Polysciences) were packed 
into teflon molds, clamped between glass slides, and placed in an oven at 120°C for 22 
hours. The glassy top layer was then scraped away, and the voids between the sintered 
spheres were filled with macromer/DMPA solutions. The constructs were crosslinked 
with ultraviolet light exposure (~10 mW/cm2, 365 nm, 10 min, Blak-Ray B-100 AP) 
between glass slides, the PMMA was removed with several washes in methylene 
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chloride, and the methylene chloride was removed with several washes in water. Samples 
were then frozen and lyophilized before SEM analysis. These scaffolds were cut to defect 
size (6.5 mm x 1.2 mm x 1.5 mm) and a small amount (21 μL) of 3% collagen (Inamed 
Biomaterials) was added into the pores either alone or loaded with 500 ng of rhBMP-2 
(R&D systems). The collagen solution was allowed to gel at 37ºC for 1.5 h and the 
scaffolds were frozen and lyophilized for implantation. 
 
8.2.2 Femur window defect 
NIH guidelines for the care and use of laboratory animals (NIH Publication #85-
23 Rev. 1985) were observed. A bilateral surgical approach was made to the 
anterolateral, femoral diaphysis of Fisher 344 rats (Charles River Laboratories 
International, 325–400 g) [25]. A large, oblong unicortical window defect, measuring 1.2 
mm in width and 6.5 mm in length, was created in each femur using a 1.6 mm fissure 
burr (Small battery drive, Synthes) as shown in Figure 8.2. The defect was then left 
empty or filled with a porous A6 scaffold with or without BMP-2 by an interference fit. 
No external or internal limb fixation devices were used postoperatively and animals were 
allowed to function without restriction immediately following surgery. The operated 
femora were dissected at 3 (n = 5 femora/group) and 10 (n = 10 femora/group) weeks 
postoperatively. At 3 weeks, all samples were scanned for µCT, and 3 samples/group 
were fixed in formalin, decalcified in 10% EDTA, and processed for histology. For 
samples at 10 week, all samples were scanned for µCT, 3 samples/group were fixed in 
formalin, decalcified in 10% EDTA, and processed for histology. Meanwhile the 
remaining samples were not fixed and reserved for mechanical testing. 
  
Figure 8.2 View of unicortical femur window defect from (A) the side and (B) a cross-
section.  This defect requires no fixation and will normally heal on its own with time. 
 
8.2.3 Micro computed tomography 
For µCT scanning, all specimens were kept moist, wrapped in saline saturated 
gauze, and stored in air tight containers at -20°C until scanned. Cortical zones of the 
femora were scanned using a VivaCT40 µCT scanner (Scanco) with X-ray acquisition 
settings set at 55 kVp and 145 mA with an integration time of 200 ms. Scans were 
performed with an isotropic voxel size of 10.5 μm and images were reconstructed in 
1,024 x 1,024 pixel matrices. A lower threshold of 697.4 mg of HA/cm3 and an upper 
threshold of 2000 mg of HA/cm3 were determined by visual inspection to best distinguish 
between bone and non-bone material. Scanco software was used to calculate the average 
density of the new bone, the bone volume, and total volume of the defect. 
 
8.2.4 Mechanical testing 
After µCT scanning, all specimens were kept moist, wrapped in saline saturated 
gauze, and stored in air tight containers at -20°C until the day of testing. On the day of 
testing, femora were then mounted in a specially designed jig that ensured proper 
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alignment, leaving a 1.5 cm length of the diaphysis subject to mechanical testing. This jig 
was designed to convert translational displacement to angular displacement using an 
Instron hydraulic materials testing machine (model #1321). Each femur was tested in 
torsion at 239°/min until failure. Load-displacement curves were continuously recorded. 
Ultimate torque (N-m), stiffness (N-m/deg), and angle of deformation to failure (deg) 
were calculated. 
 
8.2.5 Histology 
Samples were then decalcified in 10% EDTA for 3 weeks, dehydrated, and then 
mounted in paraffin wax for histology. Samples were processed using standard 
techniques for hematoxylin and eosin staining. Images were acquired with an upright 
microscope (Olympus BX-51, with Olympus DP2-BSW software). 
 
8.2.6 Statistical analysis 
Statistical analysis was performed using ANOVA with Tukey’s post-hoc among 
the groups with significance defined as a confidence level of 0.05. All values are reported 
as the mean and the standard deviation of the mean. 
 
8.3 Results and Discussion 
8.3.1 Scaffold fabrication 
Scaffolds were produced using a poragen leaching method of sintered PMMA 
microspheres (Figure 8.1B). An advantage of using free radical polymerization is the 
control over the polymerization process for a range of scaffold fabrication processes. In 
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this case, a liquid monomer with photoinitiator was able to fill the void space of the 
sintered microspheres and was then crosslinked in a mold to create a negative of the 
PMMA structure. This technique allows for great control over the pore size by altering 
the size of the poragen. The sintering allows for the microspheres to fuse together and to 
form interconnected pores in the PBAE scaffolds (Figure 8.1C and D). The size and 
extent of the interconnectivity can be varied by altering the temperature or time of the 
sintering. Both pore size and connectivity are important to osteogenesis in vivo in 
allowing cells, nutrients, and capillaries to infiltrate the entire scaffold [14].  In this work, 
a uniform scaffold was used for all studies that had a pore size of 200 μm and was 
fabricated out of the A6 material that was deemed cytocompatible and osteoconductive 
(see Chapter 7). 
 
8.3.2 Three week femur window healing 
The femur window defect was created by drilling a unicortical hole through the 
femur of a rat.  Since an entire segment of bone was not removed, no external fixation 
was required.  However, the defect is not of a critical size so there is healing that occurs 
in the bone, even without treatment.  Yet, the goal was to illustrate the potential of the 
porous scaffolds to heal bone in an alternative model to the cranial defect. 
At 3 weeks, the rat femur defects were still visible by inspection during excision 
of the femur.  The samples were first scanned using μCT to inspect the formation of bone 
throughout the wound and scaffold.  Three dimensional renderings of the cortical femurs 
are shown in Figure 8.3A.  The healing in the Empty and A6 with BMP-2 groups appear 
to span the entire wound, with new bone formed that looks similar to trabecular bone and 
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is almost even with the surface of the original bone.  However, the A6 without BMP-2 
shows very little new bone growth within the defect.  The cross sections in the same 
figure show similar results with both the Empty and A6 with BMP-2 groups showing 
bone growth in the defect, but also some bone growth within the medullary canal, unlike 
the center of the no surgery control.  In the A6 without BMP-2 group, there is some bone 
growth around the defect, but there is limited mineralization at the defect site. 
 Figure 8.3 MicroCT data of implants 3 weeks post sugery.  (A) MicroCT created 3D 
images of femurs and cross-sections for each of the four groups tested , as well as (B) the 
average density of the new bone and (C) the ratio of bone volume to total volume of the 
defect region. (* denotes significant difference from A6 + Coll, ** denotes significance 
from all groups) 
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The average density of the tissue in the defect region is shown in Figure 8.3B.  
The density for the Empty and A6 with BMP-2 were similar and roughly 50% of the 
value for intact bone.  There was a significant difference between the Empty and A6 
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without BMP-2, but not between the A6 with and without BMP-2 groups.  This was the 
same for the percentage of bone volume over the total volume of the wound (Figure 
8.3C), and these results were similar to the average density results. 
The histology of the samples shows that in all surgical cases the bone that forms 
is accompanied by fibrous tissue growth as well (Figure 8.4).  The A6 without BMP-2 
groups shows some bone growth deep inside the scaffold, but at the surface, there is 
mostly fibrous tissue.  The Empty healing looks similar to the healing in the A6 with 
BMP-2 group with branched bone formation throughout the defect.  Both are also 
accompanied with bone growth within the medullary canal, and the bone growth for the 
A6 scaffold without BMP-2 appears to initiate at the center.  This could be due to the 
large number of stem cells that are present in the bone marrow that are recruited to 
differentiate by the cytokines that are released due to the formation of the injury and the 
BMP-2 released from the scaffold.  Presumably this bone will be resorbed as the wound 
heals and this bone is no longer carrying any load. 
 
 Figure 8.4 H & E staining of femurs 3 weeks after surgery at 4x (top row) and 20x 
(bottom row) for all four groups. 
 
8.3.3 Ten week femur window healing 
At 10 weeks, the defects in the Empty and A6 with BMP-2 groups were difficult 
to determine upon macroscopic inspection.  The µCT scans revealed that new bone had 
grown to the surface in these cases to where they were nearly flush with the surrounding 
uninjured bone (Figure 8.5A).  The A6 scaffold without BMP-2 demonstrated more bone 
growth than at 3 weeks, but the healing was clearly lagging to the other groups.  Cross 
sections of the µCT scans reveal that the growth within the medullary canal was now 
largely central to the wound area.  For the A6 scaffold without BMP-2, there may be 
some thickening of the uninjured cortical bone.  The average quantity (mg) of 
hydroxyapatite per cm3 (Figure 8.5B) for the Empty and A6 with BMP-2 cases were 
greater than 80% of intact bone (850.8 ± 50.7 and 800.7 ± 43.3, respectively), and both 
were significantly greater than the A6 without BMP-2 (636.9 ± 92.3).  The same results 
were observed in the bone volume to the total volume of the defect (Figure 8.5C). 
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Figure 8.5 µCT data of implants 10 weeks post-surgery.  (A) µCT created 3D images of 
femurs and cross-sections for each of the four groups tested , as well as (B) the average 
density of the new bone and (C) the ratio of bone volume to total volume of the defect 
region. (* denotes significant difference from A6 + Coll, ** denotes significance from all 
groups) 
 
The samples at 10 weeks were tested in torsion using a jig to convert axial 
displacement to rotational strain on the bone (Figure 8.6).  The apparent stiffness of the 
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bone shaft was calculated as the slope of the torque against the angle of deformation, and 
there was wide variability between the samples in this study (Figure 8.6A).  There was no 
apparent trend and no significant differences between the groups.  The angle turned by 
the bone at fracture also showed much variation, and again no significant differences 
between groups were observed (Figure 8.6B).  In this case, intact bone was anticipated to 
be significantly lower, due to the brittleness of the bone, while the window defect allow 
for more flexibility of the bone in torsion.  While the bone with no surgery was lower on 
average than all other groups, this difference was not significant.  The amount of healing 
at 10 weeks likely prevented this effect from being apparent.  Finally, the ultimate torque 
at failure was calculated, and this too showed no significant differences between the 
groups (Figure 8.6C).  The lack of difference was likely due to the sample to sample 
variability, as well as the extensive healing at 10 weeks that was already completed.  
Perhaps mechanics at earlier time points would demonstrate more separation between the 
groups. 
 Figure 8.6 Mechanical data on femurs tested in torsion 10 weeks after surgery, showing 
the (A) stiffness of the femurs, (B) the angle of the bending femur at fracture, and (C) the 
ultimate torque reached before failure. 
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The histology showed substantial bone growth at the defect for the Empty defect 
and the A6 with BMP-2, but the healing in the Empty defect is more continuous at this 
point like normal bone.  The A6 scaffold without BMP-2 has some bone growth, but the 
defect still has fibrous tissue at the outer edge.  The new bone formed in both A6 
scaffolds appears more like trabecular bone, likely due to the porous nature of the 
scaffold which was not completely degraded at this point.  Interestingly, there is 
substantial thickening of the cortical bone into the medullary, which is especially 
apparent in the Empty group.  This could be due to the new bone growth observed at 3 
weeks growing into the rest of the bone, which likely is also aided in carrying the extra 
load until the defect is healed.  This explains why bone volume, as calculated by µCT, 
did not show any significant difference between groups, even though there were 
differences in BV/TV and average density.  This thickening may also explain why there 
were not clear differences in mechanical properties of the different groups. 
 
 
Figure 8.7 H & E staining of femurs 10 weeks after surgery at 4x (top row) and 20x 
(bottom row) for all four groups. 
 200
 201
 
From the H&E staining, there is no clear evidence that the bone is being formed 
through EO.  Distinct shapes and forms of hypertrophic cartilage was not apparent in the 
histology of any of these groups.  The 10 week time point is likely too late to catch the 
EO phase if it occurs, but the 3 week results should be short enough to capture the 
intermediate chondrocyte phase [11-13].  The reasons could be due to the structure of the 
scaffolding used, as higher porosity and larger pores have been linked to direct bone 
formation [14].  Previous usage of this model investigated scaffolds that had large pores 
(200-300 µm), but very low porosity (21%) [25].  The lower porosity often leads to 
reduced flow of nutrients or formation of capillaries, which often helps trigger 
chondrocyte hypertrophy [14].   
The bone regeneration of the A6 scaffold with BMP-2 was better than the case of 
A6 scaffold alone, but there was no separation from the natural healing of the Empty 
defect.  In fact, at 10 weeks the bone in the Empty defect was more continuous like the 
non-surgical controls.  The bone formed in the A6 scaffolds looks to have formed in the 
original pores of the scaffold, and may actually be impeded from forming more 
continuous bone until the scaffold completely degrades. The presence of additional cells 
in the area does not accelerate degradation because it is hydrolytically degradable.  These 
results highlight the ability of 3-dimensional scaffolds to template bone tissue formation 
and limitations in the use of a non-critical sized defect model for comparisons.  
One of the original design criteria for the A6 material was for a material that 
degraded in 3-5 months to be used in a critical-sized cranial defect.  In a critical-sized 
situation, there is only fibrous healing of the defect, so a slower degrading scaffold can 
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both impede the infiltration of a fibrous scar as well as provide a stable platform for the 
proliferation of cells and production of mineralized matrix.  In this application, the A6 
scaffold load with BMP-2 demonstrated substantially improved bone formation over the 
other groups.  In this non-critical-sized defect, the body can naturally form the needed 
matrix, so perhaps the materials should be faster degrading, or able to be degraded by the 
cells as needed. A better test for this polymer may be a segmental defect which is 
decidedly more surgically complex as it requires fixation, but it has been linked to the 
EO.  This particular model would likely be better to test at shorter time periods to 
investigate methods for rapid healing improvements. 
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8.4 Conclusions 
Highly porous scaffolds were produced via a poragen leaching technique for use 
in a rat femur window defect.  Three tested groups of empty defects, A6 scaffolds 
without BMP-2, and A6 scaffolds with BMP-2 were implanted in the window to 
investigate extent of bone regeneration, using histology, imaging techniques, and 
mechanical testing.  Throughout the study, the empty scaffolds performed better than the 
A6 scaffold without BMP-2, and were equivalent to the A6 scaffold with BMP-2.  Also, 
there was no significant improvement of mechanics between any of the groups.  For the 
case of a non-critical-sized defect, there is no evidence that this treatment improves bone 
regeneration compared to natural healing. 
 
 
 204
References: 
 
[1] Einhorn TA, O'Keefe RJ, Buckwalter JA. Orthopaedic Basic Science: 
Foundations of Clinical Practice. Third ed. Rosemont, IL: American Academy of 
Orthopaedic Surgeons, 2007. 
[2] Kneser U, Schaefer DJ, Munder B, Klemt C, Andree C, Stark GB. Tissue 
engineering of bone. Minimally Invasive Therapy & Allied Technologies 
2002;11(3):107-116. 
[3] Laurencin CT, Ambrosio AMA, Borden MD, Cooper JA. Tissue engineering: 
Orthopedic applications. Annual Review of Biomedical Engineering 1999;1:19-
46. 
[4] Lieberman JR, Friedlander GE. Bone regeneration and repair : biology and 
clinical applications. Totowa, N.J.: Humana Press, 2005. 
[5] Bucholz RW, Heckman JD, Court-Brown CM. Rockwood and Green’s fractures 
in adults. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2006. 
[6] Brighton CT, Hunt RM. Early histological and ultrastructural changes in 
medullary fracture callus. Journal of Bone and Joint Surgery 1991;73(6):832-847. 
[7] Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of 
bone healing. Injury-International Journal of the Care of the Injured 
2005;36(12):1392-1404. 
[8] Ferguson C, Alpern E, Miclau T, Helms JA. Does adult fracture repair 
recapitulate embryonic skeletal formation? Mechanisms of Development 
1999;87(1-2):57-66. 
 205
[9] Sundelacruz S, Kaplan DL. Stem cell- and scaffold-based tissue engineering 
approaches to osteochondral regenerative medicine. Seminars in Cell & 
Developmental Biology 2009;20(6):646-655. 
[10] Tortelli F, Tasso R, Loiacono F, Cancedda R. The development of tissue-
engineered bone of different origin through endochondral and intramembranous 
ossification following the implantation of mesenchymal stem cells and osteoblasts 
in a murine model. Biomaterials;31(2):242-249. 
[11] Kanczler JM, Ginty PJ, White L, Clarke NMP, Howdle SM, Shakesheff KM, et 
al. The effect of the delivery of vascular endothelial growth factor and bone 
morphogenic protein-2 to osteoprogenitor cell populations on bone formation. 
Biomaterials;31(6):1242-1250. 
[12] Li GH, Corsi-Payne K, Zheng B, Usas A, Peng HR, Huard J. The Dose of Growth 
Factors Influences the Synergistic Effect of Vascular Endothelial Growth Factor 
on Bone Morphogenetic Protein 4-Induced Ectopic Bone Formation. Tissue 
Engineering Part A 2009;15(8):2123-2133. 
[13] Hou LT, Liu CM, Liu BY, Chang PC, Chen MH, Ho MH, et al. Tissue 
engineering bone formation in novel recombinant human bone morphogenic 
protein 2-atelocollagen composite scaffolds. Journal of Periodontology 
2007;78(2):335-343. 
[14] Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and 
osteogenesis. Biomaterials 2005;26(27):5474-5491. 
 206
[15] Advani S, LaFrancis D, Bogdanovic E, Taxel P, Raisz LG, Kream BE. 
Dexamethasone suppresses in vivo levels of bone collagen synthesis in neonatal 
mice. Bone 1997;20(1):41-46. 
[16] Brey DM, Chung C, Hankenson KD, Garino JP, Burdick JA. Identification of 
osteoconductive and biodegradable polymers from a combinatorial polymer 
library. Journal of Biomedical Materials Research Part A 2010;93A(2):807-816. 
[17] Burdick JA, Anseth KS. Photoencapsulation of osteoblasts in injectable RGD-
modified PEG hydrogels for bone tissue engineering. Biomaterials 
2002;23(22):4315-4323. 
[18] Huang YC, Simmons C, Kaigler D, Rice KG, Mooney DJ. Bone regeneration in a 
rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for 
bone morphogenetic protein-4 (BMP-4). Gene Therapy 2005;12(5):418-426. 
[19] Meinel L, Fajardo R, Hofmann S, Langer R, Chen J, Snyder B, et al. Silk implants 
for the healing of critical size bone defects. Bone 2005;37(5):688-698. 
[20] Peng HR, Usas A, Olshanski A, Ho AM, Gearhart B, Cooper GM, et al. VEGF 
improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone 
healing through modulation of angiogenesis. Journal of Bone and Mineral 
Research 2005;20(11):2017-2027. 
[21] Winn SR, Schmitt JM, Buck D, Hu YH, Grainger D, Hollinger JO. Tissue-
engineered bone biomimetic to regenerate calvarial critical-sized defects in 
athymic rats. Journal of Biomedical Materials Research 1999;45(4):414-421. 
[22] Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The 
Healing of Segmental Bone Defects, Induced by Recombinant Human Bone 
 207
Morphogenetic Protein (Rhbmp-2) - a Radiographic, Histological, and 
Biomechanical Study in Rats. Journal of Bone and Joint Surgery-American 
Volume 1992;74A(5):659-670. 
[23] Geiger F, Bertram H, Berger I, Lorenz H, Wall O, Eckhardt C, et al. Vascular 
endothelial growth factor gene-activated matrix (VEGF(165)-GAM) enhances 
osteogenesis and angiogenesis in large segmental bone defects. Journal of Bone 
and Mineral Research 2005;20(11):2028-2035. 
[24] Fang JM, Zhu YY, Smiley E, Bonadio J, Rouleau JP, Goldstein SA, et al. 
Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. 
Proceedings of the National Academy of Sciences of the United States of America 
1996;93(12):5753-5758. 
[25] Livingston T, Ducheyne P, Garino J. In vivo evaluation of a bioactive scaffold for 
bone tissue engineering. Journal of Biomedical Materials Research 2002;62(1):1-
13. 
[26] Anderson DG, Tweedie CA, Hossain N, Navarro SM, Brey DM, Van Vliet KJ, et 
al. A combinatorial library of photocrosslinkable and degradable materials. 
Advanced Materials 2006;18(19):2614-2618. 
[27] Brey DM, Ifkovits JL, Mozia RI, Katz JS, Burdick JA. Controlling poly(beta-
amino ester) network properties through macromer branching. Acta Biomaterialia 
2008;4(2):207-217. 
[28] Bryant SJ, Cuy JL, Hauch KD, Ratner BD. Photo-patterning of porous hydrogels 
for tissue engineering. Biomaterials 2007;28(19):2978-2986. 
 208
CHAPTER 9: High-throughput Screening of a Small 
Molecule Library for Promoters and Inhibitors of 
Mesenchymal Stem Cell Osteogenic Differentiation 
 
9.1 Introduction 
As research has expanded toward the application of stem cells as a cell source for 
tissue regeneration and cell replacement therapies, the importance of driving 
differentiation and cell behavior in a controlled fashion has increased.  Human 
mesenchymal stem cells (hMSCs) are readily available adult stem cells that have been 
investigated extensively in recent years as an autologous cell source.  hMSCs have been 
shown to differentiate along chondrogenic [1-3], adipogenic [4, 5], osteogenic [4-10], and 
neuronal [11-13] lineages when provided the right chemical or physical cues.  Physical 
cues may include mechanical stiffness of the surrounding matrix [9], the presentation of 
functional groups in the encapsulating cell environment [4], or even the shape of the cell 
[14].  These are important signals that maybe incorporated into scaffold design for 
regenerative medicine to obtain specific differentiation paths by interacted on delivered 
cells. 
The assessment of the proper chemical cues has also been extensively 
investigated, and can be divided between the use of either growth factors or the use of 
small molecules.  Growth factors can naturally drive cell differentiation, such as during 
development and wound repair, through interactions with cell receptors and via cell 
signaling cascades.  For example, transforming growth factor beta (TGF-β) is crucial for 
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the chondrogenic differentiation of MSCs [1, 3], while combinations of basic fibroblast 
growth factor, epidermal growth factor, and platelet-derived growth factor may lead to 
neuronal differentiation [11].   
 Bone morphogenetic proteins (BMPs) have been important drivers of osteogenic 
differentiation [15, 16].  Of the many variations in the BMP family, the use of BMP-2, -4, 
and -7 have all been shown to stimulate osteoblast markers in osteoprogenitor cells [17-
20].  However, this effect appears mitigated when explored in human MSCs [16, 19, 21-
23].  Similarly, while BMPs have shown great bone growth in rat and rabbit models [7, 
15, 24-29], there has only been limited success in human clinical studies [30, 31], which 
often require large quantities of expensive proteins for even modest improvements.  
BMP-6 has also been shown to drive osteogenic differentiation of hMSCs [16, 22, 32] in 
vitro as well as in animal models, though these treatments have not progressed to any 
reported human clinical trials.   
These limitations have directed many researchers to the identification of small 
molecules as osteogenic promoters [6, 8, 33].  In particular, dexamethasone (Dex) is 
commonly used for in vitro cell studies.  Dex is a synthetic glucocorticoid, often used as 
an anti-inflammatory drug and in cancer treatments, but in 2D culture has acted as a 
potent osteopromoter.  Dex has been shown to induce osteogenic differentiation in MSCs, 
pericytes, bovine vascular smooth muscle cells, and mouse NIH3T3 fibroblasts [34].  
Several studies have shown optimal Dex concentrations to be between 10-100 nM [8, 35-
38] in the presence of 5-10 mM beta-glycerol phosphate (βGP) and ascorbic acid (or 
ascorbic acid-2-phosphate, AA2P).  Our lab has previously used a formulation of 10 nM 
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dexamethasone, 10 mM βGP, and 25 µg/mL AA2P to drive robust MSC osteogenic 
differentiation [7]. 
Unfortunately, these osteogenic effects studied in vitro have not translated into 
clinical practice.  First, while Dex, like many glucocorticoids, are potent anti-
inflammatories, prolonged treatment can actually lead to osteoporosis [39-42].  This is 
suspected to be due to the suppression of the proliferation of osteoblastic precursors, 
which allows osteoclasts to break down bone without subsequent replacement with new 
bone [42].  Next, intramuscular injections of Dex at the site of a spinal fusion actually 
inhibited bone graft incorporation [40].  Finally, while there has been some success with 
implanted Dex releasing, hMSC-seeded scaffolds [43, 44], this technique of delivery adds 
a level of clinical complexity, cost, and time that could be better avoided if native 
progenitor cells could be recruited and differentiated in situ.   
While tissue engineering investigates ways to stimulate tissue formation, there are 
some diseases where the prevention of differentiation and matrix may be desired.  In the 
case of bone, progenitor cells have been found to form heterotopic bone in models for 
fibrodysplasia ossificans progressiva (FOP) [45].  This disease is caused by a mutation to 
a BMP receptor, ACVR1, that causes connective tissues to spontaneously form bone 
[46].  Interestingly, Dex has also been implicated in stimulating osteogenic differentiation 
of pericytes that can lead to the formation of vascular calcification present in many 
cardiovascular diseases [34].  Therefore, new therapies to inhibit progenitor cells from 
differentiating into osteoblasts could be beneficial for common cardiovascular diseases, 
as well as rare skeletal disorders. 
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These limitations of Dex and the high cost and limited effectiveness of BMP 
therapy motivates the need for the identification of alternative factors that stimulate 
osteogenic differentiation, as well as the need that exists for molecules that may inhibit 
osteogenesis.  Little effort has been made to identify new soluble factors for their 
osteogenic potential in stem cells [6]; however, high-throughput screening (HTS) tools 
and techniques are being developed to explore large libraries of materials for a variety of 
applications [1, 33, 47-49].  Traditional techniques to identify molecules for stem cell 
differentiation have often relied on a small number of molecules and limited 
combinations of factors.  This is due to the time, cost, and complexity of these 
combinations and assessment of outcomes.  The advantages of HTS methods allows for 
more combinations to be assessed faster, and with fewer reagents, so that new 
compounds can be discovered and more complex delivery schemes can be tested.   
In this study, we developed techniques for the assessment of a library of soluble 
factors for promoters and inhibitors of the osteogenic differentiation of MSCs using HTS 
tools.  Hits were identified using statistical relationships to controls, as well as meeting 
criteria related to viability.  Towards our interests in tissue engineering, promoters were 
then screened further to confirm these effects using traditional cell culture techniques.  
The most promising of these factors were then tested in conjunction with a previously 
identified osteoconductive poly(β-amino ester), A6 (see Chapter 7), for potential future 
use in vivo [7].   
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9.2 Materials and Methods 
9.2.1 HTS assay development 
Human MSCs (Lonza) were cultured in growth media (αMEM, 17% fetal bovine 
serum, 1% penicillin/streptomycin, 1% l-glutamine) and plated onto 384 well, flat bottom 
plates (Corning) at passage 3 or 4 in 40 µl of media per well using a microplate dispenser 
(Matrix Wellmate, Thermo Scientific).  Plates were sealed with Breath-Easy gas 
permeable membranes (Research Products International Corp) to minimize evaporative 
losses.  The following day, media was changed to incomplete osteogenic media (OG-, 
growth media plus 10 mM β-glycerol phosphate and 25 µg/mL ascorbic acid-2-
phosphate) or complete osteogenic media (OG+, OG- plus 10 nM dexamethasone), 
depending on the goal of identifying either promoters or inhibitors.   
After 7 days of culture, 4 µl of Alamar Blue was added to each well and the 
fluorescence was measured (535 nm excitation/595 nm emission, EnVision, Perkin 
Elmer) after incubation for 15 and 30 minutes.  Cells were then washed with PBS, and 
lysed in the wells with 5 µl of CelLytic M (Sigma) at 37° C for 15 minutes.  Plates were 
cooled for 5 minutes on ice before the addition of 45 µl of the fluorescent ALP detection 
reagents (40 µl fluorescent buffer, 5 µl dilution buffer, 0.25 µl 4-Methylumbelliferyl 
phosphate disodium salt, APF, Sigma).  Plates were then read every 10 minutes for 1 
hour at 355 nm excitation/450 nm emission to determine ALP activity. 
Various aspects of this protocol were optimized prior to the library screening.  
These included the timing of media change (no change for the entire 7 days versus 
changing once after 4 days), the cell seeding density (24, 18, 12, and 6 thousand 
cells/cm2), and the concentration of DMSO (1.0%, 0.75%, 0.50%, 0.25%, 0.10%, and 0% 
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DMSO) used for addition of the small molecules.  Ultimate ALP activity, separation 
between ALP activity in cells grown in OG- media (negative controls) and OG+ media 
(positive controls) using Z-factor analysis [50] (see Statistics), and viability were used to 
identify the optimal conditions.   
 
9.2.2 NINDS library screen 
Once the HTS assay optimization was complete, the approach was used with the 
National Institute of Neurological Disorders and Stroke (NINDS) chemical library of 
1040 small molecules (provided and listed by Microsource Discovery Systems, Inc, 
www.msdiscovery.com/ninds.html).  The specific procedure used is shown in Figure 9.1.  
Cells were plated in each well at 12,000 cells/cm2 (~720 cells per well) in 40 µl of growth 
media.  The next day, the media was switched to OG- (for promoter studies) or OG+ (for 
inhibitor studies).  Soluble factors were diluted in DMSO and added using a robotic 
liquid handling system (Evolution P3 Pipetting Platform, PerkinElmer) for a final 
concentration of 10 µM and 0.1% DMSO.  In each plate the first and last two columns 
were reserved for positive (OG+ with 0.1% DMSO) and negative (OG- with 0.1% 
DMSO) controls.  At day 5 (4 days in differentiating media), the media and soluble 
factors were refreshed.  Finally, 7 days after soluble factors were added, cell viability and 
ALP activity were measured as described above. 
  
Figure 9.1 Flow chart for the HTS experiments. First, cells were plated in 384 well plates 
overnight to allow for attachment.  On the next day, the media was changed to OG- for 
promoter and OG+ for inhibitor experiments, and soluble factors were added at a 
concentration of 10 µM.  Four days later, the media was refreshed and factors were added 
again.  After 7 days the cell viability was assessed using Alamar Blue and then the cells 
were lysed to determine their ALP activity. 
 
Hits were determined only in plates with a Z-factor greater than 0.50 (see 
statistical analysis section below).  For promoters, hits were wells that had an ALP 
activity level greater than 3 times the coefficient of variation (CV) above the negative 
control and a cell viability greater than 75% of the negative controls.  For the inhibitors, 
hits were in wells that had an ALP activity level less the 3 times the CV below the 
 214
 215
positive control and a cell viability greater than 75% of the positive controls.  Promoters 
were then studied in a dose response experiment (3 to 100,000 nM) to confirm the 
osteogenic effects and determine the most potent hits. 
 
9.2.3 Traditional cell culture 
The most potent hits were studied further using traditional cell culture techniques.  
From the initial library, three factors were selected for further study: triamcinolone 
diacetate (TD), fludrocortisone acetate (FC), and Medrysone (Med).  For these studies, 
hMSCs were plated on 6, 12, or 24 well plates at 6000 cells/cm2 and cultured for up to 3 
weeks.  Cells were cultured in OG- (negative control), OG+ (positive controls), and 1, 10, 
and 100 nM concentrations of TD, FC, and Med.  Cells were lysed in 150 µl of CelLytic 
M at 37° C for 20 minutes at 3, 7, 11, 14, and 21 days, spun down at 12,000 G for 15 
minutes and the supernatant collected for analysis. 
Cell proliferation was measured using the Quant-iT™ PicoGreen dsDNA assay 
(Invitrogen) in a 384 well plate.  Samples were prepared by diluting 2 µl of cell lysate in 
23 µl of TE buffer and reacting with 25 µl of working solution (40 µl of PicoGreen 
reagent with 8 ml TE buffer) and read at 480 nm excitation and 520 nm emission.  The 
ALP activity was measured using the procedure as described previously with 5 µl of 
lysate.  On some plates, cells were fixed in formalin after 3 weeks and calcium deposits 
were stained with Alizarin Red [51].  RNA was extracted at 14 and 21 days using 
TRIzol® (Invitrogen).  Gene activation was measured using quantitative PCR for the 
osteogenic markers osteocalcin and CBFA1/Runx2 and normalized to the housekeeping 
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gene GAPDH (Table 9.1) followed by normalization to the cell pellet gene expression 
levels at day 0. 
 
Table 9.1 Quantitative PCR primers and probes. 
Gene Forward Primer Reverse Primer Probe 
GAPDH AGGGCTGCTTTTAACTCTGGTAAA 
GAATTTGCCATGGGTGGA
AT 
CCTCAACTACATGGTT
TAC 
Osteocalcin CTGGCCGCACTTTGCAT CTGCACCTTTGCTGGACTCT 
CACCTGCCTGGCCAG
C 
CBFA1/Runx2 TGGACCTCGGGAACCCA 
GCGGTCAGAGAACAAAC
TAGGTT 
AAGGCACAGACAGAA
GC 
 
 
9.2.4 Culture on osteoconductive polymer 
MSCs were also plated on thin films of the previously identified osteoconductive 
poly(β-amino ester), A6, synthesized by the reaction of isobutylamine and diethylene 
glycol diacrylate [7].  To form thin films, A6 macromer with photoinitiator 2,2-
dimethoxy-2-phenyl acetophenone (DMPA, 0.5% (w/w), Sigma) was dissolved in 
ethanol at 1:2 (macromer:EtOH), added to 24-well plates (30 µl) and 6-well plates (125 
µl), the ethanol was allowed to evaporate overnight, and the macromer was crosslinked 
with UV exposure in a nitrogen environment.  MSCs were seeded on the films at a 
density of 6000 cells/cm2 and cultured for up to 21 days.  Cell proliferation, ALP activity, 
mineralization staining, and RNA were all assessed as described above. 
 
9.2.5 Statistical analysis 
The quality of assay was determined using Z-Factor analysis [50] comparing the 
positive controls to the negative controls.  
 
np
npZ μμ
σσ
−
+∗−= 31  (9.1)
where σp and σn are the standard deviation of the positive and negative control values, 
respectively, and μp and μn are their means.  A score > 0.5 indicates an excellent assay 
which delineates possible hits from statistical noise on a given plate. The percent activity 
of a given well was determined as: 
 
100% ×−
−=
np
nxActivity μμ
μ  (9.2)
where x was the fluorescence reading of a given well. A ‘hit’ was determined as a factor 
whose percent activity was more than 3 times the (CV) above the negative control values 
for promoters and 3 times the CV below the positive control for inhibitors.   
Statistical analysis for non-HTS studies were performed using ANOVA with Tukey’s 
post-hoc among the groups with significance defined as a p-value less than 0.05. All 
values are reported as the mean and the standard deviation of the mean. 
 
9.3 Results and Discussion 
9.3.1 HTS assay development 
The advantage of HTS is the ability to rapidly test many conditions while using 
fewer reagents on smaller platforms.  This requires the optimization of assays and culture 
techniques that may not parallel larger scale procedures.  For this study, the optimization 
of MSC culture conditions was completed to best demonstrate osteogenic differentiation, 
as shown in Figure 9.2.  In normal culture, cell media is change once every 2-4 days to 
remove waste and provide new nutrients, but in HTS, because of the scale, these changes 
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are not always necessary.  In this study, MSCs grown for 7 days in OG+ media with a 
media change at 4 days showed nearly a 3-fold increase in ALP expression than MSCs 
grown in OG+ media without refreshing the media (Figure 9.2A). 
 Figure 9.2 Assessment of conditions for optimal osteogenesis and viability of MSCs in 
384-well plates. (A) ALP levels of MSCs grown in OG+ media for 7 days with a media 
change at 4 days and without.  (B) Differences in ALP activity of the positive and 
negative controls for osteogenesis for various cell seeding densities, the Z-factor for each 
pairing is reported above each bar. (C) MSC sensitivity (reported as viability assessed 
with Alamar Blue) to DMSO since the small molecules are added in a DMSO solution. 
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Cell seeding density has been shown to be important in determining stem cell 
differentiation [5, 14], so cells were plated at 24, 18, 12, and 6 thousand cells/cm2 in OG- 
and OG+ media to determine the density for optimal distinction of osteogenic 
differentiation.  While there was several fold differences in ALP expression in all cases 
(Figure 9.2B), the lower variability of the cells seeded at 12000 cells/cm2 led to a Z-
factor of 0.72, while samples at a higher density failed to achieve a Z-factor score > 0.5.  
Finally, the soluble factors are dissolved in DMSO so the DMSO toxicity to MSCs was 
tested using a cell viability dose response study (Figure 9.2C).  The cells were still ~90% 
viable at 0.1% and 0.25%, but dropped below 75% as DMSO quantities increased.  To 
minimize cell death from DMSO, the final concentration of DMSO in all studies was 
0.10%. 
 
9.3.2 Identification of osteogenic promoters and inhibitors 
After the cell culture conditions were optimized for HTS, the screening of the 
NINDS library was performed to identify potential promoters and inhibitors of hMSC 
osteogenic differentiation, sample plots are shown in Figure 9.3.  From the screen of 
1040 compounds, 36 potential promoters and 20 potential inhibitors were identified, as 
shown in Table 9.2, which met the requisite requirements as a ‘hit’.  Many of the 
inhibitors that met the criteria for low ALP, did so only by killing the cells, illustrating 
the importance of assessing cell viability.  Many of the compounds stimulated cell 
viability greater than 100%, indicating potential proliferative changes due to the small 
molecules.
 Figure 9.3 Sample plots of plates for promoter (A, B) and inhibitor (C, D) experiments. 
‘Hits’ for promoters (gray) needed to have (A) ALP levels greater than 3 standard 
deviations above cells in OG- and (B) cell viability at least 75% of cells in OG-. ‘Hits’ 
for inhibitors (gray) needed to have (B) ALP levels less than 3 standard deviations below 
cells in OG+ and a (B) cell viability at least 75% of cells in OG+.  
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Table 9.2 Osteogenic promoters and inhibitors of hMSCs identified by the 
initial screen of the NINDS library. 
Promoters Inhibitors 
Fludrocortisone Acetate Griseofulvin 
Triamcinolone Diacetate Desoxycorticosterone Acetate 
Avobenzone Testosterone Propionate 
Tuaminoheptane Sulfate Testosterone 
Trimebutine Maleate Cyproterone Acetate 
Fuorometholone Ethacrynic Acid 
Dienestrol Hydroxyprogesterone Caproate 
Halcinonide Mechlorethamine 
Isopropamide Iodide Norethindrone 
Medrysone Norethynodrel 
Chloroguanide Hydrochloride Norgestrel 
Protoveratrine A Phentolamine Hydrochloride 
Zolpidem 7,4'-Dihydroxyflavone 
Ropinirole Isotrentinon 
Nateglinide Menadione 
Clopamide Anethole 
Minocycline Hydrochloride Tannic Acid 
Valacyclovir Hydrochloride Clorsulon 
Inositol Securinine 
Cholecalciferol Hydroxyprogesterone 
Nalbuphine Hydrochloride  
Olanzapine  
Aspirin  
Doxycycline Hydrochloride  
γ-Aminocutyric Acid  
Gentamicin Sulfate  
Medroxyprogesterone Acetate  
Furegrelate Sodium  
Antipyrine  
Acetanilide  
Ebselen  
Fenthion  
Cephalexin  
Tolazamide  
Aminohippuric Acid  
Spiperone  
 
The inhibitors display a wide range of molecules that include antifungals 
(griseofulvin), anticancer drugs (mechlorethamine, isotretinoin), and sex hormones.  
Interestingly, there are several progestins (hydroxyprogesterone, norgestrel, 
norethynodrel, norethindrone, cyproterone acetate) which act similarly as estrogens and 
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are often elevated during pregnancy.  There is some indication that FOP disease is 
inhibited during pregnancy [52, 53], and these hits may be an indicator of how that 
occurs.  Estrogen has been implicated as being beneficial to coronary heart disease 
(CHD) [54, 55] and inhibition of osteogenesis of pericytes could prevent vascular 
calcification [34], although recent concerns with CHD associated with hormone 
replacement therapy has further complicated this picture.  At the same time, testosterone 
is also a potential inhibitor, even though testosterone and estrogen have both been shown 
to help prevent osteoporosis [56-58]. 
The promoters of hMSC osteogenic differentiation were also a diverse collection 
of factors.  These included several glucocorticoids (hydrocortisone acetate, 
metamethasone, fluorometholone, halcinonide, medrysone) that could act along the same 
pathways as Dex.  While many of the hits for osteopromoters were statistically improved 
from negative controls, many did not necessarily show improvement from OG+ media.  
The top hits were then screened again using the HTS assay for a dose response study 
which confirmed which factors were potent even at low concentrations.   
 
9.3.3 Traditional cell culture 
The most potent hits from the dose response study were mainly glucocorticoids, 
similar to Dex, though with different levels of potency [59] for the glucocorticoid 
receptor (GCR).  Therefore, three compounds were chosen that had low GCR potency 
(Med), medium GCR potency (TD), and a potent mineralocorticoid (FC) to further 
investigate with traditional cell culture techniques.  These compounds were tested for up 
to 21 days at 1, 10 and 100 nM concentrations and compared to the OG+ media with the 
highly GCR potent 10 nM Dex.  The cell proliferation was very similar in all cases 
(Figure 9.4A), but in samples with less than 100 nM of drug, the cells eventually 
detached from the tissue culture polystyrene (TCPS) in a sheet.  This is common in MSCs 
grown in growth media if they are allowed to reach over confluency.  Interestingly, this 
does not occurs in cells in OG+ media, likely due to the mineralized matrix being 
produced that alters how the cells are attached.  Similarly, cells treated with 100 nM of 
the FC, TA, and Med all remained attached throughout the 3 week study.  The ALP 
activity (Figure 9.4B) showed a slight increase in all of the 100 nM samples at 14 days 
and ~25% increase at 21 days as compared to cells grown in OG+ media. 
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Figure 9.4 Temporal response of three of the top osteopromoters at various 
concentrations. The amount of (A) DNA and (B) ALP expression with exposure to 100, 
10, and 1 nM of medrysone (Med), fludrocortisone acetate (FC), and triamcinolone 
diacetate (TD) is shown over a period of 21 days. 
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RNA expression of osteoblast genes of interest provides additional (Figure 9.5).  
CBFA1 is a transcription factor that has been associated with osteoblast differentiation, 
and while these levels are slightly elevated from the starting levels in MSCs, there does 
not appear to be much variation between the different inducers.  While CBFA1 levels 
may be marginally increased, this assay does not investigate the activity post-translation, 
which is even more important in human cells [60].  Conversely, OC is a bone specific 
matrix protein, and the expression levels improve with time.  At 21 days, the OC 
expression in the 100 nM TD samples was ~2.5 fold better than OG+ levels, which could 
indicate increased matrix production. 
 
 Figure 9.5 RNA expression of osteogenic markers. Expression of (A) CBFA1 and (B) 
osteocalcin after culture in OG+ media and 100 nM of medrysone (Med), fludrocortisone 
acetate (FC), and triamcinolone diacetate (TD) for 14, 18, and 21 days. * denotes 
significance between indicated groups, ** denotes significance from all groups at that 
time point. 
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Alizarin Red staining for calcium deposits, a component of bone matrix, show 
that only the MSCs grown in FC media deposit comparable matrix to OG+ positive 
controls (Figure 9.6).  Very minimal staining was observed on the Med and TD samples, 
even though osteogenic genes were upregulated.  Once again, this difference could be 
due to a post-translational change in the cells that could further activate CBFA1.  While 
levels of CBFA1 may be equal, their activity could be hampered or enhanced 
accordingly.   
 
 
Figure 9.6 Alizarin Red staining of MSCs on TCPS. MSCs were grown for 21 days in 
OG-, OG+, and OG- media supplemented with 100 nM Med, FC, or TD and stained for 
calcium deposits, indicating mineralized matrix production. 
 
These results show that in various ways, these new factors show improvement in 
some of the general indicators of osteogenic differentiation and mineralized matrix 
production from Dex.  ALP expression is elevated 2 and 3 weeks for all 3 factors studied, 
with comparable cell survival and proliferation.  Osteocalcin expression was increased 
for TD samples at all time points when compared in all other groups.  Unfortunately, this 
 227
 228
did not translate to improvements to mineralized matrix production, as shown in the 
Alizarin Red staining.  Interestingly, the FC samples that showed the most staining for 
calcium deposits only had modest increases in CBFA1 and OC expression.  This could be 
due to the time points assessed for analysis. 
 
9.3.4 Osteopromoters on an osteoconductive polymer 
The identification of these factors is just the first step in their potential use in 
tissue regeneration.  Specifically, these drugs may be used in conjunction with an 
osteoconductive matrix to be released locally to recruit native progenitor cells and 
stimulate osteoblast differentiation.  To test the synergy between osteogenic soluble 
factors and an osteoconductive matrix, MSCs were cultured on thin films of a previously 
identified osteoconductive PBAE, A6, and grown in the OG- media plus the best case 
inducers (FC, TD, and Med at 100 nM). 
The cell proliferation was reduced on cells grown on the A6 compare to cells 
grown on TCPS, though there was steady growth on the films until 14 days, then there 
was some cell detachment in the OG-, Med, and TD samples (Figure 9.7).  The OG+ and 
FC cell numbers remained steady over the last week.  This stability was shown with a 
steady rise in the ALP expression in OG+ and FC throughout the experiment, while the 
other samples saw a decline with detachment.  The OG- ALP expression overlapped the 
OG+ expression up to 14 days, but this may be an artifact of the larger number of cells in 
the OG- samples.  Normalizing the ALP expression value to the DNA, there is a clear 
difference between the treated groups and the negative control (OG-).  The FC samples 
showed the largest normalized ALP values throughout the experiment. 
 Figure 9.7 Temporal response of three of the top osteopromoters. Promoter were exposed 
at 100 nM to MSCs cultured on the surface of an osteoconductive PBAE, A6, and 
investigated for (A) cell proliferation (B) ALP activity, and (C) ALP expression 
normalized to amount of DNA.   
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Figure 9.8 Alizarin Red staining of MSCs on A6 thin films. MSCs were grown for 21 
days in OG+ and OG- media supplemented with 100 nM FC or TD and stained for 
calcium deposits indicating mineralized matrix production.  The light orange coloring is 
Alizarin Red S absorbed into the polymer. 
 
Since the FC showed continued cell growth and the highest levels of ALP 
activity, the mineralization on this surface was assessed.  The cells were grown on thin 
films of A6 for 21 days and stained with Alizarin Red (Figure 9.8).  The staining showed 
the presence of many nodules on the FC treated cells, which was comparable to the 
staining observed on the Dex treated MSCs on A6.  FC was able to stimulate mineralized 
matrix on both TCPS and A6.  And unlike Dex, FC is potent mineralocorticoid, which 
may demonstrate another pathway to stimulate osteogenic differentiation of stem cells. 
 
9.4 Conclusions 
The use of HTS techniques has long been employed by the pharmaceutical 
industry to more rapidly discover drugs that could be relevant to a given disease, but this 
 230
 231
technology has only been minimally applied to tissue engineering.  For this study, an 
assay for the osteogenic differentiation of MSCs was developed to screen a library of 
small molecules for their potential as promoters and inhibitors of osteogenesis.  The 
osteopromoters from this library were further investigated using standard culture 
techniques to verify that these compounds drive cellular differentiation.  These hits 
showed some improvement in the expression of ALP, osteogenic gene expression, and 
matrix mineralization when compared to the standard Dex.  When FC was used in 
conjunction with the films of an osteoconductive polymer, mineralized matrix staining 
was observed.  This work illustrates the ability of using HTS to more rapidly investigate 
new compounds (or new applications of old compounds) for tissue engineering purposes. 
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CHAPTER 10: Summary and Future Directions 
 
10.1 Summary 
Tissue engineering paradigms involve the combination of cells, signaling factors, 
and scaffold materials in order to drive the replacement or repair of damaged tissues.  As 
discussed in Chapters 1 and 3, the development of these different components for tissue 
engineering has traditionally been a methodical and iterative process due to the 
complexity and cost of materials and factors involved.  The emergence of combinatorial 
chemistry and HTS techniques offers opportunities to more efficiently develop new tissue 
engineering systems.  To that end, the goal of this thesis was to use these tools to identify 
and develop materials from a combinatorial library of poly(β-amino ester)s (PBAEs) for 
application in tissue engineering, using bone tissue engineering as a representative 
example.  Additionally, HTS techniques were used to identify new promoters and 
inhibitors of osteogenesis, with the goal of using the osteopromoters with the PBAE to 
improve mineralized matrix production. 
The PBAE library of photocrosslinkable and biodegradable materials was 
introduced in Chapter 4.  This library of commercially available monomers is formed 
through an addition reaction of amines and diacrylates at ratios that led to acrylated 
terminated molecules.  These molecules could then be photopolymerized into dense 
networks and tested for physical properties.  The degradation of these materials varied 
greatly with chemistry, with some materials degrading completely within 24 hours while 
others barely degraded over a period of 3 months.  The degradation profiles also greatly 
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varied with chemistry, with some materials degrading rapidly at first then reaching a 
plateau and other demonstrating a more linear rate of degradation.  Ultimately, this 
approach led to a library of materials with great diversity in degradation and mechanics. 
In Chapters 5 and 6, specific examples of the library were chosen to further 
develop the library and demonstrate ways in which properties could be further tuned.  By 
varying the ratio of diacrylates to amines, the molecular weight of the monomers could 
be altered.  Higher ratios led to shorter macromers, and therefore more densely 
crosslinked networks with stronger material properties and slower degradation rates, 
whereas lower ratios led to higher molecular weights and opposite trends.  Similarly, the 
addition of a triacrylate increased the branching of the macromer and led to more densely 
crosslinked networks.  This technique was able to double the mechanical properties, 
which were largely decoupled from the degradation behavior.  For the first time, 
osteoblast model cells were cultured on thin films of PBAEs and were shown to attach 
and proliferate.  Poragen leaching techniques were also developed to produce highly 
porous structures that are useful as scaffolding for tissue engineering. 
The library was then screened in Chapter 7 to identify an osteoconductive 
material.  Screening parameters included the physical properties of the materials (i.e., 
degradation and mechanics), and in vitro MSC cell proliferation, ALP expression, and 
expression of osteogenic genes.  The optimial material was identified as A6, a 
combination of diethylene glycol diacrylate (A) and isobutylamine (6).  This material 
showed minimal inflammation when implanted subcutaneously into rats and tissue 
rapidly infiltrated into a porous scaffold; however, there was no evidence of bone 
formation in the pores, unless BMP-2 was introduced into the pores to induce 
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mineralization.  These scaffolds were also implanted intramuscularly and ectopic bone 
was observed in samples with BMP-2, but not in samples without BMP-2.  These same 
scaffolds were then used to fill a critical-sized cranial defect where, once again, new bone 
was formed throughout the scaffold that was loaded with BMP-2, but there was only 
minimal bone formation in the samples scaffold alone or empty defects.  This information 
leads to the conclusion that the A6 material has osteoconductive properties, but is only 
inductive with the use of additional osteoinductive signals. 
In Chapter 8, the same scaffolding system was used in a rat femur window defect 
to investigate healing in a long bone.  The window defect was not critical-sized as with 
the cranial defect, so this made it difficult to show much improvement in the healing in 
the treated cases versus the natural healing of the empty defect.  At 3 and 10 weeks, there 
was no difference in bone formation between the empty defects and the defects filled 
with A6 scaffold loaded with BMP-2.  However, defects with unloaded scaffolds 
produced significantly less bone than the empty defect alone, yet was able to template 
bone formation better.  This implicates that the scaffold may actually impede healing at 
this point if it degrades slower than the wound heals.  Interestingly, there were no 
significant differences between the mechanical properties of the tested groups.  There 
was also histological evidence that the bone matrix in the intact bone actually thickens 
and may compensate for the loss of material in the window defect. 
The use of BMP-2 has limitations due to the high cost of production, the 
limitations of human sources for clinical use, and limited potency in clinical trials in 
humans compared to studies in rats.  Therefore, new factors were explored using HTS 
techniques for their promotion and inhibitory effects on the osteogenesis of MSCs.  This 
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study identified 36 potential promoters and 20 potential inhibitors of MSCs from a library 
of 1040 soluble compounds.  Of those promoters, three of the most potent were tested 
using traditional cell culture techniques and several indicators of osteogenic 
differentiation were increased, including ALP and the gene expression of CBFA1 and 
OC.  However, staining for mineralization showed that only FC showed consistent 
formation of calcium deposits.  When used in conjunction with thin films of A6, calcium 
nodule formation was improved in the positive control and in FC supplemented media. 
These studies show a process for the characterization of a combinatorial library of 
materials, the screening of that library to identify a material for bone tissue scaffolding, 
and the identification of new factors to improve osteogenic differentiation of MSCs using 
HTS techniques.  The improvement and acceleration of these steps will be important in 
the future as more combinatorial libraries are formed as potential sources for scaffolding 
materials.  The use of HTS tools will be increasingly relied upon to rapidly process 
factors and materials to optimize parameters for tissue engineering. 
 
10.2 Limitations and Future Directions 
10.2.1 HTS of combinatorial library of materials 
While the procedures to characterize the PBAE library of materials utilized some 
techniques for rapid assessment, the methods for screening the materials for the 
identification of an osteoconductive matrix used standard, large scale (and slow) 
methods.  The library was screened using the degradation of bulk polymers to narrow the 
list of candidates, then cells were grown on thin films of PBAEs on standard 12- and 24-
 245
well plates to test cell viability and ALP activation.  It would be advantageous to use a 
system that could more rapidly assess the cellular interactions with the materials. 
To this end, some preliminary work was completed on fabricating microwells in 
glass slides that could similarly be lined with thin films of materials to study 2D cellular 
interactions.  While these studies were unsuccessful for issues including nonspecific cell 
attachment to the well material, the development of these methods would be 
advantageous in screening larger libraries or modifications to the libraries.  The PBAE 
library was shown to have a wide range of properties at one ratio of diacrylate to amine, 
and then we showed that these properties could be further tuned by adjusting some of the 
macromer characteristics.  Therefore the screening of materials by degradation could 
have cut off more potent candidates at different ratios.   
Being able to screen more materials on a smaller platform affords many more 
opportunities for discovery.  Materials do not have to be prescreened for arbitrary reasons 
or gradients of copolymers and other modifications can more extensively investigated.  
While these materials failed to demonstrate any osteoinductive properties, several 
investigators have shown how the addition of tethers, such as phosphates or RGD, can 
influence stem cell differentiation and attachment.  These modifications can be assessed 
in gradients or in parallel to other material changes to rapidly optimize conditions for a 
given application. 
This work would also require different assay techniques for determination of 
osteogenesis.  While many of these studies have used a biochemical assay of ALP, this 
would not be possible in a microwell array that shares common media.  Plus, while ALP 
is an indicator of osteogenic differentiation, it is certainly not exclusive as it is also 
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expressed in kidney and liver cells.  In our lab, we have tried inserting an OC reporter 
gene into cells so that they fluoresce when OC is expressed.  This would allow for a 
noninvasive/nondestructive technique to indicate osteogenesis.  Some of the limitations 
include that MSCs are very difficult to stably transfect, so there was much difficulty in 
successfully transfecting the cells.  Also, while OC is much more specific to bone tissue, 
it is also expressed fairly late in the process of osteogenesis.  This may require long 
incubation times that may lead to cells detaching or experiments that are no longer as 
rapid as desired. 
Obviously, this would also help screen the same library for other applications.  
The use in bone tissue engineering was just a sample application picked for these studies.  
The material could be used in other tissue engineering applications such as tendon by 
using electrospun fibers, or directed neuronal growth by using patterned substrates.  In 
each of these cases, the ideal material would likely need to be identified according to the 
parameters of the tissue, so this process would benefit from ways to more rapidly assess 
ideal candidates. 
 
10.2.2 In vivo evaluation 
For these studies, several rat animal models were used to evaluate 
biocompatibility and bone formation.  The subcutaneous model allows for the assessment 
of the body’s reaction to a foreign body, but there is not much assessment of the 
material’s osteogenic properties.  The use of the intramuscular implant to study ectopic 
bone formation was beneficial in showing that the scaffold alone would not drive 
osteogenesis and there was a need for an osteoinductive factor.  The critical-sized cranial 
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defect was excellent at showing the benefits of the copolymer with BMP-2 in driving 
bone formation throughout the defect and the limited healing that occurs otherwise.  
While the femur window defect results may indicate that the degradation is too slow for 
certain applications of the A6 scaffold, further work needs to be performed to assess this.   
To better show the difference between the healing of long bone and flat bone, it 
would likely have been better to use a segmental defect model instead of the window 
defect.  This method would increase the complexity of the system due to the need for 
fixation of the bone, but the critical-size defect would make improvements in healing 
more apparent.  The window defect heals rapidly on its own, so there was never a 
difference between natural healing and the A6 scaffold with BMP-2.  Also, the segmental 
defect has been consistently associated with endochondral ossification, so this would 
satisfy the desire to investigate the effect of the scaffold on both modes of bone 
formation. 
Methods for incorporating the identified osteopromoters into the scaffold for in 
vivo bone formation should also be explored.  Some of the hits were loaded into collagen 
gels in the A6 copolymers and implanted into rats intramuscularly for 4 weeks.  Unlike 
the samples implanted with BMP-2, there was no new bone formation.  It is unclear 
whether this is due to the lack of osteogenic effect in vivo of these factors or if the release 
of the drug was not sustained long enough for the desire effect.  The release of small 
molecules from collagen was likely very rapid, and this burst release was not enough to 
recruit cells and cause them to differentiate.  Either swelling the drug into the 
hydrophobic A6 scaffolds or somehow tethering them to the structure itself may help the 
release to be more sustained.   
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Finally, in many ways, it is difficult to determine how much the presence of the 
A6 scaffold was beneficial in the bone regeneration.  This could be related to unknowns 
in the design criteria used in the screening process.  Ideally, selection and analysis of 
other PBAEs could help illustrate the importance of the A6 scaffold to the formation of 
this bone tissue.  If there is equivalent bone growth in other cases, it calls into question 
whether the effects we see are specific to A6.   
 
10.2.3 Development of HTS inhibitors 
The osteopromoters found in the HTS study have a clear use in bone tissue 
regeneration and stem cell differentiation.  The use of inhibitors may be less apparent at 
first.  In the disease of fibrodysplasia ossificans progressiva (FOP) there is a genetic 
defect of a BMP receptor, ACVR-1, that causes connective tissue to spontaneously form 
bone.  This can often lead to disastrous consequences where joints fuse or bone processes 
are formed that have issues including the growth of the spine and rib cage.  Methods to 
prevent or ameliorate the amount of bone growth would be beneficial to these patients.   
Therefore, we have attempted to find an ideal model of FOP cells to screen for 
inhibitors of this effect using the HTS process we developed.  First, cell transfection 
using the mutated gene was attempted, but MSCs have largely been difficult to transfect.  
So after many failed attempts, a new cell line was explored.  Stem cells from human 
exfoliated deciduous teeth (SHED) are one of the few cells lines that can be collected 
from patients with FOP.  Normal extraction methods can lead to the formation of more 
spontaneous bone growth, so care is taken to avoid any invasive procedures.  The 
isolation of stem cells from ‘baby’ teeth offers a source that can be used to directly study 
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cells with the mutated gene. Unfortunately, testing of the HTS system with healthy 
SHEDs was not able to show the same specificity between osteogenic positive and 
negative controls so that it was not possible to statistically satisfy the Z-factor score 
needed to demonstrate hits from noise.  This could be due to the SHED cells being a 
more heterogeneous population of cells, and not enough were true stem cells, or that they 
were already predisposed to osteogenic differentiation, and populations were hard to 
distinguish.  Clearly, more work could be pursued in this area. 
 
10.3 Conclusions 
With more combinatorial libraries and more methods for modifying material or 
cell behavior being developed, methods for rapid optimization will be increasing 
important.  In this work, a new combinatorial library of PBAEs was characterized to 
assess how changes in chemistry, macromer length, and macromer branching affect 
degradation, mechanical properties, and cellular interactions.  Methods were then 
developed to screen this library to identify an osteoconductive material.  The best 
candidate, A6, was then shown in several animal models to support bone regeneration 
when used in conjunction with BMP-2.  Finally, HTS techniques were used to identify 
new promoters and inhibitors of osteogenesis in MSCs. Overall, this work represents a 
process in which libraries are screened for a given application, and as combinatorial 
chemistry continues to be developed, these methods will be crucial in rapidly optimizing 
materials and conditions for stem cell differentiation towards a range of applications. 
 
